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Abstract 
Preterm infants are at increased risk of cardiometabolic and neurodevelopmental 
disorders in later life. The typical postnatal growth pattern of failure to achieve the 
equivalent of a normal fetal growth rate, followed up by catch-up growth, altered 
adiposity and altered hypothalamic-pituitary-adrenal axis (HPA) activity may be 
predisposing factors. Potential mechanisms that may mediate such programmed 
effects include altered DNA methylation and faster telomere attrition.  
A prospective cohort of 46 very preterm (25+2 to 31+5 weeks’ gestation, mean 28.6) 
and 40 full term (38+3 to 42+2 weeks’ gestation, mean 40.2) infants was established 
to investigate potential mechanisms. Infants were studied at birth, term equivalent 
age, 3 months and 1 year corrected for prematurity. At all time points, linear growth 
and body composition (by densitometry) were measured and buccal (epithelial) cells 
was collected for measurement of DNA methylation (5mC) and relative telomere 
length.  
Compared with full term infants, preterm infants were lighter (p < 0.001) and had a 
smaller head circumference (p < 0.05) at all time-points and were shorter at term 
equivalent (p < 0.001) and 3 months corrected age (p = 0.002). Preterm infants also 
had greater percentage body fat at term equivalent age (mean difference = 5.5%, p < 
0.001), which normalised by 3 months corrected (mean difference = 0.9%, p = 0.4). 
Preterm infants had a blunted salivary cortisol response (mean difference 0.4 µg/dL, 
p = 0.02) to a stressor (physical examination) at 3 months compared to term infants 
at this age, suggesting altered activity of the HPA axis. 
5mC is fundamental in the control of expression of imprinted genes involved in fetal 
growth. Notably, a number of studies in humans exposed to an adverse environment 
in early life have demonstrated altered 5mC at the differentially methylated regions 
(DMRs) controlling the expression of the key fetal growth factor insulin like growth 
factor 2 (IGF2) and at the linked H19 imprinting control region (H19 ICR). At birth, 
preterm infants had a significant decrease in 5mC at DMR2 compared with term 
infants at birth (β = –11.5, p < 0.001) and compared with preterm infants at term 
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equivalent age (mean difference = -7.4, p = 0.01). By term equivalent age, preterm 
infants had decreased 5mC at both DMR2 (β = –2.8, p = 0.01) and the H19 ICR (β = 
–2.3, p = 0.048) compared with term infants at birth, although this difference 
disappeared at 1 year corrected. Although research has suggested that catch up 
growth may confer an unfavourable metabolic phenotype, poor initial weight gain 
can associate with worse cognitive outcome. A pathway was established for 
obtaining advanced magnetic resonance images of the preterm brain. 5mC at H19 
ICR and DMR2 in buccal DNA showed no association with measures of white matter 
microstructure or whole brain volumes.  
Term infants demonstrated telomere lengthening over the first year of life (mean 
difference = -0.3, p = 0.02). There was no significant change in telomere length over 
the first year of life in preterm infants (mean difference = 0.2, p = 0.34). However, as 
preterm infants at term equivalent age had longer telomeres compared to term infants 
at birth (β = 0.6, p < 0.001), ultimately there were no differences between the term 
and the preterm groups at 1 year corrected age (β = 0.3, p = 0.07). 
The DNA modification 5-hydroxymethylcytosine (5hmC) is a stable modification in 
its own right and is also thought to be an intermediate step in DNA demethylation. 
5hmC is abundant in the placenta but has not been studied in the context of fetal 
programming. Additionally, previous research using methods such as bisulphite 
conversion would not have discriminated between 5mC and 5hmC and therefore the 
role of 5mC may not have been accurately measured. To study the relationship 
between 5mC, 5hmC and fetal growth, gene expression of candidate imprinted and 
non-imprinted genes in full term placental samples from the Edinburgh Reproductive 
Tissue BioBank was analysed. 5mC and 5hmC within the IGF2/H19 and KvDMR 
(controlling CDKN1C) loci was estimated using chemical capture and 
immunoprecipitation techniques that discriminate between modifications. 
Relationships between the expression of IGF2 (r = 0.3, p = 0.02) and CDKN1C (r = 
-0.3, p = 0.01) and birth weight across the normal range were found and in keeping 
with the known action of these genes. 5mC at IGF2 DMR0 (β = 0.3, p = 0.02) and 
KvDMR (β = 0.3, p = 0.02) and 5hmC at H19 gene body (β = 0.2, p = 0.04) 
associated with birth weight.  
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Thus, DNA modifications at imprinted DMRs may modulate environmental 
influences on fetal growth across the normal range. DNA methylation at IGF2/H19 
can be influenced by early life events. It remains to be seen whether any changes are 
present later in childhood and whether they associate with risk factors for the 
metabolic syndrome.  
  
 
  iv 
Lay summary 
Babies born prematurely are at greater risk of developing health problems and 
learning difficulties in later life than their full-term counterparts. This is very similar 
to findings in babies born small for dates compared with babies who were 
appropriately grown at full-term. The relationship between adversity early in life 
(being born early or small) and later disease is known as 'early life programming'. 
This may be caused by the initial slow growth followed by faster growth that preterm 
babies display, and also abnormal actions of stress hormone. Additionally, it has 
been proposed that one of the ways the early life environment might alter the disease 
risk is by altering the way that genes work. Potential mechanisms include changes to 
the normal chemical ‘marks’ that exist on our genes (known as epigenetic 
modifications) or how quickly the ends of our chromosomes (known as telomeres) 
shorten with age. Both can affect how genes function. 
I studied 40 full-term and 46 preterm babies over their first year of life. The preterm 
babies remained, in general, smaller than the full-term babies, but by 1 year the 
differences were not as great. The preterm babies also had abnormal stress hormone 
levels in their saliva. The preterm babies showed differences in the epigenetic 
modifications and telomere length (taken from their saliva) soon after birth, but these 
differences had disappeared by 1 year of age. These epigenetic modifications did not 
show any relationship to measures of brain development taken by MRI scans.  
Abnormalities in the placenta may also predispose to early life programming. I 
studied well-known genes in the placenta that are responsible for growth in the 
womb. Important epigenetic modifications at two of these genes varied with the 
weight of the baby, which may affect how these key genes work. 
In summary, abnormal epigenetic modifications can be found in the placenta in 
babies born small and also in the saliva of babies born prematurely. We still need to 
see if these differences in epigenetic modifications early in life associate with health 
problems later in life.  
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Chapter 1: Introduction 
1.1 Early life programming 
There is substantial epidemiological evidence linking low birth weight to an 
increased risk of hypertension, type 2 diabetes mellitus, ischaemic heart disease, 
cerebrovascular accidents, obesity, cancer (Barker et al., 1989) (Barker et al., 1993) 
(Risnes et al., 2011) (Hales et al., 1991) (Oken & Gillman, 2003) (Lawlor et al., 
2005), and neuro-psychiatric conditions (Cannon et al., 2002). The ‘early life 
programming’ or ‘developmental origins of health and disease’ concept that ensued, 
proposed that subjects exposed to adverse conditions during critical ‘windows’ of 
development, which may manifest as low birth weight, results in permanent changes 
to organ structure and function that are compensatory responses to maximise 
survival. These adaptations can be disadvantageous if the prenatal ‘prediction’ of the 
child/adult environment is incorrect as the ensuing reality is over-abundance (Barker, 
1998) (Gillman, 2005). The typical example is of a fetus that was undernourished in 
utero assuming a ‘thrifty phenotype’, which is growth restriction but with relative 
brain sparing. The metabolic syndrome develops in later life following exposure to 
the effects of a plentiful extra-uterine environment (Hales & Barker, 2001). 
Similarly, it is feasible that preterm infants, whom are exposed to a suboptimal intra-
uterine environment and thereafter withstand physiological stress and undernutrition 
ex-utero during a phase equivalent to the third trimester of pregnancy, would be at 
risk of early life programming.  
The low birth weight individuals in historical epidemiological studies would have 
predominantly been full term infants born small for gestational age or growth 
restricted, however due to uncertainties regarding gestational age, would also have 
represented infants born preterm. Thus, the adverse outcomes reported in these 
studies may be associated either with fetal growth restriction or prematurity. 
Nevertheless, the relative contribution to the outcomes by preterm infants would 
have been small, given that few would have survived into adulthood to form the 
study cohorts. In contrast, the prognosis for very premature infants has improved 
dramatically due to advances in perinatal care in recent times and in resource rich 
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settings, survival to adulthood is routine. The incidence of preterm birth worldwide is 
increasing with an estimate of 11.1% of all births in 2010 (Blencowe et al., 2013), 
and the risk of silent complications of prematurity that this group carries forward is 
of growing concern. 
I will describe the key age related conditions and their risk factors associated with 
preterm birth and the theoretical underlying biological mechanisms. 
1.2 The burden of cardio-metabolic disease risk 
1.2.1 Hypertension 
There is now considerable evidence that prematurity is associated with raised blood 
pressure (BP) in young adulthood. Several studies have revealed that this relationship 
is independent of birth weight for gestation i.e. small for gestational age (SGA) and 
by extension, intra-uterine growth restriction (IUGR) (Irving et al., 2000) (Keijzer-
Veen et al., 2005) (Hovi et al., 2007) (Rotteveel et al., 2008).  
It is possible that in these studies, the sample sizes may have been too small to detect 
any additional risk IUGR may pose over and above prematurity. Indeed, the effect of 
IUGR as a risk factor was seen in a sample of 329 495 young men with gestational 
ages ranging from 24 to 43 weeks, but only amongst those born after 33 weeks 
gestation (Johansson et al., 2005). As late preterm births are more numerous than 
very preterm births, there is greater statistical power for an effect of growth 
restriction to be measured.. Whilst both earlier gestation and low birth weight are 
powerful predictors of morbidity and mortality, these two factors are not perfectly 
correlated owing to more variation in birth weight with increasing gestation. Within 
each interval of increasing gestational age, adverse outcomes increase exponentially 
as the birth weight percentile decreases (Kiely & Susser, 1992). Therefore the effect 
of fetal growth is more likely to be borne out amongst infants born close to or at full 
term and elements of the pathophysiology may differ from preterm infants. Also, 
prematurity may be a ‘double hit’ as preterm birth is often the consequence of a 
compromised pregnancy resulting in a degree of fetal growth restriction (Bukowski 
et al., 2001)  (Lackman et al., 2001). 
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Nevertheless, these earlier studies have utilised single time point measurements of 
BP. In the largest population based study to date of 636 000 young adults born 
preterm, anti-hypertensive prescription was used as a surrogate measure for 
hypertension and the finding was that the prevalence increased with decreasing 
gestational age starting at 37 weeks gestation (Crump et al., 2011). Population 
studies such as these have been able to demonstrate that a dosage effect might exist 
according to the degree of prematurity (Johansson et al., 2005) (Crump et al., 2011). 
Additionally, adults born preterm have higher BP from ambulatory measurements 
(Kistner et al., 2005) but also higher individual BP variability, an independent risk 
factor of cardiovascular disease (Sipola-Leppänen et al., 2015). 
A recent comprehensive systematic review and meta-analysis confirmed the 
estimation made in a previous review (de Jong et al., 2012) suggesting an increase of 
about 4 mmHg in systolic BP in preterm compared with term subjects and 
additionally that an increase in diastolic BP only occurs in women born preterm 
(Parkinson et al., 2013). This is significant when taking into account that lowering 
diastolic BP by as little as 2 mmHg can reduce overall morbidity: including the 
prevalence of hypertension by 17%, risk of coronary artery disease by 6% and risk of 
stroke and transient ischaemic attacks by 15% (Cook et al., 1995).  
A few studies, but not all (Bonamy et al., 2005) (Bonamy et al., 2007), have 
suggested that preterm birth results in abnormalities to the vascular tree in childhood, 
adolescence and young adulthood, as indicated by raised carotid intima-media 
thickness (an early sign of atheroma formation) (Hovi et al., 2011) (Finken, et al., 
2006) or impaired arterial elasticity (McEniery et al., 2011) (Rossi et al., 2011) or 
both (Lazdam et al., 2010), but sometimes only where there is also IUGR (Cheung et 
al., 2004) (Skilton et al., 2011). More recently, reduced capillary density was shown 
to contribute towards elevated BP (Lewandowski et al., 2015). These may mediate or 
even exacerbate the development of hypertension. Striking alterations in cardiac 
structure and function have been described by magnetic resonance imaging (MRI) in 
young adulthood, with increased left and right ventricular mass, but smaller right 
ventricle and impaired parameters of systolic and diastolic function. Systolic 
dysfunction of the right ventricle (which was worse than that of the left) and 
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increased left ventricular mass index are important predictors for cardiovascular 
morbidity and mortality. The severity of the changes was graded along with the 
degree of prematurity, again highlighting a dosage effect. These changes were 
independent of microvascular abnormalities and BP (Lewandowski et al., 2013a) 
(Lewandowski et al., 2013b) (Lewandowski et al., 2015). 
1.2.2 Insulin resistance/ type 2 diabetes 
Of the components of the metabolic syndrome, insulin resistance and associated 
hyperinsulinism has been recognised to be an early manifestation amongst 
individuals born SGA and is a precursor of type 2 diabetes (Reaven, 1993). A recent 
systematic review concluded that preterm birth is associated with insulin resistance 
throughout the life course, however individual studies have yielded conflicting 
evidence, particularly in adulthood, due to their heterogeneity (Tinnion et al., 2014). 
In childhood, prematurity associates with insulin resistance in children as young as 4 
years of age (Hofman et al., 2004) with up to 50% lower insulin sensitivity (Regan et 
al., 2006). Of note, the indices were of similar magnitude in children born SGA at 
term. Gestational age at birth associated inversely with elevated plasma insulin levels 
in a prospective study of 1358 subjects at birth and at a median age of 1.4 years, 
indicating that insulin resistance may be present from very early in life (Wang et al., 
2014). 
There were no significant differences in fasting glucose or insulin concentrations 
between adults (at a mean age of 19.6 years) born preterm and at term in a large 
systematic review and meta-analysis, although the authors comment that more robust 
assessments such as homeostasis model assessment (HOMA) are wanting (Parkinson 
et al., 2013). Hovi et al demonstrated that young adults born  very low birth weight 
(VLBW) had higher fasting insulin and, in response to an oral glucose tolerance test, 
higher 2 hour insulin, 2 hour glucose concentration and HOMA index versus controls 
(Hovi et al., 2007). Insulin resistance was also observed using the clamp design, 
considered the gold standard for measuring insulin sensitivity (Rotteveel et al., 
2008). No significant differences were observed between individuals born SGA or 
appropriate for gestational age (AGA) in all of these studies. However, this is in 
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contrast to some authors who argued that SGA was an independent determinant of 
insulin sensitivity and secretion (Bazaes et al., 2004) (Fewtrell et al., 2000). 
Two large retrospective cohort studies showed a relationship between prematurity 
and a medical diagnosis of type 2 diabetes mellitus (Lawlor et al., 2006) (Kaijser et 
al., 2009), however these are historical cohorts and most very preterm individuals 
surviving due to modern neonatal intensive care have yet to reach high-risk age. As 
with raised BP, small differences in glucose homeostasis detected in young 
adulthood could translate into clinical significance later in life and the degree of fat 
mass is a potent modifier of risk (Finken, et al., 2006) (Tinnion et al., 2014). 
1.2.3 Altered adiposity 
Several techniques have been used to quantify the adiposity of preterm infants at 
term corrected age, chiefly MRI, air displacement plethysmography and dual energy 
x-ray absorptiometry (DEXA). They individually yield mixed results as they all are 
indirect techniques and require prior assumptions (Ellis, 2007). However, a meta-
analysis concluded that preterm infants have a 3% greater percentage fat mass at 
term corrected age compared with full term infants and that this appears to be 
attributed to the reduced acquisition of lean tissue rather than excess fat mass 
(Johnson et al., 2012). This pattern, with decreased weight, relative greater adiposity, 
and most importantly, a deficit in lean tissue, echoes that which has been observed in 
full-term Indian babies (‘thin-fat’), where it has been associated with an increased 
risk of type 2 diabetes and relative adiposity in later life (Yajnik et al., 2003). 
Compared to SGA full term infants at birth, preterm infants who were SGA had 
greater percentage fat mass by term corrected age (Giannì et al., 2009) suggesting 
that prematurity may be a greater risk for altered adiposity. 
MRI allows not only quantification of total adiposity, but also detailed assessment of 
partitioning. Whilst preterm infants at term corrected age had no difference in total 
adiposity compared to term-born infants at birth, fat distribution may differ: for 
example one study showed that preterm infants have less subcutaneous fat and more 
intra-abdominal fat compared to term infants (Uthaya et al., 2005). The severity of 
illness was related to the volume of intra-abdominal fat, which led the authors to 
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speculate that the observed pattern of fat deposition may be due to the raised levels 
of endogenous cortisol that preterm infants are thought to have, similar to the 
pathogenesis of Cushing’s syndrome (Uthaya et al., 2005). Furthermore, preterm 
infants had raised intra-hepatocellular fat at term age, similar to that seen in adults 
with visceral adiposity (Thomas et al., 2008).  
Percentage body fat measurements by densitometry approximate those of term born 
babies by 3 to 4 months corrected age (Ramel et al., 2011), though during childhood, 
ex-preterm infants have a lower body mass index (BMI) than term born counterparts 
(Hack et al., 2003). However, the pattern of fat deposits favours the trunk relative to 
the extremities (Giannì et al., 2008). Thereafter, there may be a greater change in 
BMI z-score between childhood and adolescence such that the rate of obesity in ex-
preterm adolescents mirrors that of their term born counterparts (Hack et al., 2011). 
Although the BMI of ex-preterm individuals may remain equivalent to that of term 
born individuals in young adulthood (Parkinson et al., 2013), the aberrant 
distribution of adiposity and increased intra-hepatocellular fat noted at term corrected 
age may persist, along with an increase in total body fat (Thomas et al., 2011). These 
are recognised components of the metabolic syndrome and probably related to the 
rapid change in BMI between childhood and adolescence. There were similar 
findings of increased total body fat as measured by DEXA, which was inversely 
proportional to gestational age (Breukhoven et al., 2012). This finding, given that the 
cohort was relatively mature (average gestational age of 32 weeks) and infants with 
serious neonatal complications were excluded, is significant. Whether this altered 
body composition persists into mature adulthood remains to be seen.  
1.3 Potential mechanisms 
1.3.1  Catch-up growth 
Currently used preterm growth charts are based on cross-sectional data using birth 
weights of infants born preterm and term, so that preterm infants are expected to 
achieve the weight of a term newborn by their expected date of delivery. Further 
complicating the matter is that the birth weight of an average preterm infant reflects 
the end of a compromised pregnancy and may be less than that of a healthy fetus 
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(Bukowski et al., 2001) (Lackman et al., 2001). A recent UK population wide study 
has shown that, in reality, infants born <32 weeks gestation dropped two percentile 
channel widths to reach a steady state of growth between the 0.4th to 9th percentile 
during their hospital stay (Cole et al., 2014). This reflects the nutritional management 
and other aspects of intensive care practised in recent years, where difficulties with 
enteral and parenteral nutrition, increased metabolic demands and illness can lead to 
a slower rate of weight gain than in fetal life and a divergence away from the birth 
percentile. Because preterm infants do not mimic normal intra-uterine growth 
patterns during the equivalent period, they may resemble the thrifty phenotype of the 
growth restricted term newborn (Hales & Barker, 2001). Here, compensatory 
changes that occurred in ‘fetal’ life (during hospitalisation) that would be predicted 
to enable survival are mismatched with the postnatal environment (post-discharge) of 
nutritional abundance.  
This period of slower growth restriction sets the scene for what is described as catch-
up growth (Karlberg & Albertsson-Wikland, 1995). There is evidence that catch-up 
growth confers additional risk for the metabolic syndrome or may be an independent 
risk factor. A systematic review of 80 studies from 1996 to 2000 reported that both 
birth weight and head circumference at birth were inversely related to systolic blood 
pressure and also, that accelerated postnatal growth was associated with raised blood 
pressure (Huxley et al., 2000). Low birth weight, thinness in infancy and an upward 
trajectory in BMI in childhood associated with insulin resistance and coronary events 
(Barker et al., 2005). Similarly, in a study of Indian children: gain in BMI in 
childhood without becoming overweight led to impaired glucose tolerance, diabetes 
and obesity in adulthood (Bhargava et al., 2004). The accretion of fat mass, being a 
major determinant of insulin sensitivity, may explain this association (Hyppönen et 
al., 2003). As in growth restricted term infants, preterm infants have demonstrated 
catch-up growth during infancy, childhood and adolescence (Hack et al., 2003). 
Specifically, increased height and weight gain in childhood have been linked with 
insulin sensitivity and blood pressure (Fewtrell et al., 2000) (Rotteveel et al., 2008) 
and increase in BMI and fat distribution (Euser et al., 2005). 
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Follow on studies of early randomised controlled trials (RCTs) of nutritional 
interventions in neonatal care suggested that lower nutrient intake and slower initial 
growth was associated with a reduced risk of insulin resistance (Singhal et al., 2003) 
and that the use of donor breast milk, as opposed to preterm formula, associated with 
lower blood pressure in adolescence (Singhal et al., 2001). Therefore the authors 
proposed that the causative factor in metabolic programming was the phenomenon of 
postnatal growth acceleration in both growth restricted term infants and preterm 
infants, independent of birth weight or gestation (Singhal & Lucas, 2004). Further 
studies showing that infants fed a nutrient enriched formula promoting weight gain 
had higher blood pressure than infants fed standard formula supported this argument 
(Singhal et al., 2007). Additional arguments against promoting rapid weight gain 
have come from animal studies of low or normal birth weight where dietary 
interventions to slow postnatal growth increase longevity and protect against the 
risks posed by a high carbohydrate, high fat diet in later life (Ozanne & Hales, 2004) 
(Jimenez-Chillaron et al., 2006).  
However, in preterm infants, any potential benefits of slow postnatal growth must be 
weighed against the deleterious effects of undernutrition on the developing brain. 
These appear to be competing outcomes with a complex trade-off to be made 
between avoiding adverse metabolic outcomes, through slower weight gain, and 
optimising brain development, by increasing weight gain. Indeed, faster weight gain 
in infancy associated with better neurodevelopmental outcome in childhood and with 
an increase in blood pressure, albeit modest (Belfort et al., 2010). Preterm infants 
with faster weight gain in hospital and in the first 2 years show better 
neurodevelopmental outcomes at 2 years (Ehrenkranz, 2006) (Latal-Hajnal et al., 
2003). Growth rate is related to nutritional intake (Ehrenkranz et al., 2011). Higher 
protein and energy intake in the first week after birth associated with better 
developmental outcomes at 18 months (Stephens et al., 2009). These are nevertheless 
observational studies and illness severity associates with reduced growth and poorer 
outcomes. In post hoc mediation analyses of prospectively collected data following a 
glutamine supplementation trial, total (parenteral and enteral) energy intake in the 
first week was a significant mediator of the relationship between illness severity and 
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later growth and adverse outcomes (Ehrenkranz et al., 2001). Further post hoc studies 
in babies who had taken part in those early RCTs of nutritional intervention showed 
that nutrient enriched formula intake associated with larger caudate volumes and 
better cognition in adolescence (Isaacs et al., 2008). Besides the early trials showing 
that standard infant formula led to worse cognitive scores in childhood when 
compared with nutrient enriched preterm formula (Lucas et al., 1998), there is little 
experimental data showing that nutritional regimens aiming to achieve more rapid 
growth lead to improved neurodevelopmental outcome. In a contemporaneous RCT, 
higher parenteral nutritional intake (protein and total calorie) in very preterm infants 
benefited head growth as measured by occipito-frontal circumference (OFC) as the 
primary outcome and data on neurodevelopmental outcome is awaited (Morgan et 
al., 2014). 
Whilst acknowledging that studies on the effects of breast milk are confounded by 
factors that affect the mother’s choice to breastfeed or not, such as maternal 
education and socio-economic status, several lines of evidence indicate that 
neurocognitive outcomes are better in term and preterm breast milk fed infants (Vohr 
et al., 2006) despite slower growth (Dewey, 1998). Breast milk intake in hospital 
favoured tests of intelligence quotient (IQ), brain volume and white matter 
development in childhood in a dose-response manner (Isaacs et al., 2010). Also, the 
extent of breast milk exposure predicted the degree of head growth in the neonatal 
period despite a decrease in standard deviation scores for weight (Cockerill et al., 
2006). More recently, studies in two independent cohorts of very preterm infants 
suggested that breast feeding at the time of discharge home is associated with better 
neurodevelopment despite poorer weight gain in hospital (Roze et al., 2012).  
In summary, it is not known which growth pattern in the neonatal period is ideal for 
very preterm infants in the long-term with respect to both metabolic health and intact 
neurodevelopment. That the rate of growth should approximate that of the healthy 
fetus is unproven and, based on studies above, may be unfavourable. Furthermore, 
weight gain is a poor indicator of the quality of growth, as it does not reflect changes 
in body composition.  
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1.3.2 Dysregulation of the hypothalamic-pituitary-adrenal 
(HPA) axis 
Fetal overexposure to glucocorticoids may also lead to early life programming 
(Edwards et al., 1993). In animal studies, maternal administration of glucocorticoids 
led to low birth weight, raised blood pressure (Benediktsson et al., 1993), insulin 
resistance and also altered HPA axis activity with some gender specific differences 
(Sloboda et al., 2002) (O'Regan et al., 2004). It is thought that this alteration in the 
HPA axis may be one mechanism that contributes to the development of cardio-
metabolic disease by changing the trajectory of maturation of organ systems 
(Edwards et al., 1993). Supporting this are several population studies of adults born 
small where elevated fasting plasma cortisol levels or cortisol reactivity associated 
with cardiovascular risk factors such as raised blood pressure, glucose intolerance 
and dyslipidaemia (Phillips et al., 1998) (Phillips et al., 2000) (Reynolds et al., 
2001). Moreover, a meta-analysis showed an inverse relationship between circulating 
cortisol levels and birth weight (van Montfoort et al., 2005). Early morning fasting 
cortisol levels representing a ‘stressed’ state rather than basal levels associated with 
cardiovascular risk factors, thus linking maladaptation to early life stress (Reynolds, 
2013b). Additionally, the neurological sequelae associated with low birth weight 
may be attributable to HPA axis activation given the concomitant reduction in fetal 
brain growth (Huang et al., 1999) and function (Aghajafari et al., 2002), delay in 
myelination (Dunlop et al., 1997), and behaviour reminiscent of anxiety (Welberg et 
al., 2001) observed in animals following maternal glucocorticoid administration. 
Antenatal glucocorticoids, in the form of synthetic betamethasone or dexamethasone, 
are crucial in reducing mortality and morbidity in preterm infants born at less than 35 
weeks gestation and in some instances repeated courses may be administered 
(McKinlay et al., 2012) but the latter remains controversial. The fetus is generally 
protected from excess maternal glucocorticoids by the action of the type 2 isoform of 
11β hydroxysteroid dehydrogenase (HSD11β2) in the placenta, which converts 
active cortisol to inactive cortisone. This ‘barrier’ effect is not complete as maternal 
glucocorticoids are essential for normal development and maturation of fetal organs 
(Benediktsson et al., 1997). Betamethasone and dexamethasone are not inactivated 
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by HSD11β2 and thus freely cross the placenta to exert their intended effects on the 
fetus (Blanford &  Murphy, 1977). 
Preterm infants who have been exposed to antenatal glucocorticoids have altered 
stress reactivity, according to a systematic review of 49 studies: suppression of 
endogenous cortisol production after birth seems to recover by 2 weeks of age and 
thereafter, a blunted response to pain was observed, persisting throughout the first 4 
months of life. This response was inversely proportional to the number of courses of 
antenatal glucocorticoids or the total dose administered (Tegethoff et al., 2009). 
Cortisol responses to corticotropin releasing hormone (CRH) stimulation in a group 
of preterm infants <30 weeks gestation were significantly lower at 2 weeks of age 
compared to term equivalent age, and the responses to CRH were further blunted in 
those exposed to antenatal glucocorticoids (Niwa et al., 2013). In the longer term, 
there appears to be a switch from low levels of cortisol (at 3 months) to elevated 
levels at 8 and 18 months in preterm infants in general compared with full term 
infants (Grunau et al., 2007). 
Observational and experimental studies suggest that antenatal glucocorticoid 
exposure has some long-term adverse clinical effects, both metabolic and 
neurological. Exposure to a single course of antenatal betamethasone was associated 
with higher systolic and diastolic blood pressures in adolescence (Doyle et al., 2000). 
However, this finding was not mirrored in an separate study of 19 year old 
individuals born preterm (Finken et al., 2008). Infants from the Auckland Steroid 
Trial – whose mothers were randomised to receive either betamethasone or placebo - 
were examined at 30 years of age. Whilst there were no effects on body size, 
hypertension, diabetes or cortisol levels, there were indications of insulin resistance, 
particularly in women (Dalziel et al., 2005b). There were no indicators of cognitive 
impairment or psychiatric symptoms (Dalziel  et al., 2005a). 
A recent systematic review suggested consideration of repeated doses of 
glucocorticoids to reduce neonatal morbidity, and whilst there were no demonstrable 
benefits or significant harm in very early childhood (McKinlay et al., 2012), some 
findings cause concern. Follow-up of children in the Australasian Collaborative Trial 
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of Repeat Doses of Steroids reported no differences in either BP or body size at 2 
years, however those exposed to repeat doses were more likely than the placebo 
group to have problems with attention (Crowther et al., 2007). The similar National 
Institute of Child Health and Human Development (NICHD) trial of repeated dosing 
also showed no difference in anthropometry, BP or scores of cognitive or motor 
development at 30 months, but although not statistically significant, there were more 
cases of cerebral palsy in the repeated dosing group (Wapner et al., 2007). In an 
observational study, increasing numbers of courses of betamethasone was associated 
with increased aggression, distractibility and hyperkinetic behaviour in children at 
both 3 and 6 years of age (French et al., 2004). Surprisingly, a reduction in cerebral 
palsy was noted (French et al., 2004), despite a reduction in birth weight and head 
circumference (French et al., 1999). 
Whether preterm infants have altered HPA axis activity due to antenatal steroids per 
se is difficult to ascertain. Various aspects of neonatal intensive care may confound 
the effect: the number of painful procedures during neonatal intensive care predicted 
higher cortisol secretion (Grunau et al., 2004), as did earlier gestational age at birth 
(Grunau et al., 2004) (Niwa et al., 2013), both possibly related to illness severity (Ng 
et al., 2011). Glucocorticoids are occasionally used postnatally to treat hypotension 
or to aid in reducing respiratory support in bronchopulmonary dysplasia and may 
further affect cortisol homeostasis. Ultimately, preterm infants have higher levels of 
plasma cortisol in the first 4 weeks of life than fetuses of equivalent gestations who 
have the advantage of the placental barrier (Glover et al., 2005). To address this 
confounding effect of prematurity, Alexander et al studied 6-10 year old children 
who were born at term, but were exposed to glucocorticoids during gestation to 
promote fetal maturation. Compared to controls, these children had increased cortisol 
reactivity to a standardised laboratory stressor (Alexander et al., 2012). Maternal 
stress can itself exert an effect on the developing HPA axis, brain morphology and 
behaviour (Buss et al., 2012) and the study addressed this additional confounding 
factor by including a group of children whose mothers were hospitalised during 
pregnancy and did not receive glucocorticoids (Alexander et al., 2012). More 
recently, a large population study which robustly adjusted for confounders by design 
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and analysis identified a link between antenatal glucocorticoid exposure and 
symptoms of attention deficit hyperactivity disorder (ADHD) in childhood and 
adolescence (Khalife et al., 2013). The mechanisms may include thinning of the 
rostral anterior cingulate cortex which associated with affective symptoms observed 
in term born children exposed to betamethasone compared to controls (Davis et al., 
2013). 
The unequivocal benefits of antenatal glucocorticoids outweigh the small risks of 
HPA axis alteration, but this in addition to stressors associated with preterm birth 
may be a mechanism of disease programming. As discussed below, potential 
molecular mediators may be epigenetic modifications or telomere attrition. 
1.3.3 Epigenetics 
The term ‘epigenetics’ is commonly used to describe alterations in gene function 
without changes to the DNA sequence. Epigenetic processes are not only essential 
for the development of cellular identity and normal development (Li et al., 1992), but 
might also mediate the interaction of the environment with the genome (Jaenisch & 
Bird, 2003). Alterations in the epigenome may be an important mechanism linking 
factors in the early life environment (such as nutrition and stress) with later disease 
risk (Jirtle & Skinner, 2007).  
Changes to the epigenome occur via several molecular modifications such as DNA 
methylation, histone modifications and non-coding RNAs. Of these, DNA 
methylation is considered to be the main component and is the best characterised. It 
is also considered the most stable and accessible epigenetic mark for quantitative 
measurements in human populations. DNA methylation is where the addition of a 
methyl group at the 5-position of a cytosine base forms 5-methylcytosine (5mC) 
through the action of the DNA methyltransferase enzymes (DNMTs), which use S-
adenosyl methionine (SAM) as a methyl donor (Figure 1.1). DNA methylation 
mainly occurs at cytosine bases paired with guanine by a phosphate residue  - known 
as cytosine-phosphate-guanine (CpG) dinucleotides. In general, when DNA 
methylation occurs at gene promoters, it tends to be associated with recruitment of 
methyl-CpG-binding proteins, gene silencing and heterochromatin formation. DNA 
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methylation is also responsible for the silencing of repetitive elements and X 
chromosome inactivation (Bird, 2002). 
 
Figure 1.1 Unmodified cytosine, 5mC and 5hmC. 5mC is formed by the addition 
of a methyl group to cytosine by the action of DNA methyltransferases (DNMTs), 
which uses S-adenosyl methionine (SAM) as a methyl donor. 5hmC is formed 
though the action of TET proteins, which uses oxygen to transfer a hydroxyl group to 
5mC. Figure obtained from Dahl et al (Dahl et al., 2011). 
Patterns of DNA methylation across the genome are conserved during mitosis during 
life, but are removed from somatic and germ cell lines and reset during embryonic 
development, in tissue specific patterns (Jaenisch & Bird, 2003). This is a critical 
period where alterations in this process could have long-term effects. Notably, 
methylation marks at imprinted genes are maintained during the post fertilisation 
period of epigenetic reprogramming, but data is emerging that other regions are also 
resistant to reprogramming (Radford et al., 2014).  
1.3.3.1 Genomic imprinting 
Genomic imprinting is the phenomenon whereby genes are expressed from one allele 
according to its parental origin (McGrath & Solter, 1984). In many cases, the 
silencing of the inactive allele is achieved by DNA methylation marks that are laid 
down at differentially methylated regions (DMRs) (Li et al., 1993). During 
gametogenesis in the new organism, these sex-specific imprint marks are erased and 
re-established in the germ line. They are known as primary DMRs and these 
methylation marks are maintained post-fertilisation in somatic cells undergoing 
organogenesis (Reik & Walter, 2001). ‘Secondary’ DMRs are established after 
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fertilisation as a consequence of DNA methylation at primary DMRs and contribute 
to stable mono-allelic expression. Most imprinted genes are found in clusters and 
share a common primary DMR regulating the imprinting of multiple genes in the 
cluster (Edwards & Ferguson-Smith, 2007). 
A large cluster of imprinted genes, which is located at chromosome 11p15.5, is 
organised into two regulatory domains, each with a specific imprinting control region 
(ICR) and contains several genes important for growth and metabolism of which the 
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The telomeric domain includes the Insulin like growth factor 2 (IGF2) and H19 
genes which are oppositely imprinted (DeChiara et al., 1991) (Bartolomei et al., 
1991). Allele-specific expression is regulated by DNA methylation at the H19 
promoter and three DMRs - DMR0 and DMR2 proximal to the IGF2 gene and the 
ICR upstream of H19 (Phillips & Corces, 2009). The H19 ICR contains 7 binding 
sites for the methylation sensitive, zinc finger protein CCCTC binding factor 
(CTCF). CTCF binds to the unmethylated maternal allele and facilitates the assembly 
of a chromatin insulator, preventing the IGF2 promoter from accessing the enhancers 
downstream, resulting in silencing of IGF2 and transcription of H19. On the paternal 
allele, CTCF binding (and insulator assembly) is blocked by DNA methylation 
allowing functional communication between promoters and enhancers which drive 
IGF2 expression (Kurukuti et al., 2006) (Phillips & Corces, 2009). 
In mouse knock out models, Igf2 has been shown to be the major driver of prenatal 
growth (DeChiara et al., 1990) by its action on the diffusional exchange capacity of 
the placenta (Constância et al., 2002) (Sibley et al., 2004). H19 transcribes a large 
non-coding RNA (Brannan et al., 1990) and its function is unclear although evidence 
suggests it may function as a tumour suppressor (Hao et al., 1993) (Yoshimizu et al., 
2008) which may account for its action to restrict growth. In mice, targeted deletions 
of H19 yield an overgrowth phenotype and conversely, H19 overexpression result in 
growth restriction (Gabory et al., 2009). Further data has shown that H19 transcribes 
a microRNA that is expressed exclusively in placenta and can suppress genes 
promoting placental growth (Keniry et al., 2012). More recently, H19 is thought to 
interact with methyl-CpG-binding domain protein 1 which maintains repressive 
histone marks on 9 targets of an Imprinted Gene Network (Monnier et al., 2013). In 
humans, classical examples of altered expression of imprinted genes leading to 
growth abnormalities are the disorder of overgrowth, Beckwith–Wiedemann 
Syndrome (BWS, Online Mendelian Inheritance in Man (OMIM) 130650), and the 
growth restriction disorder, Silver–Russell Syndrome (SRS, OMIM 180860), where 
opposite alterations in DNA methylation at DMRs controlling IGF2 have been 
reported (Reik et al., 1995) (Eggermann et al., 2008) (Murrell et al., 2008).  
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The larger centromeric domain of 11p15.5 includes several growth-related genes, 
such as CDKN1C, encoding a cyclin dependent kinase inhibitor, and PHLDA2, 
pleckstrin homology-like domain family A member 2, both major negative regulators 
of embryonic growth (Andrews et al., 2007) and extra-embryonic growth (Tunster et 
al., 2010). Both genes are expressed from the maternal chromosome (Matsuoka et al., 
1996). The ICR, KvDMR (also known as ICR2) corresponds to the promoter of the 
potassium channel, voltage-gated, KQT-like subfamily, member 1 (KCNQ1) gene, 
whose non-coding RNA, KCNQ1 overlapping transcript 1 (KCNQ1OT1), is normally 
expressed only from the paternal chromosome and elongation silences the adjacent 
imprinted genes (Mancini-DiNardo, 2003). Loss of KvDMR methylation on the 
maternal chromosome, resulting in KCNQ1OT1 activation and bi-allelic CDKN1C 
silencing (Diaz-Meyer et al., 2003), is the most frequent cause of BWS (Lee et al., 
1999) (Smilinich et al., 1999). On the other hand, CDKN1C and PHLDA2 
overexpression have been found in cases of fetal growth restriction and demise 
where there have been mutations in KCNQ1 resulting in lack of function (De 
Crescenzo et al., 2013). Although duplications of the KvDMR domain result in a 
SRS-like phenotype (Schönherr et al., 2007), in the vast majority of SRS, abnormal 
DNA methylation (hypomethylation) occurs at the H19 ICR and promoter (Netchine 
et al., 2007) (Azzi et al., 2015). 
There are further interesting aspects of imprinted genes. ICRs are known to repress 
genes by utilising one of two mechanisms: transcription of a non-coding RNA or by 
CTCF mediated insulation of enhancers (Lewis & Reik, 2006). The former is usually 
on a maternally methylated region (such as KvDMR) and contains the promoter for 
an anti-sense transcript, the latter is usually on a paternally methylated region, does 
not contain a promoter and is inter-genic (such as H19 ICR) (Edwards & Ferguson-
Smith, 2007) Both KvDMR and H19 ICR are primary (gametic) regions (Edwards & 
Ferguson-Smith, 2007) and, as mentioned above, aberrant imprinting can result in 
BWS or SRS. So, whilst they function differently, they result in similar phenotypes. 
According to the parental ‘conflict’ or ‘kinship’ theory proposed by Moore and Haig, 
imprinted genes evolved as a result of competition between the maternal and paternal 
genomes over provision of maternal nutrients to the developing fetus (Moore & 
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Haig, 1991). They predicted, correctly, that in general, paternally imprinted 
(expressed) genes act to increase fetal growth by promoting acquisition of maternal 
resources and conversely, maternally imprinted (expressed) genes act to restrict fetal 
growth. (The leading example is that of IGF2 and the oppositely imprinted IGF2 
receptor (IGF2R) which acts to degrade IGF2 (Haig & Graham, 1991), however the 
latter is imprinted in mouse and not in human (Tycko & Morison, 2002).) This 
occurs since in many mammalian species, an offspring’s paternally derived genes are 
less likely to be present in the mother’s other offspring, therefore they have less to 
lose from the costs to the mother’s future reproduction. Moore and Haig also 
theorised that imprinted genes would further affect how much an offspring would 
extract from its mother at the expense of its siblings after birth. As such, imprinted 
genes would be involved in suckling, appetite, postnatal metabolism, behaviour and 
growth (Moore & Haig, 1991). These characteristics are typified by the phenotypes 
of the syndromes already mentioned, BWS and SRS, but also Prader-Willi (OMIM 
176270) and Angelman syndromes (OMIM 105830) (Nicholls, 1993) (Haig & 
Wharton, 2003). Indeed, studies of several imprinted genes support the kinship 
theory (Tycko & Morison, 2002).  
The kinship theory further predicted that imprinting would have an important role in 
the development of the placenta – the key conduit of limited nutrients to the embryo 
(Reik et al., 2003). Indeed, it is believed that imprinting evolved along with 
placentation. Imprinting is absent in the egg-laying platypus, which displays both 
mammalian and reptilian features, and belongs to the lineage preceding the later 
divergence of marsupials and eutherian mammals (John & Surani, 2000). Marsupial 
fetal development is short lived, the placenta more rudimentary and the majority of 
support for growth of the offspring occurs during an extended and complex period of 
lactation. Despite this, imprinting is present and much is conserved with eutherian 
mammals (John & Surani, 2000). 
In this regard, imprinted genes are of particular interest as they are developmentally 
regulated by DNA methylation, important for growth and development, abundant in 
the placenta and aberrations acquired in early life can have consequences later on. 
Despite IGF2/H19 being a classically imprinted locus, evidence indicates that 
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variation or heterogeneity in DNA methylation can occur in the normal population 
(Rancourt et al., 2013) as a result of heritable, environmental and stochastic factors 
(related to inaccuracies of the machinery maintaining epigenetic patterns) and may 
be a normally distributed trait (Heijmans et al., 2007). 
1.3.3.2 DNA methylation in fetal growth and preterm birth 
Experimental studies have shown that transient environmental influences can cause 
persistent changes to the epigenome and can ‘programme’ adult disease. Data in 
humans have been limited to cross-sectional or quasi-experimental studies. 
The mechanism(s) underlying increased disease risk in infants exposed to excessive 
glucocorticoids may include altered DNA methylation. This can be seen in the 
dexamethasone programmed rat model. The growth restricted offspring that would 
have gone on to develop glucose intolerance (Nyirenda et al., 1998) were found to 
have altered DNA methylation of Igf2 in liver in association with altered gene 
expression (Drake et al., 2011). Glucocorticoids have been shown to cause 
demethylation of specific fetal hepatic gene promoters in late gestation (Thomassin 
et al., 2001). Endogenous glucocorticoids also appear to exert an effect on DNA 
methylation: maternal stress/anxiety during pregnancy is associated with increased 
DNA methylation of the promoter of the glucocorticoid receptor – nuclear receptor 
subfamily, group C, member 1 (NR3C1) (implying reduced transcription and 
glucocorticoid receptor activity) in umbilical cord blood cells and a heightened 
cortisol response to stress in the infant (supposedly from deficient negative feedback) 
(Oberlander et al., 2008). Deficient early care giving behavior in rodents caused 
increased DNA methylation at the hippocampal NR3C1 promoter (Weaver et al., 
2004). Translating this finding: increased DNA methylation of the NR3C1 promoter 
(and reduced transcript levels) in the hippocampus of suicide victims with a history 
of childhood abuse was described (McGowan et al., 2009). The impact of early life 
stress may extend more broadly on a genome wide scale, as measured in adolescence 
(Essex et al., 2013). 
Stressors accompanying low socio-economic status can also have a bearing on DNA 
methylation. Early life socio-economic status appeared to embed into DNA 
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methylation as measured in adult life such that DNA methylation was a greater 
predictor than current socio-economic status (Borghol et al., 2012) and was also 
related to cortisol secretion and perceived stress (Lam et al., 2012). A component of 
low socio-economic status or perhaps compounding it is exposure to cigarette 
smoking. Alterations in DNA methylation can be seen as early as in fetal life at the 
candidate genes IGF2 and NR3C1 (Drake et al., 2015). In umbilical cord blood, 
changes at IGF2 (Murphy et al., 2012) and genome wide (Joubert et al., 2012) have 
been described. The sensitivity of the methylome to prenatal maternal smoking 
appears to persist into childhood and the late teens (Richmond et al., 2015). 
Early nutrition could also influence the adult phenotype via DNA methylation. 
Dietary methyl donors and cofactors (such as B12, folate, pyridoxine and 
methionine) are necessary for the synthesis of S-adenosyl methionine, required for 
establishing and maintaining methylation during development. Restriction of B12, 
folate and methionine at clinically relevant levels around the time of conception 
resulted in adulthood hypertension, insulin resistance, adiposity and widespread 
changes to the epigenome in sheep (Sinclair et al., 2007). In humans, children whose 
mothers took peri-conceptional folic acid at the recommended dosage had higher 
methylation at IGF2 DMR0 compared to those whose mothers did not (Steegers-
Theunissen et al., 2009). Folic acid during pregnancy may also contribute to DNA 
methylation at IGF2, but the direction of change was not consistent (Hoyo et al., 
2011). The European Society of Paediatric Gastroenterology, Hepatology and 
Nutrition recommend that preterm infants should receive folic acid supplementation 
(Agostoni et al., 2010). Although evidence is sparse, due to supplementation in 
parenteral nutrition and breast milk fortifiers, it has not been shown that very preterm 
infants are at risk of becoming folate deficient unless their sole nutrition has been 
unsupplemented human milk, born to mothers who smoked or mothers with prior 
folate deficiency (Oncel et al., 2014). 
A reduction in methylation was seen at IGF2 DMR0 in peripheral blood of adults 
who were conceived during the Dutch Hunger Winter of 1944-1945 (a period of 
severe, acute malnutrition) (Heijmans et al., 2008). A similar decrease in methylation 
was seen at neighbouring DMRs at the IGF2 locus such as DMR2, but not the H19 
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ICR (Tobi et al., 2012). Further candidate genes involved in metabolism, growth and 
cardiovascular disease also showed alterations in DNA methylation (Tobi et al., 
2009) and from an unbiased and genome wide approach, changes were found to be 
preferentially at regulatory regions mapping to genes enriched for differential 
expression during early development, and in pathways involved in metabolism and 
growth (Tobi et al., 2014). Whilst changes were measurable if famine occurred at 
any time during gestation, the greatest effect was exposure in the first 10 weeks 
suggesting that critical windows of programming exist (Tobi et al., 2015), the timing 
of which may depend on the specific insult and the outcome. In a similar vein, the 
offspring of mothers who consumed a harsh, unbalanced diet during pregnancy in 
Motherwell, Scotland, had altered DNA methylation at the H19 ICR, NR3C1 and 
HSD11β2 in peripheral blood in adulthood (Drake et al., 2012).  
It is remarkable that changes in the methylome can be detected several decades after 
the sentinel event further suggesting that they are stable alterations. These changes 
may be causal in the increased risk of obesity, type 2 diabetes, dyslipidaemia and 
schizophrenia observed in the Dutch cohort (Lumey et al., 2011) and hypertension 
and altered HPA axis activity in the Motherwell cohort (Drake et al., 2012). 
Additionally, malnutrition, as severe as in these studies, may also evoke a stress 
response on the mother and fetus and alter the epigenome or mediate the phenotypic 
outcomes. However, confounding by postnatal and life-course factors are highly 
possible and it is also plausible that changes in DNA methylation might arise as a 
consequence of the disease state rather than be causative, hence the importance of 
undertaking longitudinal studies from early life.  
Studies of early life in humans have been cross-sectional showing associations 
between DNA methylation and variation in birth weight. Accessible tissues such as 
cord blood, umbilical cord, but mostly placenta were used and either targeted 
specific genes implicated in growth or metabolism, or were methylome wide. 
Notable was the methylome wide study in cord blood from IUGR and AGA subjects. 
The finding of altered DNA methylation at the promoter of the nuclear transcription 
factor hepatic nuclear factor 4α (HNF4α) was important as mutations in HNF4α is 
linked to diabetes in later life and hence this offers a possible functional outcome 
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(Einstein et al., 2010). In addition to IGF2/H19 and IGF2R, other imprinted genes 
have been popular candidates because of their key roles in development (Reik et al., 
2003) and the fact that they are abundantly expressed in the placenta (Coan et al., 
2005). These include CDKN1C, PHLDA2, delta like homolog 1 (DLK1), growth 
factor receptor-bound protein 10 (GRB10), paternally expressed gene 10 (PEG10) 
and zinc finger gene 2 (ZIM2) (Tycko & Morison, 2002) (Coan et al., 2005). Non-
imprinted genes have been under-represented in studies, in particular GR and 
HSD11β2 considering their roles in stress regulation. Of additional interest is 
peroxisome proliferator-activated receptor-gamma (PPARγ) which is proposed to 
have a pivotal role in placental development and adipogenesis and expression has 
been shown to vary with birth weight (Diaz et al., 2012). Several studies have 
examined both DNA methylation and its relationship with gene expression. Most 
prior studies have compared IUGR/SGA (with variable definitions of IUGR and 
SGA) vs. AGA pregnancies with inclusion of preterm pregnancies with slow intra-
uterine growth in the IUGR/SGA cases (Tables 1.1 to 1.4), but as morbidity and 
mortality is graded across the normal birth weight range with the lightest and 
heaviest babies being most affected (Basso et al., 2006) it would be important to treat 
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Little is known about the epigenome in preterm infants. Studies so far suggest that 
DNA methylation changes with respect to gestational age at birth. From an 
epigenome wide interrogation, DNA methylation in cord blood associated 
incrementally with gestational age at birth. Implicated were 3 neighbouring genes 
responsible for organ development – skeletal muscle, brain and haematopoietic 
system raising the possibility that this may in part confer the pathologies seen in 
prematurity (Lee et al., 2012). The differences were significant considering the most 
immature subjects were 30 weeks gestation and the preterm group comprised a 
minority of the total. These findings were replicated in another genome wide study 
and additionally at genes important for shaping the epigenome – DNMTs and Ten-
eleven translocation (TET1) (Parets et al., 2013). Changes genome wide were 
observed with gestation, even at term (Schroeder et al., 2011) and across the 
trimesters in the placenta which may reflect changing cellular composition, or 
accumulating environmental and/or stochastic factors (Novakovic et al., 2011). 
Nevertheless, these are changes seen at birth and may be regarded as risk factors in 
the aetiology or consequence of the pathologies leading to preterm delivery. Whether 
any changes persist at term corrected age is not known; though transient alterations at 
critical periods of development may alter gene expression and possibly organ 
structure and function with long term effects. 
The pathogenesis of cardiovascular disease is thought to be an inflammatory 
response to constituent risk factors (Libby, 2006). Recent studies have indicated a 
relationship between global DNA methylation at repetitive genomic regions and 
degrees of inflammation, obesity and cardiovascular risk (Stenvinkel et al., 2007) 
(Kim et al., 2010). Women who have had a prior preterm delivery are at increased 
risk of developing cardiovascular disease, perhaps suggesting a common mechanism 
(Bonamy et al., 2011), and the observation that very preterm birth appears to have 
inflammatory antecedents (Goldenberg et al., 2000) raises the possibility that 
epigenetic processes may be involved along the way. The available evidence is 
limited: higher DNA methylation at the repetitive elements - long interspersed 
nuclear element-1 (LINE-1) in maternal blood during the first trimester, but not cord 
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blood, was associated with longer gestation and reduced odds of preterm birth 
(Burris et al., 2012). Out of 8 candidate imprinted genes, pleomorphic adenoma 
gene-like 1 (PLAGL1) in cord blood was found to be differentially methylated in 
preterm birth following infection/inflammation (Liu et al., 2013). Regardless of the 
presence or absence of infection/inflammation, genome wide differences in cord 
blood are apparent even following preterm labour with intact membranes compared 
to term controls (Parets et al., 2013).  
Pre-eclampsia is a leading obstetric indication for preterm delivery and a cause of 
IUGR (Goldenberg et al., 2008). Women who develop pre-eclampsia have a higher 
risk of cardiovascular disease in later life (Bellamy et al., 2007). The commonality 
for both conditions may be that the women were born preterm or IUGR, as disorders 
of placental dysfunction tend to occur across the generations and it has been 
suggested that this may be due to genetic and/or shared environmental factors 
(Wikström et al., 2011). Indeed, it has been recognised that the risk of hypertension 
is increased if the subject has a hypertensive parent (Wang et al., 2008) and several 
studies have identified multiple common genetic variants that predispose to 
hypertension (Padmanabhan et al., 2015). Likewise, the familial nature of pre-
eclampsia and common genetic variants have been recognised. This may explain the 
association between prematurity and later high blood pressure, but the data from 
Johansson et al and Lewandowski et al indicate that the degree of prematurity relates 
to the severity of the hypertension (Johansson et al., 2005) and cardiac structural 
changes (Lewandowski et al., 2013) suggesting environmental factors play a role. 
Epigenetic processes are also implicated in pre-eclampsia. For example, altered DNA 
methylation has been described in early onset pre-eclamptic placentas identified from 
genome-wide (Chu et al., 2014) and candidate gene approaches (controlling cortisol 
and hormonal signa1ling) (Hogg et al., 2013). However, it is unknown whether these 
changes are causal or consequential.  
Are early changes in DNA methylation in preterm infants detectable in the long 
term? An epigenome wide study using DNA extracted from stored neonatal blood 
spots showed that differences in methylation profiles between preterm and term 
infants had mostly resolved by 18 years of age (Cruickshank et al., 2013). 
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Nevertheless, some of these loci showed persistent changes in DNA methylation at 
both time points suggesting that these may offer biomarkers of risk, although it is not 
known whether they associate with risk factors for disease (Cruickshank et al., 2013). 
Decreased DNA methylation at IGF2 DMR0 was seen in adults born preterm and 
with cardiovascular risk factors (Wehkalampi et al., 2013) but whether the changes 
were present in early life is not known. Differential gene expression and DNA 
methylation (of several genes including CDKN1C) in peripheral blood associated 
with postnatal growth in ex-preterm and term born children with replication in cord 
blood (Relton et al., 2012) (Groom et al., 2012). Despite all these studies being 
correlative and not causative, epigenetic profiles may still offer biomarkers of 
disease risk in preterm infants.  
1.3.3.3 5-hydroxymethylcytosine 
In 2009, a second DNA modification, 5-hydroxymethylcytosine (5hmC) was re-
discovered having originally been described in bacteriophages in 1953 and again in 
1972 in animal brain tissue (Wyatt et al., 1953) (Penn et al., 1972). DNA of mouse 
Purkinje neurons and embryonic stem (ES) cells were found to contain significant 
levels of 5hmC (Kriaucionis & Heintz, 2009). Also described were the enzymatic 
oxidation reactions involving the Ten-eleven translocation (TET) proteins that are 
responsible for converting 5mC to 5hmC (Tahiliani et al., 2009) (Figure 1.1). This is 
an active and energy consuming process (as opposed to passive loss of 5mC during 
cell division in the absence of DNMTs). Particularly as this was observed in post-
mitotic neurons, the suggestion is that 5hmC may behave as a stable mark with 
regulatory function in its own right rather than merely an intermediate in the de-
methylation pathway (Tahiliani et al., 2009) (Song & He, 2013).Further cytosine 
modifications, 5-formylcytosine and 5-carboxylcytosine, have been described as 
oxidative derivatives of 5hmC also involving the action of TET proteins (Ito et al., 
2011). Thereafter, it has been found that 5-carboxylcytosine is excised from DNA by 
base excision repair machinery to revert to unmodified cytosine (He et al., 2011). 
This additionally suggests that 5hmC can be part of an active demethylation cycle 
(Maiti & Drohat, 2011). 
 
           31 
Increasing evidence points towards 5hmC having a role in chromatin structure and 
gene regulation. From analyses of human and mouse ES cells and neuronal genomes, 
5hmC is enriched in gene bodies (Williams et al., 2011), in greater amounts at those 
that are more highly expressed (Song et al., 2011) and with correspondingly low 
enrichment of 5mC (Mellén et al., 2012), indicating that 5hmC can activate and/or 
maintain gene expression. 5hmC is also present at enhancer elements (Stroud et al., 
2011), CpG-rich transcription start sites (Williams et al., 2011), promoters and 
insulator binding sites (Shen & Zhang, 2013) indicating, again, that 5hmC may have 
a role in initiating and maintaining transcription. The function of 5hmC at other 
regions is unknown, where it may indeed be a transient modification (Hahn et al., 
2014). 
5hmC varies greatly between tissues. It is approximately 10-fold more abundant in 
neurons than in ES cells or peripheral tissues and its location in the genome also 
varies between the neurons and ES cells (Szulwach et al., 2011). Given also that 
neurons are post-mitotic whereas ES cells are proliferative these data suggests that 
the function of 5hmC depends on tissue type (Mellén et al., 2012) (Nestor et al., 
2012). Assuming a model of passive demethylation, 5hmC loss resulting from failure 
to maintain the mark after DNA replication, one would predict that tissues with a 
relatively low proliferation rate (e.g. brain) have the highest levels of 5hmC and 
highly proliferative tissues (e.g. blood or epithelium) would contain the least, as was 
broadly observed (Nestor et al., 2012). 
Whilst the distribution of 5hmC across the genome can differ from 5mC, the two 
marks often co-exist, and much of this has been gleaned from work that has used 
techniques specific for 5hmC (Shen & Zhang, 2013). In particular, large areas of 
5hmC enrichment have been noted over the IGF2/H19 locus (Thomson et al., 2013) 
(Nestor et al., 2012), a region where 5mC has been studied with bisulphite 
sequencing in the placenta with respect to fetal programming (Tabano et al., 2010) 
(St-Pierre et al., 2012) (Bourque et al., 2010) (Koukoura et al., 2011) (Buckberry et 
al., 2012). 5hmC is known to be present in the mature placenta (Nestor et al., 2012), 
so bisulphite sequencing would not have technically distinguished 5mC from 5hmC 
(Huang et al., 2010), therefore the role of the latter and less well-studied 
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modification may have been underestimated. Moreover, the true abundance of 5mC 
may not have been accurately captured. Yet 5hmC in the placenta has not been 
studied in the context of fetal programming nor as a potential regulator of placental 
function.  
Finally, since that the action of the TET enzymes requires oxygen, this suggests that 
it is a process potentially sensitive to environmental states such as oxidative stress 
and may adapt to altered cellular states (Branco et al., 2011) (Chia et al., 2011). TET 
mediated conversion of 5mC to 5hmC has been recognised as one mechanism for the 
global erasure of 5mC, including over imprinted regions, during the development of 
primordial germ cells during embryogenesis (Hackett et al., 2013). Thus any 
alterations to this process and also the re-programming that occurs later in gestation 
may be transmitted to later generations (Rose et al., 2014) and may manifest as 
aberrant patterns of both 5mC and 5hmC. Therefore, it would be important to study 
both DNA modifications in the context of fetal programming.  
1.3.4 Telomere attrition 
Telomeres are strings of highly conserved, repetitive, non-coding DNA sequences 
that cap the end of chromosomes and preserve genomic DNA integrity (Blackburn, 
2005). In the absence of restoration, telomeres shorten during each cycle of mitosis, 
due to DNA polymerase being unable to replicate the lagging strand completely. 
Eventually, cells with enough depleted telomeres and essential sequences undergo 
replicative senescence (Harley et al., 1990) (Blackburn, 2005), thus telomeres are 
thought of as ‘mitotic clocks’. Telomerase is a ribonucleoprotein that stops the 
shortening of telomeres by replicating new telomeric DNA in the parent chromosome 
(Greider & Blackburn, 1985) (Blackburn, 2005). Telomerase is normally expressed 
in cells where complete replication of DNA (incomplete replication is balanced by 
replication) is important (such as germ cells and certain adult stem cells) and in 
cancer cells and levels in somatic cells are low (Kim et al., 1994). The introduction 
of telomerase into normal cells results in telomere elongation and vigorous cell 
division (Bodnar et al., 1998). As such, a decline in telomerase activity has also been 
considered to have a causal role in ageing (Jaskelioff et al., 2011).  
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Telomere length may be a marker of biological ageing and not just chronological 
ageing (Lindsey et al., 1991). Although there is an inverse relationship between 
telomere length and age (Frenck et al., 1998), the wide variation in telomere length at 
any given age even at birth (Okuda et al., 2002), suggests influence by other factors. 
There is high heritability of telomere length (Broer et al., 2013) and several genes 
have been identified that influence telomere length and that are also implicated in age 
related illnesses such as cancer and coronary artery disease (Codd et al., 2013). This 
recapitulates the seminal work showing the association between short telomere 
length and mortality from heart disease (Cawthon et al., 2003). However, the 
presence of risk factors (insulin resistance and adiposity) alone are linked with 
telomere attrition (Gardner et al., 2005). Telomeres probably go beyond being 
biomarkers given the known diseases of telomere dysfunction (dyskeratosis 
congenita, forms of aplastic anaemia, lung and liver fibrosis) (Calado & Young, 
2009) and telomere biology has been linked to mitochondrial function, metabolism 
and by extension, organ dysfunction and pathogenesis of disease (Sahin et al., 2011).  
Environmental factors may also play a major role in modifying telomere length. 
Lifestyle, nutrition and stress are factors that can predispose to age-related disease 
and they have been shown to influence telomerase activity in adults (Ornish et al., 
2008). A large body of work has focussed on telomere attrition as a means of 
explaining how stress gets ‘under the skin’ (Epel et al., 2004). Psychological stress in 
pre-menopausal women has been shown to associate with lower telomerase activity 
and shorter telomere length (Epel et al., 2004). In childhood, social deprivation 
associated with shorter telomeres (Mitchell et al., 2014) and exposure to violence 
associated with telomere attrition (Shalev et al., 2012). Intra-uterine stress (albeit 
assessed retrospectively) was shown to associate with shorter telomere length in the 
offspring as adults (Entringer et al., 2011). Given that telomere length in early life is 
a strong predictor of realised lifespan (Heidinger et al., 2012) and the ‘set-point’ may 
be established in early life (Daniali et al., 2013), these studies suggest that early 
adversities can alter the trajectory of attrition with measurable differences in later 
life. Moreover, the telomere system may be partly under epigenetic control by DNA 
methylation at subtelomeric loci (Buxton et al., 2014) and the promoter region of the 
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telomerase reverse transciptase gene (TERT) that regulates telomerase activity 
(Daniel et al., 2012), and folate seems to be a required common substrate (Moores et 
al., 2011). 
Whilst some studies suggest that adults (Entringer et al., 2011) and children (Raqib et 
al., 2007) born small have shorter telomeres, no differences in telomere length was 
observed in a large cohort of adults with low birth weight or very preterm birth 
compared to controls (Kajantie et al., 2012). Of note, this was a cohort where birth 
status predicted a number of adult diseases and their risk factors such as 
hypertension, type 2 diabetes or impaired glucose tolerance, use of lipid lowering 
medication and depressive symptoms (Kajantie et al., 2012). 
There are, however, very few studies on telomere biology in early life or in preterm 
infants. Whilst data do not indicate that fetal growth restriction associates with 
shorter telomeres at birth (Akkad et al., 2006), it appears that telomere length is 
inversely proportional to gestational age – at least when measured at a single time 
point in a range of preterm infants at birth (Friedrich et al., 2001) (Menon et al., 
2012). Serial measurements during hospital stay indicated steady shortening of 
telomeres in preterm infants compared with unborn fetuses matched for gestational 
age (Holmes et al., 2009) and although this was a very small study (total n = 13), it 
suggests premature cellular ageing in the preterm group. Mechanisms proposed for 
this include oxidative stress from in vitro studies (Kawanishi & Oikawa, 2004) 
(Zglinicki, 2002) or inflammation from a human study (Wong et al., 2014). These 
mechanisms were explored in a mouse model: low grade chronic inflammation 
induced telomere dysfunction and ageing via reactive oxidative species (Jurk et al., 
2014). Both oxidative stress and inflammation are implicated in morbidity in the 
neonatal period in preterm infants (Vento et al., 2012) (Dammann & Leviton, 2000). 
These previous studies of telomere biology were limited to the perinatal period, the 
preterm groups did not have telomere length measured at term corrected age and 
there was no longitudinal study in infancy or childhood. 
As opposed to the mean telomere restriction fragment method used in the study by 
Holmes et al (Holmes et al., 2009) and Friedrich et al (Friedrich et al., 2001), the 
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quantitative polymerase chain reaction (qPCR) method (Cawthon, 2002) used by 
Menon et al (Menon et al., 2012) allows for larger numbers of samples to be 
analysed. Comparing telomere length measurements of a larger sample of preterm 
infants with term infants from birth over an equivalent time period is required to 
determine whether preterm infants have faster telomere attrition and to explore the 
possibility of telomere length as a marker of early life stress response. 
1.4 DNA methylation and preterm brain development  
Neurodevelopmental impairment is one of the most important outcomes following 
preterm birth. Major motor deficits only occur in 5-10% of VLBW infants, but up to 
50% can have subtle learning difficulties at school age (Aarnoudse-Moens et al., 
2009). There is an inverse relationship between statutory special educational needs 
(SEN) and gestation at birth up until 41 weeks (MacKay et al., 2010). Here, SEN 
included behavioural problems such as autistic spectrum disorder (ASD) and ADHD 
(MacKay et al., 2010). Extreme preterm children are more than 3 times as likely to 
have such a psychiatric disorder and the presence of inattention, social difficulties 
and also anxiety comprise a consistent “preterm behavioural phenotype” (Johnson et 
al., 2010) (Johnson & Marlow, 2011). A Swedish nation-wide study showed that the 
risk of hospitalisation for psychiatric disorders (most commonly depression, bipolar 
disorder and psychoses) as adults, rose monotonically with decreasing gestational 
age (Nosarti et al., 2012) and similarly for prescription of psychiatric medication 
(Crump et al., 2010).  
The main neuropathology in the preterm infant comprising periventricular 
leucomalacia (PVL) and neuronal/axonal disease, accounts for the large majority of 
the observed neurodevelopmental abnormalities and collectively, this is now known 
as “the encephalopathy of prematurity” (Volpe, 2009). PVL consists of focal necrosis 
deep in cerebral white matter and a more diffuse white matter disturbance. The focal 
necroses are usually microscopic (macroscopic cysts are now unusual) and the 
diffuse white matter disturbance is characterised by injury to pre-myelinating 
oligodendrocytes. The pathology results from a combination of destructive processes 
and abnormal development (trophic/maturational), with the key insults being 
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ischaemia, inflammation, excitotoxicity and free-radical injury (Volpe, 2009) (Volpe, 
2011).  
On conventional MRI, the neuropathology comprises a ‘signature’ of preterm birth at 
term equivalent age consisting of enlargement of the ventricular system, reduced 
cortical complexity and diffuse signal abnormalities in the white matter (Woodward 
et al., 2006). Advanced MRI tools to capture and analyse images have further 
delineated how preterm birth affects neural systems (e.g. white matter microstructure 
(Counsell et al., 2008) and focal volume loss in the deep grey matter and thalami 
(Boardman et al., 2006) (Boardman et al., 2010)). However, central to the 
encephalopathy of prematurity are the neuronal/axonal deficits (Volpe, 2009) and 
diffusion MRI tractography has been able to demonstrate reduced connectivity of 
neural tracts in preterms at term corrected age in relation to cognitive deficits in 
toddlerhood (Ball et al., 2015) and also social deficits at school age (Fischi-Gómez et 
al., 2014). 
Diffusion MRI (dMRI) assesses the Brownian motion of water in tissues to define 
white matter microstructure.  Fractional anisotropy (FA), a derived metric, measures 
the directionality of water diffusion parallel to the fibre tract and detects differences 
in integrity due to maturation and damage (Le Bihan, 2003). In the preterm brain, the 
normal increase in FA in various fibre tracts is blunted (Hüppi et al., 1998). This 
occurs as in the early preterm period the brain is about 92% water (Dobbing & 
Sands, 1973) and largely unmyelinated (Brody et al., 1987). As the brain matures, 
cellular and axonal size, density and the coherence of fibres all increase, while the 
water content declines to 88% at birth. Simultaneously, myelination starts with the 
development of oligodendrocytes and collectively, there is more restriction in tissue 
causing increased water directionality (Miller et al., 2002). Thus, FA is a composite 
measure of all of these factors (Beaulieu, 2002). By studying the preferred direction 
of diffusion, the orientation of white matter fibre bundles can be inferred and tract 
averaged FA values can be determined (Basser et al., 2000).  
dMRI has demonstrated regions of the brain that are impaired in several brain 
disorders, for example in a meta-analysis, the splenium of the corpus callosum 
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showed significantly reduced FA in adults with schizophrenia compared to controls 
(Patel et al., 2011). dMRI based abnormalities have been shown in other conditions: 
post-traumatic stress disorder, bipolar mood disorder, obsessive-compulsive disorder 
and major depression (Daniels et al., 2013) (Sussmann et al., 2009)  (Zarei et al., 
2011) (Carballedo et al., 2012) but not universally (Kochunov et al., 2013). Studies 
combining dMRI and genetic variation have increased the understanding of how 
white matter integrity relates to cognition and the susceptibility to schizophrenia and 
related disorders (Chiang et al., 2011a) (Chiang et al., 2011b) (Sprooten et al., 2011) 
(Kohannim et al., 2012) (Carballedo et al., 2012), which are regarded fundamentally 
as disorders of myelin and connectivity (Davis et al., 2003). Similarly, preterm white 
matter injury has been related to common genetic variants (from a candidate enquiry) 
that modulate the risk of schizophrenia and possibly cognition, namely rs2518824 in 
armadillo repeat gene deleted in velocardiogacial syndrome (ARVCF) and rs174576 
in fatty acid desaturase 2 (FADS2) (Boardman et al., 2014). Common variants in 
ARVCF are also associated with altered FA in adult subjects who have schizophrenia 
(Sim et al., 2012). FADS2 encodes for δ-6 desaturase which modifies dietary fatty 
acids leading to long-chain polyunsaturated fatty acid (LC-PUFA) production that 
are important for brain development. Most interestingly, the FADS2 rs174575 
genotype alters LC-PUFA availability and carriage appears to interact with breast 
milk exposure to influence childhood IQ (Caspi et al., 2007). 
Common genetic and not epigenetic variation has been the focus of these studies. 
Since the brain is highly plastic in function, there is constant adaptation in neural 
function in response to environmental cues; potentially mediated by epigenetic 
processes, such as DNA methylation (Meaney & Ferguson-Smith, 2010) and DNA 
methylation is required for proper postnatal brain development (Hutnick et al., 2009). 
Several studies have indicated the mediation of early life stress and later mental 
illness by DNA methylation including the control of glucocorticoid action 
(McGowan et al., 2009) (Essex et al., 2013) (Mehta et al., 2013) (Khulan et al., 
2014). As already described, preterm delivery with its associated practices and 
complications results in abnormal stress regulation and behavioural difficulties. Such 
early stressors may embed into DNA methylation and underpin acquired brain injury. 
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In a study of DNA methylation changes in the human pre-frontal cortex across the 
lifespan, the greatest change occurred during fetal life (Numata et al., 2012) but there 
is also considerable change during fetal and early postnatal life (Spiers et al., 2015). 
This suggests that preterm birth may impact greatly on normal methylation during 
brain development. Whilst recent studies have revealed alterations in peripheral 
blood or brain tissue in adults with ASD and schizophrenia (Aberg et al., 2014) 
(Ladd-Acosta et al., 2014) (Pidsley et al., 2014), studies following preterm birth are 
now emerging (Behnia et al., 2015).  
Imprinted genes are recognised to play a key role in normal neurodevelopment and 
brain function (Wilkinson et al., 2007). For example, children with the well-known 
imprinting disorders Angelman and Prader-Willi syndromes have cognitive 
impairment and characteristic behavioural changes and children with Beckwith-
Wiedemann syndrome have an increased risk of autism. This had led to the theory 
that ASD has its origins in aberrant imprinting (Badcock & Crespi, 2006). Similarly, 
conditions with psychosis (schizophrenia, bipolar mood disorder and depression) are 
also characterised by disturbance of cognition, affect and behaviour and may too be 
due to imbalance of imprinting (Badcock & Crespi, 2008). In general, schizophrenia 
is considered to be a neurodevelopmental disorder and also obstetric complications 
are an additional risk factor (McGrath et al., 2003) (Cannon et al., 2002). Structural 
brain abnormalities (focal white matter hyper-intensity and decreased brain volume) 
(Hulshoff Pol et al., 2000) and altered DNA methylation at IGF2/H19 locus 
(Heijmans et al., 2008) have been demonstrated following severe perinatal adversity 
in the form of maternal undernutrition during the Chinese and Dutch famines (St 
Clair et al., 2005) (Susser & Lin, 1992). Since IGF2 is expressed in the brain in a 
parent of origin specific manner, and has been shown to have roles in brain function 
such as cognition and memory (Chen et al., 2011) and in synapse formation 
(Schmeisser et al., 2012), altered DNA methylation at IGF2/H19 could be one 
mechanism in preterm brain injury. 
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1.5 Search for biomarkers of risk 
Epigenetic mechanisms and telomere attrition may be potential explanations for the 
effects of early life environmental effects on developmental trajectories. If the 
‘signature’ is present before the development of the phenotype, it could be used as a 
biomarker of disease risk (or resilience) rather than relying on the surrogate marker 
of low gestational age or low birth weight. Identifying those preterm infants who are 
most at risk of later disease would allow the development and targeting of 
appropriate therapies.  
Appropriate accessible tissue from preterm infants is a source of challenge for 
genomic studies. It is impractical to study brain tissue. Peripheral white cells may be 
a more direct means of understanding the role of inflammation on the pathogenesis 
of both brain injury and cardio-metabolic disease, but collecting blood from infants 
poses ethical as well as practical hurdles. The composition of peripheral blood can 
also vary and this would need to be taken into account. Buccal epithelium consists of 
more homogenous cells and is also easily accessible, but must be seen as a surrogate 
marker. The placenta is also highly accessible, but offers information only of intra-
uterine events. Whilst telomere length may differ between tissues, the rate of attrition 
is equivalent in epithelia compared with other somatic tissues (Daniali et al., 2013). 
DNA methylation differences can be tissue specific, but some regions may be 
conserved (Ollikainen et al., 2010) (Schultz et al., 2015) and research so far has 
indicated that buccal epithelia may be superior to blood for the study of human 
disease including brain disorders (Smith et al., 2014) (Lowe et al., 2013). Ultimately, 
it may be possible to use epigenetic signatures for diagnostic purposes once tissue 
specific profiles for diseases are known and the most suitable accessible tissue can be 
chosen. 
1.6 Hypotheses 
1. Preterm infants have altered DNA methylation at IGF2/H19 over the first year of 
life compared with term infants.   
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2. DNA methylation at the IGF2/H19 locus relates to fractional anisotropy (FA), a 
measure of microstructural integrity of key white matter tracts, and/or whole brain 
volume in preterm infants. 
3. Preterm birth is associated with faster telomere attrition during the first year of life 
compared with term infants.  
4. The expression of candidate imprinted and non-imprinted genes that mediate fetal 
growth in the placenta associate with birth weight. 
5. Placental DNA methylation (5-methylcytosine) and 5-hydroxymethylcytosine at 
candidate genes associate with birth weight.  
1.7 Aims 
1. Establish a cohort of preterm infants (23 to 31 weeks gestation) and full term 
controls within the first week of age. Follow up the infants at term corrected age, 3 
months and 1 year corrected. Measure growth parameters, including body 
composition, and collect saliva for buccal epithelial DNA and cortisol. Study DNA 
methylation at the IGF2/H19 locus.  
2. Establish a pathway for the acquisition of magnetic resonance (MR) images of the 
brain of preterm infants at the University of Edinburgh, Clinical Research Imaging 
Centre. Establish recruitment of preterm infants, supervise their scanning at term 
corrected age, collect saliva for buccal epithelial DNA and study DNA methylation 
at the IGF2/H19 locus. 
3. Measure relative telomere length at birth, term corrected age and 1 year corrected 
in the same cohort of infants.  
4. Study expression of candidate imprinted and non-imprinted genes in term 
placental samples that represent the normal birth weight range obtained from the 
Edinburgh Reproductive Tissue Biobank.  
5. Study epigenetic control mechanisms that might affect gene dosage using new 
affinity based techniques that would distinguish between DNA methylation (5 
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methylcytosine) and 5-hydroxymethylcytosine allowing exploration of their 
individual relationship with birth weight. 
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Chapter 2: Materials and methods 
2.1 Clinical methods 
2.1.1 Cohort of preterm and full term infants 
Following written parental consent, 50 preterm and 40 full term infants were 
recruited within the first week of age. Recruitment started on 12 July 2011 and ended 
11 November 2012. All infants were born at the Royal Infirmary of Edinburgh, apart 
from one full term infant who was born at St John’s Hospital, West Lothian.  
The inclusion criteria were preterm infants born at < 32 weeks gestation with no 
congenital abnormality. For the full term infants, inclusion criteria were: singleton 
babies born between 37 and 42 weeks gestation of mothers who did not smoke 
during pregnancy, did not undergo assisted reproduction and had no chronic health 
condition that would impact fetal growth. This was in line with an existing research 
study at the University of Edinburgh examining outcomes following birth to women 
with a body mass index exceeding 40kg/m2. The inclusion criteria for the term 
control group matched those of my study. This facilitated identification for 
recruitment by myself and research midwives and participation in both studies. 
Excluding women with adverse risk factors tries to ensure that the newborns are as 
healthy as possible. This is likely to exaggerate differences observed against infants 
born after an abnormal pregnancy. However, keeping the inclusion criteria strict 
allows the cohort to be similar as possible to each other and offered a valuable 
resource for subsequent study of DNA methylation in preterm infants in The 
University. 
For the purposes of obtaining anthropometric measures including body composition 
and collecting biological samples, infants were seen within the first week of age 
(“birth”), 3 months/3 months corrected for preterm infants (“3 months”) and 1 year/1 
year corrected (“1 year”). Additionally, the preterm infants were seen at a 
postmenstrual age of 37 to 42 weeks (“term corrected age”). All time points 
mentioned henceforth refer to the corrected age denoted within brackets. Follow up 
visits were conducted at the Clinical Research Facilities at The Royal Infirmary of 
Edinburgh and Royal Hospital for Sick Children Edinburgh. All follow up 
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arrangements were made by myself. All follow up visits were conducted by myself, 
except in a few exceptional circumstances, and completed by 14 October 2013. 
Demographic details and history were obtained during follow up visits and from the 
infant and the mother’s hospital records.  
For all term infants, mothers were approached in the antenatal period in order to 
obtain consent for cord blood, maternal blood and placental samples. This was also 
achieved for 30% of preterm infants. These samples were collected under the 
Edinburgh Reproductive Tissue BioBank (ERTBB) which works with ethical and 
governance approval from the Scottish Academic Health Sciences Collaboration, 
Human Annotated BioResource (East of Scotland Research Ethics Service 
13/ES/0126) and previously the West of Scotland Research Ethics Committee (REC) 
4 (09/S0704/3). I participated on a rota, both working hours and out-of-hours, for the 
collection and processing of samples for the ERTBB. Infant samples were collected 
under the framework of the ERTBB following an amendment (Reference AM07/1, 
17 March 2011). 
For the purposes of establishing the cohort of infants, substantive ethical approval 
was obtained from the South East Scotland REC (Reference 11/AL/0329) on 15 Jun 
2011. National Health Service (NHS) management approval was obtained on 30 June 
2011 (Lothian Research & Development Project number 2011/R/NE/03). These 
approvals included permission for 15 of the 50 preterm infants to be enrolled into a 
pilot study of brain imaging using magnetic resonance. At the end of recruitment, 
these infants had participated in brain imaging under REC Reference 11/SS/0061 
with approvals to enrol a larger group of preterm infants into brain imaging (Section 
2.1.2). However, in order to collect saliva for DNA analysis from these infants, an 
amendment (Reference AMO1-1, 30 July 2012) to the initial application (Reference 
11/AL/0329) permitted this. The permission was to collect saliva for DNA analysis 
to study DNA methylation and common genetic variants in relation to brain 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.2 Establishing a pathway for brain imaging of preterm 
infants using magnetic resonance 
The objective was to establish a pathway for brain imaging in preterm infants in 
Edinburgh and to obtain high-resolution magnetic resonance images at 3 Tesla that 
would be suitable for understanding brain growth during early development. Eligible 
babies were preterm infants born at < 32 weeks gestation, with no major congenital 
abnormality, cystic periventricular leucomalacia, post-haemorrhagic ventricular 
dilatation or porencephalic cysts. Brain imaging was obtained at 38 to 42 weeks 
corrected age.  
My tasks included compiling a study protocol, obtaining ethical and NHS 
management approval and obtaining approval from the Clinical Research Facility, 
which manages the Clinical Research Imaging Centre. Obtaining the necessary 
approvals required liaising with imaging scientists, radiographers, research nurses, 
pharmacists and personnel in medical physics to tackle all practical aspects of the 
study. We obtained approval to sedate infants with chloral hydrate, and although 
ultimately no infant was sedated, initial preparations involved an added layer of 
complexity. I explored arranging training in neonatal resuscitation for the research 
nurses and radiographers and collated materials and equipment from the neonatal 
unit and medical physics for the conduct of the study and for use in the case of an 
emergency. I created a checklist for setting up the resuscitaire and ensuring adequacy 
of equipment prior to each session. I also created the documentation to be completed 
by medical and nursing staff for each infant, noting relevant history, physical 
examination and observations of vital signs confirming that the infant is fit for the 
scan and afterwards, fit for discharge home. I also created the documentation to 
gather all the relevant clinical data from clinical records and history from parents and 
the electronic databases that have continued to be in use. 
The South East Scotland REC granted approval to enroll 50 preterm infants 
(Reference 11/SS/0061) on 8 November 2011 and NHS management approval was 
obtained (Lothian Research & Development Project number 2011/R/NE/04) on 22 
December 2011. I enrolled and supervised the scanning of the first 18 infants, 
starting on 20 April 2012, collected clinical data and samples for DNA and ensured 
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smooth running. Thereafter the process was taken over by Dr James Boardman’s 
students - Drs Sarah Sparrow, Rozalia Pataky and Emma Moore – with the retention 
of samples for DNA for my study. Data from infants scanned up until 14 October 
2013 was used for this thesis. 
2.1.3 Clinical assessments 
2.1.3.1 Anthropometry 
Birth weight was extracted from the patient record. Thereafter, weight was measured 
using electronic scales (Seca, Birmingham, UK) to the nearest 0.05kg. Body length 
was measured to the nearest 0.5cm with a measuring mat (Seca, Birmingham, UK) in 
full extension using two people. OFC was measured to the nearest mm with a non-
stretch tape (Spentex BCA Ltd, Sherburn in Elmet, UK) and the largest measurement 
of three recorded.  
2.1.3.2 PEAPOD 
Percentage body fat mass was measured using the PEAPOD Infant Body 
Composition System (COSMED, Chicago, USA) after birth in the full term infants, 
at term corrected age in the preterm infants and 3 months in both groups. The weight 
limit for the PEAPOD is 8kg therefore it was not used beyond 3 months of age. 
The PEAPOD uses densitometry to determine body composition and has been 
validated against the gold standard 4 compartment model and deuterium dilution (Ma 
et al., 2004) (Ellis et al., 2007). 
The infant was undressed and weighed using the integral scale to the nearest 0.1g. 
Any items on the infants that could not be removed such as umbilical clamps, 
identification bracelets, and in one instance, a naso-jejunal tube, were used to tare the 
scale and volume chamber. Following mass measurement, the infant was placed in 
the chamber of the PEAPOD for 2 minutes and body volume was measured using air 
displacement plethysmography. The PEAPOD calculated body density by dividing 
the mass by the volume. Body mass was modeled into two compartments: fat mass 
and fat free mass. The density of fat is constant throughout life (0.9007 g/ml), and 
the density of fat free mass was assigned by the PEAPOD depending on the infant’s 
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age and gender and based on published data. The PEAPOD’s model also takes into 
account changes in total body water in the first 6 days post-partum from published 
data. From this, fat mass and fat free mass were calculated and expressed as 
percentage of body mass. The Fomon equation was used as it has been shown to be 
better than that of Butte (Eriksson et al., 2011). 
The PEAPOD was stationed in the Clinical Research Facility at the Royal Infirmary 
of Edinburgh and was calibrated prior to each use. A cylinder with a known volume 
and a 2kg weight, both supplied by COSMED, were used to calibrate the chamber 
and the scale. 
2.1.3.3 Skin fold thickness 
Skin fold thickness (SFT) was measured at 1 year. The triceps and subscapular 
regions were more reproducible and more acceptable to the child than biceps and 
supra-iliac and therefore used for analysis. All measurements were made on the left 
side of the body and using a standard skinfold caliper (Holtain Ltd, Crymych, UK). 
Triceps SFT was measured parallel to the long axis of the arm midway between the 
acromion and the olecranon, with the arm slightly flexed. The subscapular SFT was 
measured below the inferior angle of the scapula at a diagonal in the natural cleavage 
of the skin. Triplicate measurements were performed and the mean was used. 
2.1.3.4 Magnetic resonance image acquisition 
Infants were scanned without sedation and whilst asleep, with pulse oximetry, 
electrocardiography and temperature monitoring. Ear protection was with earplugs 
and earmuffs (MiniMuffs, Natus Medical Inc, CA, USA).  
A Siemens Magnetom Verio 3 T MRI clinical scanner (Siemens AG, Healthcare 
Sector, Erlangen, Germany) and 12-channel phased-array head coil were used to 
acquire: T1-weighted magnetisation-prepared rapid gradient echo (MPRAGE) 
volume scan (~1 mm3 resolution), T2-weighted short time inversion recovery 
(STIR), T2-weighted fluid-attenuated inverted recovery (FLAIR), and diffusion MRI 
(11 T2- and 64 diffusion encoding direction (b=750 s/mm2) single-shot spin-echo 
echo planar imaging (EPI) volumes with 2 mm isotropic voxels. 
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2.1.3.5 MR Image analysis 
White matter tract integrity was measured by probabilistic neighbourhood 
tractography and performed by Dr Devasuda Anblagan. Diffusion MR images were 
pre-processed using FSL (FMRIB Software Library) (Functional Magnetic 
Resonance Imaging of the Brain, Oxford, UK; http://www.fmrib.ox.ac.uk) to extract 
brain, and bulk infant’s motion and eddy current induced artefacts were removed by 
registering the diffusion-weighted to the T2-weighted EPI volume for each subject. 
Using “DTIFIT”, FA volumes were generated for every subject. The 
BedpostX/ProbTrackX algorithm was run with its default parameters of a 2-fibre 
model per voxel, 5000 probabilistic streamlines for each tract with a fixed separation 
distance of 0.5 mm between successive points to generate the underlying white 
matter connectivity data (Behrens et al., 2003). The tracts of interest (TOI) 
segmented were: genu and splenium of corpus callosum, left and right projections of 
the corticospinal tract, cingulum cingulate gyri and inferior longitudinal fasciculi. 
Reference tracts for these structures were generated from the tractography output 
produced from a training set of 20 term controls (Anblagan et al., 2015). 
Whole brain volumes were computed by Dr Ahmed Serag according to published 
methods (Serag et al., 2012) Briefly, a 4 dimensional detailed atlas (model) of the 
brain had been created using 203 preterm infants scanned between 26.7 to 44.3 
weeks post menstrual age (PMA). Adjusting for sampling variation at each PMA and 
change in brain volume over time, the average of the inter-subject variation at each 
PMA was computed. The resulting probability maps encode the variation in shape of 
anatomical structures occurring longitudinally and between subjects. This provides 
prior information on whole brain volumes and also sub-structures. For each infant in 
the current cohort, registering the images against the reference atlas allowed for 
computing the anatomical differences between the subject and the atlas and by 





2.1.4 Sample collection and storage 
2.1.4.1 Saliva for cortisol 
Saliva was collected using sorbettes (BD Visitec, Massachusetts, USA) and latterly 
Salimetrics Infant’s Swab (Salimetrics Europe, Suffolk. UK) and placed in a storage 
tube (Salimetrics Europe). Samples were centrifuged at 200 revolutions per minute 
(rpm) at 4°C for 10 min as soon as possible and stored at -20°C until analysis.  
2.1.4.2 Saliva for buccal DNA 
The Oragene OG-250 kits with 5 saliva sponges CS-1 (DNA Gentotek, Ottawa, 
Canada) were used. Saliva was collected at least 30 min after feeding. The solution 
in the kit stabilises the sample at room temperature and inhibits bacterial growth.  
2.1.4.3 Placenta 
The samples were collected once the attending midwife had examined the placenta 
and according to a standard operating procedure. Tissue was excised from the fetal 
surface, near the insertion of the cord but away from large blood vessels. A 1cm3 
portion was snap frozen to -80ºC. A second 1cm3 portion was placed in RNAlater 
Stabilising Reagent (Qiagen, Crawley, UK), refrigerated at 4ºC for 24 hours and then 
removed from RNAlater and frozen at -80ºC. 
2.2 Laboratory methods 
2.2.1 Buffers and solutions 
All chemical and reagents were from Sigma-Aldrich (Dorset, UK) unless otherwise 
stated. 
2.2.1.1 10x (immunoprecipitation) IP buffer  
100m Molar (M) sodium phosphate pH 7.0 (mono and dibasic), 1.4M sodium 
chloride and 0.5% Triton X-100 in sterile water 
2.2.1.2 10x TBE buffer 
890mM Tris base, 890mM boric acid and 20mM (Edetic acid) EDTA pH 8.0 in 
Milli-Q water (Merck Millipore, MA, USA). Autoclaved and diluted to 0.5x with 
Milli-Q water before use 
 
 54 
2.2.1.3 Phosphate buffered saline – bovine serum albumin (PBS-BSA) 
0.1%  
A sufficient quantity was constituted prior to use. 1ml bovine serum albumin 
(10mg/ml stock solution in sterile water, filtered via a 0.22 micron filter and frozen 
in aliquots) added to 9ml phosphate buffered saline (Oxoid Ltd, Basingstoke, UK) (1 
tablet dissolved in 100ml of Milli-Q water and autoclaved). 
2.2.1.4 Proteinase K digestion buffer 
50mM Tris pH 8.0, 10mM EDTA pH 8.0 and 0.5% SDS in sterile water. A sufficient 
quantity constituted and filtered via a 0.22 micron filter prior to use. 
2.2.1.5 Sodium dodecyl sulphate (SDS) 10% 
10g dissolved in 100ml sterile water. 
2.2.1.6 Sodium Phosphate buffer 
2M sodium phosphate monobasic and 2M sodium phosphate dibasic solutions made 
and combined (in a ratio of 21:54) to achieve a 1M solution of pH 7.0. 
2.2.1.7 TE (Tris EDTA) pH 8.0 
10mM Tris pH 8.0 and 1mM EDTA pH 8.0 in Milli-Q water and autoclaved 
2.2.1.8 1M Tris pH 8.0 
121.14g Trizma base dissolved in 800ml of Milli-Q water. pH adjusted to 8.0 with 
HCl, made up to 1000ml with Milli-Q water and autoclaved. 
2.2.1.9 0.5M EDTA pH 8.0 
93.06g EDTA dissolved in 400ml of Milli-Q water. pH adjusted to 8.0 with Sodium 
hydroxide, made up to 500ml with Milli-Q water and autoclaved. 
2.2.2 Salivary cortisol assay 
The High Sensitivity Salivary Cortisol Enzyme Immunoassay Kit was used 
(Salimetrics Europe, Suffolk, UK) and the manufacturer’s instructions were 
followed.  
All reagents and the microtitre plate (coated with monoclonal antibodies to cortisol) 
were brought to room temperature. 25µl of samples and the supplied Controls and 
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Standards were loaded in duplicate into the appropriate wells of the plate. 25µl of 
Assay diluent were loaded into 2 wells to serve as a zero value and into 2 wells 
designated as Non-Specific Binding. 200µl of diluted Conjugate Solution (1:1600 
dilution made using Assay Diluent) was added into each well. The plate was mixed 
on an IKA MS 3 shaker (IKA -Werke, Staufen, Germany) at 500rpm for 5 min and 
then incubated at room temperature for 55 min. The cortisol in the standards and the 
samples compete with cortisol linked to horseradish peroxidase for the antibody 
binding sites. To remove unbound components, the plate was washed 4 times on a 
Labtech LT-3000 plate washer (Labtech International, East Sussex, UK) with 1X 
Wash Buffer (Wash Buffer Concentrate diluted 10-fold with distilled water). The 
plate was then blotted on paper towels. 200µl of tetramethylbenzidine (TMB) 
solution was added to each well, the plate mixed on the shaker at 500rpm for 5 min 
and incubated in the dark at room temperature for 25 min. The peroxidase reacts with 
the substrate TMB and produces a blue colour. The reaction was stopped with 50µl 
of Stop Solution (sulphuric acid) and a yellow colour was produced. The plate was 
mixed again on the shaker at 500rpm for 3 min before optical density was read on a 
plate reader (Molecular Devices OptiMax, Sunnyvale, CA) at 450nm. The minimal 
concentration of cortisol that can be distinguished from 0 is 0.007µg/dl. The intra-
assay coefficient of variation was 10.8%, within the range quoted in the manual for 
the measured concentrations. 
2.2.3 DNA extraction from saliva 
The Gentra Puregene Buccal Cell Kit with buccal brushes (Qiagen, Crawley, UK) 
was tested against the Oragene OG-250 kits with saliva sponges CS-1 (DNA 
Genotek, Ontario, Canada). The Oragene kits were chosen as they yielded more 
DNA. However, the manufacturer’s protocol does not accommodate the use of 
RNase when extracting DNA. There is an abundance of RNA in buccal cells and 
removing it would necessitate re-extracting the DNA and treating with RNase. 




First, the sample needed to be recovered from the saliva sponges and the 
manufacturer’s guidance was followed. The sample in the kit was mixed by inversion 
5 times and then incubated at 50°C in a hybridisation oven (Techne Hybridiser HB-
1D, Bibby Scientific Ltd, Staffordshire, UK) for 2 hours to inactivate nucleases. As 
much of the free liquid as possible was transferred in to a 15ml conical centrifuge 
(Falcon) (BD, Oxford, UK) tube. The barrel (without the plunger) of a 5ml sterile 
disposable syringe (BD) was placed in the same Falcon tube and the sponges from 
the Oragene kit were transferred into the syringe barrel using sterile disposable 
forceps (Griprite Blue, Rocialle, Wales, UK). The tube with the syringe barrel 
containing sponges was centrifuged at 1000 rpm at 20°C for 10 min.  
Thereafter, DNA was extracted from the liquid in the tube following instructions in 
the “Laboratory Protocol for Manual Purification of DNA from whole sample”. The 
volume of the liquid was noted and 1/25th volume of prepIT-2LP reagent (DNA 
Genotek, Ottawa, Canada) was added, mixed by vortexing for a few seconds and 
incubated on ice for 10 min to precipitate impurities. The tube was then centrifuged 
at 20°C for 20 min at 4000 rpm (Eppendorf Centrifuge 5810R, (Eppendorf, 
Stevenage, UK). The supernatant was transferred to a new 15ml Falcon tube without 
disturbing the pellet. To precipitate the DNA, 1.2 times the volume of room 
temperature 100% ethanol was added, mixed by inversion 10 times and then the 
sample was allowed to stand at room temperature for 10 min to allow the DNA to 
fully precipitate. The tube was centrifuged at 4000 rpm at 20°C for 10 min and the 
supernatant was removed as completely as possible. The pellet was washed with 1ml 
of 70% ethanol by first allowing to stand at room temperature for 1 min, then 
swirling the tube before removing the ethanol as much as possible. The DNA was 
rehydrated in 200µl of TE pH 8.0 by first vortexing (Rotamixer, Hook&Tucker 
Instruments, Croydon, UK) the sample for 30 s and then placing on an orbital shaker 
(Voss Instruments, Maldon, UK) at room temperature overnight. DNA was stored at 
4°C. 
2.2.3.1 DNA quality assessment 
Quality of DNA was assessed using electrophoresis. 5µl of 100 base pair (bp) DNA 
ladder (1µg/µl) (Invitrogen, Life Technologies, Paisley, UK) and 2µl of each DNA 
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sample was mixed with 2µl of Orange-G dye with glycerol and loaded on to an 
agarose (SeaKem, Lonza, USA) gel (1% in 0.5x TBE buffer) containing nucleic acid 
gel dye (GelRed 10,000x in water, Biotium, Hayward, CA, USA). Gels were 
electrophoresed at 100 volts for ~1 h in a Power Pack 200 system (Bio-Rad 
Laboratories, CA, USA). Gels were visualised with a transilluminator (UVitec, 
Cambridge, UK) and DNA integrity was determined by the presence of a discrete 
high molecular weight band and no smearing.  
2.2.3.2 DNA quantification 
To quantify only the DNA fraction for the downstream applications and to maximise 
accuracy, we acquired a Qubit 2.0 Fluorometer (Invitrogen, Life Technologies, 
Paisley, UK). This technique utilises fluorescence-based dyes that bind specifically 
to DNA and thus accurately measures the concentration of DNA, whereas a 
NanoDrop spectrophotometer, which quantifies DNA by absorbance, does not 
discriminate between DNA and RNA in the same sample.  
The Qubit assay was carried out according to the manufacturer’s instructions. All 
Qubit reagents were first brought to room temperature. A ‘Working Solution’ was 
prepared by diluting the selected Qubit Reagent 1:200 in Qubit Buffer. The two 
Standards provided in the kit were assayed each time a Working Solution was 
prepared and prior to assaying the samples. 10µl of the Standard was added to the 
190µl of the Working Solution. 2µl of each sample was added to 198µl of the 
Working Solution. All tubes were vortexed for 2 – 3 s and incubated for 2 min at 
room temperature prior to being measured in the Fluorometer.  
The ds DNA HS (high sensitivity) reagent was used at first. If the measured 
concentration exceeded the capacity of the reagent, then the sample was re-measured 
using ds DNA BR (broad range).  
2.2.4 Pyrosequencing 
Pyrosequencing of bisulphite converted DNA utilises the sequencing by synthesis 




2.2.4.1 Bisulphite treatment 
Bisulphite treatment deaminated unmethylated cytosines to uracil, whilst methylated 
cytosines remain unaffected. 500 ng of buccal DNA were treated using the EZ DNA 
Methylation Gold Kit (Zymo Research Corporation, CA, USA) following the 
manufacturer’s instructions.  
First, 900µl of PCR grade water, 300µl of M-Dilution Buffer and 50µl of M-
Dissolving Buffer was added to a tube of CT Conversion Reagent and mixed on an 
orbital shaker (Voss Instruments, Maldon, UK) for 10 min. 130µl of this solution 
was added to 500 ng of DNA (made up 20µl with PCR grade water). Denaturing of 
DNA and CT conversion was achieved in a thermal cycler (G-Storm1, Labtech 
International, East Sussex, UK) with the following steps: 98°C for 10 min, 64°C for 
2.5 h and then cooled to 4°C. The sample was loaded into a Zymo-Spin IC Column 
containing 600µl M-Binding Buffer. After mixed by inverting, the column was 
centrifuged at full speed for 30 s and the flow through discarded. 100µl of M-Wash 
Buffer (prepared from concentrate with 100% ethanol) was added to the column and 
centrifuged at full speed for 30 s. 200µl of M-Desulphonation Buffer added to the 
column, allowed to stand at room temperature for 15 min and centrifuged at full 
speed for 30 s. 200µl of M-Wash Buffer was added to the column, centrifuged at full 
speed for 30 s and the wash repeated. To elute the DNA, 10µl of M-Elution Buffer 
was added directly to the column matrix placed in a 1.5ml tube and centrifuged at 
full speed for 30 s. The eluate was diluted with 30µl PCR grade water and stored at -
20°C until analysed. 
2.2.4.2 PCR amplification of region of interest 
Published assays for regions that are known to control the expression of IGF2 
(DMR2 and the H19 ICR) were used. All primers were purchased from Invitrogen 
(Life Technologies, Paisley, UK) and detailed in Table 2.6. The primers were re-
constituted to make a 100µM stock solution. An aliquot was made combining the 
reverse and the forward primers and diluted with PCR grade water such that the 
concentration of each primer in this aliquot was 5µM. 
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1µl of the diluted bisulphite converted DNA was amplified by PCR using 10µl 
Amplitaq Gold 360 Master Mix (Applied Biosystems, Life Technologies, Paisley, 
UK), 0.8µl of the forward and reverse primer mix and PCR grade water to make up 
to 20 to 30µl. The conditions in the thermal cycler were: pre-incubation (95ºC for 10 
min), 45 amplification cycles (95ºC for 20 s, the appropriate annealing temperature 
(Table 2.1) for 20 s and 72ºC for 20 s for elongation). The profile finished with a 
final extension of 72ºC for 7 min and then cooled to 4ºC.   
Randomly selected PCR products and all non-template controls were visualised on a 
2% agarose gel along with a 100bp DNA ladder to ensure a discrete band at the 
appropriate molecular weight, no PCR products in the non-template control and no 
primer-dimers. Prior to the definitive procedure, this process was performed to 
ascertain the optimal annealing temperatures.  
2.2.4.3 Measuring percentage methylation 
The PyroMark Q24 system (Qiagen, Crawley, UK) was used, which utilises a 
vacuum filtration sample transfer device and Pyrosequencing technology (Biotage 
AB, Uppsala, Sweden). 
10 or 20µl of PCR product was immobilised to 2µl of Streptavidin Sepharose beads 
(GE Healthcare, Sweden) with 40µl of Binding Buffer (Qiagen, Crawley, UK), and 
28 or 18µl of Milli-Q water. The mixture was agitated on an IKA MS 3 Basic shaker 
(IKA – Werke, Staufan, Germany) for 5 to 10 min at 1400 rpm. The immobilised 
PCR product was captured and denatured on the PyroMark Q24 Vacuum Prep 
workstation.  The DNA strands were released onto a PyroMark Q24 Plate that had 
been loaded with 0.75µl of sequencing primer (used at 10µM) mixed with 24.25µl 
Annealing Buffer (Qiagen, Crawley, UK). After annealing by heating the Plate for 2 
min to 80°C using the thermal cycler, the Plate was allowed to cool to room 
temperature for at least 5 min. The Plate was analysed on a PyroMark Q24 
Instrument. A PyroMark Q24 Cartridge was loaded with PyroMark Gold 24 reagents 
(substrate and enzymes) and nucleotides as stipulated by the PyroMark Q24 Software 
2.0. Data were analysed using PyroMark Q24 Software 2.0. Due to the large number 
of samples, Pyrosequencing was not done in duplicate. Pyrosequencing results that 
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did not work or were of poor quality as indicated by the Software was removed prior 
to assignment to group and statistical analysis. Hence, data reported in experimental 
chapters are less than DNA samples acquired. Dr Jessy Cartier assisted with 














































































































































































































































































































































































































































































































































































































2.2.5 Relative telomere length assay 
Telomere length values were measured from buccal DNA using a validated qPCR 
assay that determines the relative ratio of telomere repeat (T) copy number to single-
copy gene (S) number (T/S ratio) in experimental samples as compared with a 
reference DNA sample (Cawthon, 2002).  
Published primers that were designed to amplify the telomere sequences were used 
(Table 2.7). 36B4, which encodes the acidic ribosomal phosphoprotein PO located 
on chromosome 12, was used as the single-copy control gene. The resulting PCR 
signal is a measure of telomere length, as the number of telomere primers that can 
bind the telomeric DNA at the beginning of the PCR is directly proportional to the 
total summed length of all the telomeres in the cell. T/S = 1 when the unknown DNA 
is identical to the reference DNA in its ratio of telomere repeat copy number to single 
copy gene copy number. 
Relative telomere length was quantified using a LightCycler 480 system (Roche, 
Burgess Hill, UK). All DNA samples were diluted to 0.4ng/µl concentration with 
nuclease free water and kept at -20°C until assayed. Pooled buccal DNA from 4 
infants from the study sample but collected at age of 6 months was used to create 
standards. The standards were 4 serial dilutions of 1:10 starting at 10ng/µl. The same 
standards were used for all PCR runs. Two master mixes of PCR reagents were 
prepared, one with the T primer pair, the other with the S primer pair. The 
composition of the 10µl final reaction mix for the T and the S PCRs were identical 
except for the primers and they contained the following: 1.2ng DNA, 5µl 
LightCycler 480 SYBR Green I Master, 0.9µl forward primer, 0.9µl reverse primer 
and 0.2µl LightCycler Water. All primers were purified by High Performance Liquid 
Chromatography (HPLC) at source and used at a final concentration of 300µM. 
Telomere PCR and single copy gene PCR assays were done on separate plates whilst 
preserving the sample grid positions between plates. All DNA samples and standards 
were run in triplicate. The reaction conditions were: pre-incubation (95ºC for 10 
min), 50 amplification cycles (95ºC for 15 s for denaturing and single acquisition at 
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62ºC for 1 min), followed by a melt curve and then cooling (40ºC for 10 s). Mean 
concentrations of the PCR products were calculated according to the standard curve 
method for both T and S separately. Finally, the telomere length (TL) relative to the 
amount of single copy transcript was calculated using the ratio T/S.  
2.2.6 RNA extraction from placenta 
Tissue homogenisation and RNA purification and was carried out using RNeasy 
Fibrous tissue Mini Kits (Qiagen, Crawley, UK) according to the manufacturer’s 
instructions (November 2006 edition). 
2.2.6.1 Homogenisation 
The RNeasy spin columns can be used to process a maximum of 30mg of tissue but 
as the tissue in RNAlater Stabilising Reagent is dehydrated it was important to weigh 
the tissue and I aimed for between 15 to 20mg of tissue. The remainder of the 
procedure was done at room temperature. Tissue was placed in round-bottomed 2ml 
microtubes with 300µl Buffer RLT plus 10µl/ml of β-mercaptoethanol and one 5mm 
stainless steel bead (Qiagen, Crawley, UK). Thereafter, tissue was immediately 
homogenised using the TissueLyser (Qiagen, Crawley, UK) at 25Hz for 2 min. The 
tubes were re-arranged so that the outermost tubes are innermost and vice versa and 
the homogenisation repeated.  
2.2.6.2 Total RNA purification 
All centrifugation was done at 10,000 rpm unless stated otherwise. The lysate was 
transferred into a new tube after short centrifuge. 590µl nuclease free water plus 10µl 
proteinase K added, mixed by pipetting and incubated at 55ºC for 10 min on a heat 
block. The lysate was centrifuged for 3 min. The supernatant was transferred to a 
new tube and 450µl 100% ethanol added and mixed by pipetting. 700µl of this 
solution was placed in a spin column in 2ml collection tube and centrifuged for 15 s. 
The eluate was discarded and the process repeated with the remainder of the lysate. 
The spin column was washed with 350µl of Buffer RW1 by centrifuging for 15 s and 
the eluate discarded. 80µl of DNase I (made up of 10µl DNase I stock solution to 
80µl Buffer RDD) was added directly to the spin column and incubated for 15 min. 
The spin column was washed with 350µl of Buffer RW1 followed by 500µl of 
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Buffer RPE, centrifuged for 15 s and the eluate discarded after each spin. A final 
wash was with 500µl Buffer RPE and centrifuged for 2 min. The spin column were 
placed in clean 2ml collection tubes and centrifuged at full speed for 1 min to dry the 
membrane and eliminate any possible carryover of the buffer. To elute the RNA, the 
spin columns were placed in new collection tubes and 30µl of nuclease free water 
was added directly to the membrane and centrifuged for 1 min. This step was 
repeated using the eluate to obtain high concentration of RNA. RNA was 
immediately placed on ice for the purposes of quantification and quality assessment 
and thereafter stored at -80ºC. 
2.2.6.3 RNA quality assessment 
A 2100 Bioanalyser system with the RNA 6000 Nano kit (Agilent Technologies, 
Cheshire, UK) was used and the manufacturer’s instructions (April 2007 edition) 
were followed. The RNA 6000 Nano microchip contains a sieving polymer and a 
fluorescent dye. When samples and ladder are loaded into the wells, the chip 
becomes an electrical circuit. As in normal gel electrophoresis, the RNA is driven by 
the voltage gradient and the molecules separated by size. The dye molecules 
integrate into the RNA and the speed of movement can be compared to a reference 
ladder. The provided software translates the data into a virtual ‘gel’ image and 
electropherograms. Samples were regarded to be of good quality if two discrete 
bands on the ‘gel’ image and on the electropherogram, two peaks were shown 
corresponding to 28S and 18S RNA. Degradation products, if present, will be evident 
on both the gel image and the electropherogram. Sample 4 in Figure 2.1 (a) and (b) 
shows an example of degradation products. For most samples, a RNA Integrity 
Number (RIN) was available. An algorithm that analyses the entire electrophoretic 
trace generates the RIN and a score of 1 to 10 is assigned. A sample with a RIN of 8 
or above was considered suitable for further analysis. Sample 4 in this example had a 







Figure 2.1 Representative Bioananalyzer ‘gel’ and electropherogram 
The dark and light bands on the gel (a) correspond to 28S and 18S RNA respectively. 
The tall and short peaks on the electropherogram (b) correspond to 28S and 18S 
RNA respectively.  
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2.2.6.4 RNA quantification 
A NanoDrop ND1000 spectrophotometer (Thermo Fisher Scientific, Leicestershire, 
UK) provided concentrations in ng/µl. The ratio of absorbance at wavelength of 
260nm compared with 280nm (260/280) gave an indication of protein contamination. 
Values between 1.8 and 2.2 were deemed acceptable.  
2.2.7 Reverse transcription 
1µg of RNA was made up to 9.9µl with nuclease free water and denatured by 
incubating at 70ºC for 10 min in a thermal cycler. The Promega Reverse 
Transcription system (Promega, Southampton, UK) was used according to the 
manufacturer’s instructions. Reagents and Random Primers were added to each 
sample in this order: 4µl of 25mM Magnesium Chloride, 2µl of Reverse 
Transcription 10X Buffer, 2µl of 10mM dNTP mixture, 0.5µl of Recombinant 
RNasin Ribonuclease inhibitor, 15u (0.6µl) of AMV Reverse Transcriptase (High 
Conc.) and 0.5µg (1µl) of Random Primers. The final volume was 20µl. Two 
negative controls were created: one with no RNA and the second with no AMV 
Reverse Transcriptase to ensure reagents were not contaminated and to detect 
genomic DNA. Samples were incubated at room temperature for 10 min for 
annealing and extension. Then using the thermal cycler, incubated at 42ºC for 15 min 
(for reverse transcribing), then at 95°C for 5 min (to inactivate enzymes) and finally 
cooled to 4ºC for 5 min. The resulting complementary DNA (cDNA) was stored at -
20ºC. 
2.2.8 Gene expression by qPCR 
Relative expression of messenger RNA (mRNA) was quantified using a LightCycler 
480 system (Roche, Burgess Hill, UK). Primers (detailed in Table 2.8) were a 
combination of inventoried assays (Taqman Gene Expression Assays, Applied 
Biosystems (ABI), Life Technologies, Paisley, UK) and custom made assays using 
the Universal Probe Library (UPL) (Roche, Burgess Hill, UK). The latter were 
designed to span intron boundaries. For analysing gene expression of H19, suitable 
primer sequences were obtained from Guo et al (Guo et al., 2008) and ordered from 
Invitrogen (Life Technologies, Paisley, UK) and the assay was carried out using 
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SYBR Green I technology. Primers were reconstituted to make 100µM stock 
solutions. 
2µl from each cDNA sample were pooled together to make a stock solution and this 
was serially diluted to make a standard curve from 1:4 to 1:128. 10µl of the cDNA 
sample along with the two negative controls were diluted with 190µl of LightCycler 
H2O (1 in 20 dilution). The standard curves were used to validate the primers and 
thereafter perform the assay. For the assay, the samples and the two negative controls 
were loaded in triplicate onto the 384 well plate for each gene.  
2µl of cDNA was loaded into each well of a 384 well plate for each gene followed 
by 8µl of ‘Master Mix’. For the Taqman assays, this comprised of 5µl of LightCycler 
480 Probes Master, 2.5µl of LightCycler H2O, and 0.5µl of the ready-made Primer 
Probe mix. For the UPL system, the ‘Master Mix’ comprised 5µl of LightCycler 480 
Probes Master, 2.86µl of LightCycler H2O, 0.02µl of forward primer, 0.02µl of 
reverse primer, and 0.1µl of the appropriate Probe (Roche Applied Science, West 
Sussex, UK). For the H19 assay, the ‘Master Mix’ comprised 5µl of LightCycler 480 
SYBR Green I Master, 0.05µl of forward primer, 0.05µl of reverse primer, and 2.9µl 
of LightCycler H2O. 
The reaction conditions were: pre-incubation (95ºC for 5 min), 50 amplification 
cycles (95ºC for 10 s for denaturing, 60ºC for 30 s for annealing, 72ºC for 1 s for 
elongation) and cooling (40ºC for 30 s). The reaction conditions for SYBR Green 
were: pre-incubation (95ºC for 5 min), 50 amplification cycles (95ºC for 10 s for 
denaturing, 62ºC for 20 s for annealing, 72ºC for 30 s for elongation), followed by a 
melt curve and then cooling (40ºC for 10 s). 
The concentrations of the PCR products were calculated from the standard curve. 
The ‘concentration’ of mRNA for each sample was calculated as a mean of the 
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2.2.9 Reference genes 
Endogenous reference genes are used to normalise gene expression levels allowing 
comparison across samples and the use of internal controls (‘housekeeping genes’) is 
the most common method. A pre-requisite for a suitable reference gene should be to 
demonstrate adequate expression levels and show minimal variability between the 
normal and experimental conditions. The utility of the reference gene must be 
experimentally validated for a particular tissue type and the specific experimental 
design as physiological and pathological processes can influence expression (Bustin 
et al., 2009). This is particularly applicable to human studies where homogeneity of 
participants and conditions cannot be guaranteed unlike in animal models, and where 
the tissues are subject to variation in collection and prone to degradation. The human 
placenta typifies this scenario: following delivery, the immediate attention is to the 
mother and newborn and sampling from the placenta may be delayed. This can lead 
to degraded RNA and artificial changes in gene expression (Lanoix et al., 2012; 
Vermeulen et al., 2011). Furthermore, gender may influence the expression of 
housekeeping genes in the placenta (Cleal et al., 2010). 
The MIQE (Minimum Information for Publication of Quantitative Real-Time PCR 
Experiments) Guidelines recommend objectively evaluating reference genes (Bustin 
et al., 2009) and the search for the optimal reference gene in the placenta has been 
the subject of a few studies using geNorm 
(http://medgen.ugent.be/wjvdesomp/genorm/, accessed 11 Apr 2011) software . Out 
of 7 candidates, TATA box binding protein (TBP) and succinate dehydrogenase 
complex subunit A (SDHA) were found to be the most stable followed by Tyrosine 
3-monooxygenase/tryptophan 5-mono-oxygenase activation protein, zeta polypeptide 
(YWHAZ) (Meller et al., 2005). In a similar study, ubiquitin C (UBC) and 
topoisomerase DNA (TOP1) appeared to be the most stable, followed by YWHAZ 
(Cleal et al., 2009). Comparing placental samples from late preterm pregnancies with 
fetal growth restriction with gestation matched controls, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and 18S ribosomal RNA (18S rRNA) showed the most 
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stability again followed by YWHAZ (Murthi et al., 2008). Hypoxanthine 
phosphoribosyl-transferase 1 (HPRT1), peptidylprolyl isomerase A (PPIA) and 
TOP1 were the most stable when comparing normotensive and pre-eclamptic 
pregnancies whereas PPIA, YWHAZ and GAPDH were optimal for comparing 
normal pregnancies with gestational diabetes (Lanoix et al., 2012) indicating that 
pathological processes affect reference genes. This study then went on to show that 
the choice of reference gene affected the gene expression result significantly (Lanoix 
et al., 2012). 
Based on the above results and availability of primer sets in the laboratory, I 
therefore chose to assess the stability of TBP, SDHA, YWHAZ and GAPDH in the 
placenta samples using geNormPLUS as part of the qbasePLUS software (Eclipse v 3.7), 
the updated software available from Biogazelle (Zwijnaarde, Belgium) at the time. 
The premise of the geNormPLUS program is that the ratios between stably expressed 
genes should remain regular. The program calculates M, which is the average pair-
wise variation of a single reference gene from the raw expression data. The highest 
M value denotes the gene with the most instability (TBP in this study) and this is 
removed at each step. Thereafter, a new M value is calculated for the remaining 
genes until only 2 genes remain viz. GAPDH and YWHAZ in this study, which 
cannot be resolved from each other (Vandesompele et al., 2002) (Figure 2.2). The 
MIQE Guidelines define reference gene stability with M values below a threshold of 
1.0 for heterogeneous samples and below 0.5 for homogeneous samples (Bustin et 
al., 2009). Both GAPDH and YWHAZ had M values of 0.98, just below the threshold 
for heterogeneous samples. 
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Figure 2.2 geNormPLUS output depicting stability of genes 
The candidate genes were further assessed by NormFinder, a Microsoft Excel add-in 
freely available on the internet (http://www.mdl.dk/publicationsnormfinder.htm, 
accessed 24 Aug 2011) (Andersen et al., 2004). The algorithm ranks the set of 
candidate reference genes according the their expression stability in a given sample 
and given experimental design. The algorithm estimates the overall expression 
variation but also the variation between sample subgroups of the sample set. A low 
stability value indicated high intra- and inter-group expression stability. SDHA had 
the lowest stability value despite a high M value according to geNormPLUS (Table 
2.9). Differences in results between geNorm and NormFinder where also found by 
Lanoix et al and SDHA was also inconsistent (Lanoix et al., 2012). Considering the 
two outputs, YWHAZ was chosen as the reference gene. 
Gene name Stability value 
 
Best gene SDHA 
TBP 0.131 
   GAPDH 0.103 
   SDHA 0.079 
   YWHAZ 0.087 
    
Table 2.9 NormFinder output indicating stability values of reference genes 
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2.2.10 Assessment of 5mC and 5hmC by qPCR 
The process requires RNA free DNA to be sheared to the appropriately sized 
fragments. Capturing 5mC is based on the Methylated CpG Island Recovery Assay 
(MIRA) which utililises the high affinity of the methyl binding domain 
MBD2b/MBD3L1 (methyl binding domain) protein complex for 5mC. DNA with 
5hmC is immunoprecipitated by a rabbit polyclonal antibody against 5hmC. The 
remainder of the techniques for the enrichment of 5mC and 5hmC are similar. 
Protein-DNA/antibody-DNA complexes are then captured with nickel-coated 
magnetic beads and subsequent wash steps remove fragments with little or no 
methylation. Proteinase K is then used to cleave off the DNA off the beads and the 
DNA is eluted. Percentage enrichment of 5mC and 5hmC at regions of interest were 
studied by qPCR. A pictorial overview of the procedure is in Figure 2.3. 
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Figure 2.3 The 5mC and 5hmC assay 
a) Genomic DNA b) shearing to fragments by sonication c) capturing DNA 
fragments with 5mC using MBD protein d) immunoprecipitation of DNA fragments 
with 5hmC e) qPCR to study regions of interest. 
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2.2.10.1 DNA extraction from placenta 
DNA extraction was carried out using DNeasy Blood & Tissue Kit (Qiagen, 
Crawley, UK) according to the manufacturer’s instructions (November 2006 edition) 
and with modifications. All centrifugation was done at room temperature. 
25mg of placental tissue was placed in 360µl Buffer ATL with 40µl Proteinase K 
(23mg/ml) and incubated at 56°C overnight in a hybridisation oven. (The suggested 
volumes for both Buffer ATL and Proteinase K were doubled to increase DNA 
yield). 15µl of RNase A (10mg/ml) (Sigma Aldrich, UK) was added, vortexed to mix 
and incubated for 2 min at room temperature (the suggested amount of 40µl of 
10mg/ml RNase A was reduced in steps and 15µl was chosen to yield RNA free 
DNA whilst minimising the possibility of reducing total DNA yield). After a further 
vortex for 15 s, 400µl of Buffer AL plus 400µl 100% ethanol (pre-mixed) was added 
and mixed by vortexing (the suggested volumes for both Buffer AL and 100% 
ethanol were doubled to increase DNA yield). This mixture was transferred into a 
DNeasy Mini spin column and centrifuged at 8000 rpm for 1 min. The flow through 
was discarded. The column was placed in a new collection tube, 500µl Buffer AW1 
was added, centrifuged at 8000 rpm for 1 min, flow through and collection tube 
discarded. The column was placed in a new collection tube, 500µl Buffer AW2 
added, centrifuged at 14,000 rpm for 3 min to dry the membrane and the collection 
tube with the flow through discarded. 100µl of Buffer AE was transferred directly 
onto the membrane, incubated at room temperature for 1 min and centrifuged at 8000 
rpm for 1 min to elute the DNA. The final step was repeated to increase overall DNA 
yield.  
2.2.10.2 DNA quality assessment 
DNA quality was assessed according to the method described in 2.2.3.1. 
Additionally, the aim was to show no products suggestive of RNA on the gels. If 
RNA was found, the sample was discarded and DNA extraction repeated from a new 
piece of tissue.  
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2.2.10.3 DNA quantification 
DNA was quantified according the method described in 2.2.6.4 using the NanoDrop 
Spectrophotometer. Additionally, DNA was quantified using the Qubit 2.0 
Fluorometer according the method described in 2.2.3.2. This technique utilises 
fluorescence-based dyes that bind specifically to DNA and thus accurately measures 
the concentration of DNA whereas the NanoDrop does not discriminate between 
DNA and RNA in the same sample. The measured concentrations of the DNA 
samples by the Qubit approximated those by the NanoDrop further indicating that the 
DNA was free of RNA. The value obtained by the Qubit was used for calculations.  
2.2.10.4 Sonication 
Initial sonication was using a random selection of 12 DNA samples using the 
Bioruptor ultrasonic disruptor (Diagenode, Liège, Belgium). Briefly, 5µg of each 
sample was halved. Each 2.5µg of DNA was made up to 200µl with Buffer AE and 
sonicated for 30 s on and 30 s off at 4°C. The sonication was for cycles of 8 to 15 to 
achieve, for one half the samples, DNA fragments with a mean size of 200 to 300bp 
and for the other half, mean size of 500 to 600bp. 5µl of each sample was 
electrophoresed for ~ 45 min at 140 volts on a 1.2% agarose gel to check the 
fragments at intervals until the desired size was achieved. 
The Covaris E220 ultrasonicator with Adaptive Focused Acoustics (AFA) (Covaris, 
MA, USA) was used for the remainder of the samples as it allowed for higher 
throughput and fidelity. 2.5µg of DNA in 100µl Buffer AE was transferred to Crimp-
Cap microTUBEs with AFA fibre via the pre-split septum taking care to avoid 
bubbles and the tubes loaded onto the Covaris rack. Initially, surplus DNA was used 
to test variations on the manufacturer’s recommended acoustic parameters to achieve 
the desired mean fragment sizes. Increasing the duration, the duty factor and the peak 
incident power resulted in smaller fragments. Ten different variations were tested in 
total with the following parameter ranges: time (60 – 180s), Peak Incident Power 
(105 – 175 Watts) and Duty Factor either 5 or 10%. The Cycles per Burst was kept 
constant at 200. To achieve a peak between 200 and 300bp, the sonication was for 
180 s with a Peak Incident Power of 175 Watts and a Duty Factor of 10%. To 
 
   76 
achieve a peak between 500 and 600bp, the sonication was for 65 s with a Peak 
Incident Power of 105 Watts and a Duty Factor of 5%.  
Following the sonication, the samples were removed from the microTUBEs and 
sonication profiles were measured using the Agilent 2200 TapeStation Instrument 
(Agilent Technologies, Cheshire, UK) with the D1K ScreenTape assay according to 
the manufacturer’s instructions. The principle of the technique is similar to that 
described in 2.2.6.3. Electropherograms depict the distribution of the fragment sizes 
and indicate the peak value. Following batch sonication of the samples, 15 were 
randomly selected for quality assurance using the TapeStation. The amalgamated 
electropherograms showed that the shearing by the Covaris is reproducible (Figure 
2.3 (b)).  
2.2.10.5 Capture of 5mC by methyl binding domain (MBD) protein 
The Active Motif MethylCollector Ultra Kit (catalogue #55005) (was used and the 
manufacturer’s instructions were followed. Sample DNA can amount from 1ng to 
1µg. A range of sample DNA amounts was tested and 500ng was chosen to yield 
quantifiable amplification by qPCR whilst conserving DNA. DNA that had been 
sonicated to a peak fragment size of 200 to 300bp was required. 10% of this DNA 
i.e. 5ng was kept aside as the ‘input’ and made up to 10µl with Buffer AE. To make a 
binding reaction, the following were added to a PCR tube in order: 10µl Magnetic 
beads, 70µl Complete Binding Buffer (Low Salt Binding Buffer plus Protease 
Inhibitor Cocktail), 500ng DNA and 10µl His-MBD2/MBD3L1 protein complex. 
After mixing, the tube was incubated on an orbital shaker (Stuart Rotator SB2, Biby 
Sterilin LT8, Stone, UK) at 4°C for 1 h. The PCR tube was centrifuged briefly, 
placed on the magnetic strand to pellet the beads and the supernatant discarded. The 
beads were washed 4 times with 200µl Binding Buffer, each time the beads were re-
suspended by pipetting several times and the supernatant removed by using the 
magnetic strand to pellet the beads. After the final wash and the supernatant 
removed, the beads were re-suspended in 100µl Complete Elution Buffer (2µl 
Proteinase K added to 98µl Elution Buffer) by pipetting 2-3 times and incubated at 
50°C for 30 min in a hybridisation oven. The beads were pelleted using the magnetic 
strand, the supernatant with methylated DNA fragments transferred to new a tube 
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and 2µl of Proteinase K Stop Solution (previously warmed to 37°C on a hot block for 
10 min) added and pipetted 2-3 times to mix.  
2.2.10.6 Immunoprecipitation of 5hmC 
2.5µg of DNA with peak fragment size 500 to 600bp was made up to 450µl with 
Buffer AE, denatured for 10 min in boiling water on a heat block and then 
immediately cooled on ice water for 5 min. 50µl of 10x IP buffer was added (then 
50µl was removed (i.e. 10%) and set aside from this procedure as the ‘input’) and 
DNA immunoprecipitated with 2µl of a rabbit polyclonal antibody against 5hmC 
(Active Motif, catalogue #39791) at 4°C for 2 h. 40µl of magnetic M-280 protein G 
Dynabeads (Invitrogen #100-03D) was pre-washed with 800µl PBS-BSA 0.1% with 
shaking (Stuart Gyro-rocker SSL3, Bibby Scientific, Staffordshire, UK) at room 
temperature. The beads were collected using a magnetic rack (Dynal MPC-S 
Magnetic Particle Concentrator, Dynal Biotech, Norway), re-suspended in 40µl of 1x 
IP buffer and added to the DNA-5hmC mix. The resulting mixture was incubated at 
4°C for 1 h on the orbital shaker prior to washing all unbound fragments three times 
with 1ml 1x IP buffer. The first wash was with cold IP buffer; the second and third 
washes were with IP buffer at room temperature. Each wash was for 10 min on an 
orbital shaker. Washed beads were re-suspended in 250µl Proteinase K digestion 
buffer, 10µl Proteinase K (20mg/ml) added and incubated at 50°C with mixing 
(Thermomixer, Eppendorf, Hamburg, Germany) set at 400 rpm overnight. Samples 
were briefly centrifuged at 2000 rpm and beads removed with the magnetic rack. 
2.2.10.7 Purifying DNA fragments 
The samples with DNA fragments pulled down by MBD protein and 
immunoprecipitated DNA fragments along with the corresponding ‘input’ samples 
were then purified. The QIAquick PCR Purification Kit (Qiagen, Crawley, UK) was 
used and the manufacturer’s instructions were followed (March 2008 edition). All 
centrifugation steps were carried out at 13,000 rpm at room temperature. 
5 volumes of Buffer PB (with 1:250 volume of pH indicator I added to increase DNA 
yield) were added to 1 volume of DNA sample. If the resulting mixture did not turn 
yellow, then 10µl of 3M sodium acetate pH 5.0 was added and mixed. To bind the 
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DNA, the sample was applied to the QIAquick column in a collection tube, 
centrifuged for 60 s and the flow-through discarded. The column was washed with 
750µl Buffer PE and centrifuged for 60 s and the flow-through was discarded. The 
centrifugation was repeated to remove residual ethanol and the column was placed in 
a clean microcentrifuge tube. To elute DNA, 50µl Buffer EB was applied directly to 
the membrane, allowed to stand for 1 min and then centrifuged for 1 min. The eluate 
was further diluted with Buffer EB in a ratio of 1:3. 
2.2.10.8 Analysis of percentage enrichment by qPCR 
Percentage enrichment of 5mC and 5hmC was quantified using the LightCycler 480 
system (Roche, Burgess Hill, UK). Primers (detailed in Table 2.10) were obtained 
from Invitrogen (Life Technologies, Paisley, UK), reconstituted to make a 100mM 
stock solution and carried out using SYBR Green I technology.  
Randomly chosen sonicated DNA samples that were surplus were pooled to 200µl 
and serially diluted in Buffer AE to create a standard curve from 1:10 to 1:1000. The 
standard curves were used to validate the primers and thereafter perform the assays. 
For each assay, the samples and a negative control were loaded in triplicate and the 
corresponding ‘input’ samples and negative control were loaded in duplicate onto the 
384-well plate. This compromise was to ensure that one plate was used for each 
assay.   
2µl of sample was loaded into each well followed by 8µl of ‘Master Mix’. This 
comprised of 5µl of LightCycler 480 SYBR Green I Master, 0.025 - 0.05µl of the 
forward primer, 0.025 - 0.05µl of the reverse primer, and 2.9 - 2.95µl of LightCycler 
H2O. The amount of primers was halved in some instances to diminish the formation 
of primer dimers. The reaction conditions were: pre-incubation (95ºC for 5 min), 50 
amplification cycles (95ºC for 10 s for denaturing, 62ºC for 20 s for annealing, 72ºC 
for 30 s for elongation), followed by a melt curve and then cooling (40ºC for 10 s). 
The concentrations of the PCR products were calculated from the standard curve. 
The percentage enrichment of 5hmC or 5mC each sample was calculated as the mean 
of the sample assay relative to the mean of the assay for the corresponding ‘input’ 
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sample (multiplied by 10) and further multiplied by 100. Percentage enrichment of 
5hmC and 5mC at the GAPDH promoter was assayed as a negative control and there 
were very low levels of enrichment of 5hmC and no amplification in many instances 
for 5mC. Therefore GAPDH was not used as a reference gene. 
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Primer name Primer sequences Chromosome location 
      
GAPDH1 F: CGGCTACTAGCGGTTTTACG chr12:6513796+6513984 
  R: AAGAAGATGCGGCTGACTGT   
      
H19 promoter1 F: CCTGGAATTCTCCAAAGACG chr11:1975813+1975927 
  R: AGTGGTCTGGGAGGGAGAAG   
      
H19 genic 11 F: CTCAGCTCTGGGATGATGTG chr11:1973443+1973573 
  R: AGCCCAACATCAAAGACACC   
      
H19 genic 31 F: CTGGTGCTCACCTTCCAGAG chr11:1973671+1973802 
  R: ATGGTGCTACCCAGCTCAAG   
      
H19 genic 41 F: GCCAGCTACACCTCCGTTG chr11:1975242+1975378 
  R: AGCTAGGGCTGGAAAGAAGG   
      
H19 DMR1 F: GATCTCGGCCCTAGTGTGAA chr11:1977756-1977943  
  R: GTGATGTGTGAGCCTGCACT   
      
H19 CTCF32 F: CACACCACGTCTTCGTATCG chr11:1979701-1979890 
  R: ATTTGGGGGCTGTCCTTAGT   
      
H19 CTCF62 F: AGTTGTGGAATCGGAAGTGG chr11:1977617-1977807 
  R: GATAATGCCCGACCTGAAGA   
      
IGF2 DMR02 F: TTTCATATTCCGTGCCATGA chr11:2125774-2125987 
  R: CCTGCCTAGAGCTCCCTCTT   
      
IGF2 DMR22 F: CGTTGAGGAGTGCTGTTTCC chr11:2111194-2111431 
  R: CACAGCAAGCAAGGAAGTCA   
      
KvDMR3 F: TGCGGATTCCAGACTCCAAT chr11:2676925+2677065 
  R: GCTCCCATCTGCACCTTATG   
      
Table 2.10 Primer sequences for 5mC and 5hmC qPCR 
Chromosome location refers to UCSC Genome Browser hg18. Primer sequences 
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2.3 Statistics 
All statistical analysis was using SPSS for Mac v19 (IBM, New York, USA). 
Independent and paired samples t tests were used to compare continuous variables 
between groups and multivariate linear regression was used to adjust for 
confounders. Paired samples t tests were used where appropriate. The chi square test 
was used for categorical variables. Pearson’s correlation coefficient was used to 
measure relationships between normally distributed variables and multivariate linear 
regression was used to adjust for confounders. Further details are given in each 
experimental chapter. 
All graphs were created using Prism v5.0b for Mac OS X (GraphPad Software Inc, 
CA, USA). 
Weight, head circumference, length, weight gain, subscapular skinfold and triceps 
skinfold measurements were converted to standard deviation scores using 
LMSgrowth version 2.71. This is a Microsoft Excel Add-in to access growth 
references based on the LMS method provided by the Child Growth Foundation 
(http://www.healthforallchildren.com/?product=lmsgrowth, accessed 7 February 
2011). They define the UK-WHO growth charts. 
The following sources were used: 
“UK_WHO_term.xls” includes values for term birth at 37-42 weeks computed from 
the “British 1990 reference data, reanalysed 2009”. This is combined with the “WHO 
Child Growth Standards” from 2 weeks to 4 years. From 4 years, the data is from the 
“British 1990 reference”. 
“UK_WHO_preterm.xls” is identical the above except that it includes values for 
births from gestations 23 to 42 weeks, which is also from “British 1990 reference 
data, reanalysed 2009”. 
“WHO2006.xls” includes data for subscapular and triceps skinfold for 0.25-5 years.  
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2.4 Software 
SPSS for Mac v19 (IBM, New York, USA) 
Prism v5.0b for Mac OS X (GraphPad Software Inc, CA, USA) 
PyroMark Q24 Software 2.0 (Qiagen, Crawley, UK) 
NormFinder Microsoft Excel 2003 Add-in v0.953 
geNormPLUS (qbasePLUS Eclipse v3.7, Biogazelle, Zwijnaarde, Belgium) 
2100 Expert Software (Agilent Technologies, Cheshire, UK) 
LightCycler 480 release 1.5 O SP3 (Roche, Burgess Hill, UK) 
ND-1000 v3.3 (NanoDrop Technologies, Thermo Fisher Scientific, Leicestershire, 
UK) 
SoftMax Pro 5.0 Microplate Data Acquisition and Analysis (Molecular Devices Ltd, 
Berkshire, UK) 
2.5 Funding 
The studies were funded by the Chief Scientist’s Office for Scotland. 
 
 
    83 
Chapter 3: Programming in the preterm 
3.1 Introduction 
Preterm infants are at increased risk of the metabolic syndrome in later life 
(Parkinson et al., 2013) (Tinnion et al., 2014). The mechanisms accounting for such 
‘programming’ effects are unclear, but may include extra-uterine growth restriction 
followed by catch-up growth (Fewtrell et al., 2000) (Rotteveel et al., 2008) and 
abnormal HPA axis activity (Grunau et al., 2007) (Reynolds et al., 2001). 
Changes to the epigenome may be one molecular mechanism mediating such 
programmed effects. Early life stress in the form of exposure to an unbalanced diet or 
famine during gestation has been associated with cardio-metabolic outcomes in the 
offspring as adults, along with altered DNA methylation at the H19 ICR (Drake et 
al., 2012) and IGF2 DMR0 and DMR2 (Tobi et al., 2012) (Heijmans et al., 2008). 
Altered DNA methylation at the IGF2 DMR0 has also been measured in adults born 
preterm (Wehkalampi et al., 2013). However it is not known whether differences 
such as these would have been present and identifiable at birth or whether they 
develop later in life. By virtue of being an imprinted region, IGF2/H19 is 
developmentally regulated by DNA methylation and can be susceptible to 
environmental insults. Given that changes in DNA methylation at this locus are 
thought to be stable over decades (Heijmans et al., 2007) and that changes to the 
methylome have been identified with respect to gestation (Schroeder et al., 2011), 
IGF2/H19 is a candidate for study of DNA methylation in preterm infants. 
3.2 Aims and Hypothesis 
I aimed to (1) recruit a cohort of preterm infants and term controls (2) measure 
growth (including body composition) and HPA axis activity and (3) test the 
hypothesis that preterm infants have altered DNA methylation (5mC) at IGF2/H19 
over the first year of life compared to term infants.  
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3.3 Methods 
3.3.1 Subjects 
Following ethical approval and written parental consent, preterm and term infants 
were recruited within the first week of life. Demographic details and history were 
obtained following consent, during clinic visits and from the mother’s hospital 
records. 
Infants were seen within the first week of life (“birth”), 3 months/3 months corrected 
for preterm infants (“3 months”) and 1 year/1 year corrected age (“1 year”). 
Additionally, the preterm infants were seen at postmenstrual age of 37 to 42 weeks 
(denoted as “term corrected age”). All time points mentioned henceforth refer to the 
corrected age denoted within brackets for simplicity. 
3.3.2 Clinical assessments 
Weight, length and occipito-frontal circumference (OFC) was measured at all time 
points. 
Percentage body fat mass was measured by air displacement plethysmography 
(densitometry) using the PEAPOD Body Composition System at birth/term corrected 
age and 3 months.  Skin fold thickness was measured at 1 year.  
Saliva for cortisol was collected at 3 months at the end of the clinical examination. 
All clinic visits were scheduled in the afternoon for consistency.  
3.3.3 Laboratory methods 
Salivary cortisol was measured by the High Sensitivity Salivary Cortisol Enzyme 
Immunoassay Kit. 
Saliva for buccal DNA was collected using Oragene DNA (OG-250) kits. DNA was 
extracted following the manufacturer’s guidance. Percentage methylation was 
analysed using Pyrosequencing after bisulphite conversion.  
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3.3.4 Statistics 
Weight, length, OFC, skin fold thickness measurements and weight gain were 
adjusted for age and gender by converting to standard deviation (SD) scores (z-
scores) using LMSgrowth, a Microsoft Excel Add-in to access growth references that 
define the UK-WHO growth charts.  
Independent samples t testing was used to test the differences in growth attainment 
and cortisol between term and preterm infants. Multivariate linear regression was 
used to assess differences in body composition. Multivariate linear regression 
analysis was also used to test the hypothesis that preterm birth is associated with 
altered DNA methylation. Covariates that could confound the association or be in the 
causal pathway were added into the model in a hierarchical manner. Outcome 
variables were percentage DNA methylation at birth, term corrected age and 1 year. 
Also included were variables that were grossly unequal between the groups: breast 
milk at 3 months (entered into the model for analyses beyond the neonatal period) 
and mode of delivery (entered into the model for analyses in the neonatal period). 
The unstandardised regression (β) coefficients from these models indicate the 
number of units that percentage DNA methylation will change as a result of one unit 
change in the other predictors. Paired samples t testing was used where appropriate. 
Pearson’s correlation coefficient to test for relationships between normally 
distributed variables and Spearman’s rho for ordinal values. 
Since in general, neighbouring CpG sites tend to have similar levels of methylation 
(Nautiyal et al., 2010), percentage DNA (cytosine) methylation (%5mC) is expressed 
as the average across all CpG sites in the locus tested rather than at individual CpG 
sites and analysed as such.  
Salivary cortisol values were log transformed using natural logs to achieve a normal 
distribution. All other values were normally distributed or converted to standard 
deviation scores.  
 
    86 
Based on a previous study in this department, 25 infants were needed in each group 
to detect a 5% difference in DNA methylation (Drake et al., 2012). We obtained 
approval to recruit 50 in each group to account for drop out.  
Data are expressed as mean ± standard error of the mean (SEM). Statistical 
significance was set at p < 0.05 (2 tailed). 
3.3.5 Covariates 
Social deprivation was coded as DEPCAT (deprivation category) scores. These are 
based on the mother’s postcode at booking and obtained from “Carstairs scores for 
Scottish postcode sectors from the 2001 Census” (McLoone, 2004). The scores are 
from 1 to 7 where 7 indicates the worst social deprivation. Maternal smoking was 
categorised as current smoker, never smoked, former (stopped pre-pregnancy) or 
former (stopped during pregnancy). Labour was whether the mother experienced 
labour prior to delivery or not.  Breast milk at 3 months indicates whether or not the 
infant was receiving any breast milk at 3 months corrected age.  
3.4 Results 
3.4.1 The cohort 
Forty infants at full term were recruited. Five of the term infants were admitted to the 
neonatal unit for problems with transitioning: respiratory distress syndrome, 
excessive early weight loss, and haemolysis from Rh isoimmunisation. The average 
length of stay was 4.5 days, range of 2 – 9 days. None were routinely followed up in 
the neonatal clinic.   
Fifty preterm infants were recruited. Four of these infants died in the neonatal period 
and buccal DNA was not obtained for analysis. In three infants, saliva for buccal 
cells was not collected in view of the severity of their clinical condition and in the 
fourth infant, the DNA sample was of very poor quality. Therefore 46 preterm 
infants were included for analysis. There were two further deaths in the neonatal 
period, however buccal cells were collected after birth and the DNA was suitable for 
analysis. The synthetic steroid available to the obstetricians during the period of 
recruitment (to help fetal maturation when preterm delivery was threatened) was 
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dexamethasone due to a national shortage in the supply of betamethasone. None of 
the preterm infants received postnatal steroids for hypotension or for dependence on 
mechanical ventilation.  
  Term Preterm 
      
Gestation at birth, weeks 40.2 (38+3-42.2) 28.8 (25+2–31+5) 
Birth weight, g 3649 (2640–4740) 1174 (550–1820) 
Birth weight SDS 0.44 (-1.52–2.92) -0.42 (-3.15–1.05) 
Male, n (%) 15 (38) 31 (67) 
Bronchopulmonary dysplasia, n (%) 0 13 (30) 
Laser for retinopathy of prematurity, n (%) 0 4 (9.1) 
Necrotising enterocolitis, n (%) 0 6 (13.3) 
Intraventricular haemorrhage, n (%) 0 1 (2.2) 
Periventricular leucomalacia, n (%) 0 2 (4.5) 
Late onset sepsis, n (%) 0 17 (37) 
TPN duration, days 0 14.9 (0–107) 
Any breast milk at 3 months, n (%) 28 (75.7) 9 (22.5) 
      
Table 3.1 Characteristics of the study participants 
Values are means (range). N = 40 full term and 46 preterm infants. Birth weight SDS 
was different between the groups, p < 0.001 (independent samples t test) and the 
frequency of male gender was different between the groups, p = 0.006 (Pearson Chi 
square test). Bronchopulmonary dysplasia (BPD) is defined as need for respiratory 
support and/or supplemental oxygen at 36 weeks’ postmenstrual age to maintain 
oxygen saturations of 90% or more. A diagnosis of necrotising enterocolitis was 
applied when cases achieved Bell stage 2 or greater. Intraventricular haemorrhage is 
defined as only grade III or IV events. The definition of late onset sepsis is taken 
from the Vermont Oxford Network Manual of Operations, release 16.3. Missing 
data: 2 preterm infants died before an age where retinopathy of prematurity develops 
or a diagnosis of BPD is given. Three term infants and 6 preterm infants were not 
seen at 3 months. Abbreviation: SDS – standard deviation score. 
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  Term Preterm 
      
Age, years 35.2 (25.5-44.2) 31.3 (20 –41.4) 
BMI at booking, kg/m2 24.3 (19.1-33.5) 27.2 (17.9-46) 
DEPCAT score, mode 3 4 
Caucasian ethnicity, n (%) 40 (100) 38 (92.7) 
Smoking, n (%)     
Current 0 8 (19.5) 
Former – stopped during pregnancy 2 (5) 4 (9.8) 
Former - stopped pre-pregnancy 12 (30) 11 (26.8) 
Never 26 (65) 18 (43.9) 
Primiparity, n (%) 21 (52.5) 25 (61) 
Folic acid during first trimester, n (%) 40 (100) 35 (94.6) 
Assisted reproduction, n (%) 0 6 (14.6) 
Multiple pregnancy, n (%) 0 8 (19.5) 
Hypertension or pre-eclampsia, n (%) 0 10 (24.4) 
Diabetes during pregnancy, n (%) 0 3 (7.3) 
Antenatal steroids, n (%)     
None 40 (100) 3 (7.3) 
Incomplete course - 11 (26.8) 
Complete course - 27 (65.9) 
Antenatal Magnesium sulphate, n (%) 0 9 (22) 
Caesarean section, n (%) 28 (70) 23 (56.1) 
Labour, n (%) 18 (37.5) 24 (58.5) 
Age of partner 35.3 (26.7-46.2) 32.9 (21.9-46.7) 
      
Table 3.2 Maternal characteristics of the study participants 
Values are means (range). N = 40 mothers for full term infants and 41 for preterm 
infants. Abbreviation: DEPCAT – deprivation category. Maternal age and BMI were 
different between the two groups, p = 0.002 and p = 0.017 respectively (independent 
samples t test). Age of partner was not significantly different, p = 0.07. 
3.4.2 Anthropometry in infancy 
3.4.2.1 Longitudinal growth 
Term infants were measured on average 2.1 days (range 0 to 8) after birth, at 3 
months (13.3 weeks; range 10.4 to 16.9) and 1 year (52.6 weeks; range 48.1 to 57.4). 
Preterm infants were measured at term corrected age at an average of 39.3 (range 
35+0 to 44+1) corrected weeks, at 3 months corrected (13.8 weeks; range 10.3 to 
18.3) and 1 year corrected (54.4 weeks; range 52.1 to 68.7). 
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The mean birth weight SD score for the preterm cohort was -0.4 ± 0.9 however by 
term corrected age, the mean SD score for weight was -1.4 ± 0.2, indicating 
downward deviation from the birth SD score. In contrast, the mean SD score for head 
circumference in preterm infants at term corrected age was -0.2 ± 0.2. The significant 
difference in head circumference SD score at term corrected age is in the context of 
greater than average measurements in the term infants. (Figure 3.1) Growth 
restriction during the third trimester occurs as a result of factors such as placental 
insufficiency or maternal illness and there is a relative sparing of head growth 
(Kramer et al., 1989). Data suggests that this pattern of growth tends to persist in the 
neonatal unit, with sparing of head growth (Cockerill et al., 2006) resulting in 
asymmetric growth restriction at term corrected age (Uthaya et al., 2005).  
Preterm infants were lighter and shorter than term infants at all comparative time 
points, p < 0.05. The exception to this is at 1 year corrected, where the preterm 
infants had a length measurement equivalent to that of term infants, p = 0.26. By 1 
year, mean SD score for weight was -0.01 ± 0.2 in the preterm group.  The 
differences later in infancy are mainly as the term infants are larger than the 
reference mean. In preterm infants, weight and length SD scores at term corrected 
age were significantly less than zero (p <0.001), as were weight and length SD scores 
at 3 months (p <0.001 and p = 0.008 respectively), but not at 1 year (p = 0.89 and 
0.15 respectively). OFC SD scores at term corrected age and 3 months were not 
significantly different from zero (p = 0.35 and 0.15 respectively) but significantly 
larger than zero at 1 year (p <0.001) (Figure 3.1). 
Although it therefore appears as though preterm infants exhibited ‘catch-up’ weight 
gain, there were no significant differences between preterm and term infants in mean 
weight gain SD scores between birth/term corrected age and 3 months (mean 
difference -0.02, 95% confidence interval (CI) [-0.6, 0.5], t =-0.1, p = 0.93). Nor was 
there a significant difference in mean weight gain SD scores between 3 months and 1 
year (mean difference -0.2, 95%CI [-0.7, 0.2], t = -1.1, p = 0.29). In other words, the 
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Figure 3.2 Change in weight SD score between term and preterm infants over 
the first year 
Mean ± SEM. Term (birth to 3 months), n = 35, (3 months to 1 year), n = 33. Preterm 
(term age to 3 months), n = 36, (3 months to 1 year) n = 34.  
3.4.2.2 Body composition 
Term infants had body composition measured on average 2 days (range 0 to 7) after 
birth and again at 3 months (13.2 weeks; range 10.4 to 16.9). Preterm infants had 
body composition measured at average 39.8 weeks post-menstrual age (range 36+2 
to 42+4) and again at 3 months (13.8 weeks; range 10.6 to 18.3). Not all infants 
recruited were assessed. For the term infants, 8 parents declined for assessment after 
birth. At 3 months, 2 parents declined, the PEAPOD was out of order for 2 infants, 1 
infant was in a Pavlik harness for developmental dysplasia of the hips and 5 infants 
were not seen. For the preterm infants at term equivalent age, 8 infants were 
receiving respiratory support for BPD and 4 were dependent on parenteral nutrition 
on the neonatal unit. Many who do well are discharged either home or to their local 
neonatal unit well before term age, thus measurements at term corrected age were not 
obtained for 11 such infants. This was recognised as the study was conducted and 
parents were invited to return for assessment. Assessments obtained > 36 weeks 
corrected age was used for analysis. At 3 months, 2 parents declined, 1 infant was 
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1, the measurement was aborted accidentally and not repeated as the infant was 
distressed. The numbers studied at each time point are shown in the graphs. 
Preterm infants had a higher percentage body fat (17.1 ± 1.0%) at term corrected age 
when compared with term infants at birth (11.6 ± 0.7%). The difference, 5.5%, 
95%CI [8.0, 3.0], was significant t = 4.4, p < 0.001 and remained so with adjustment 
for gender, β = 5.7, 95% CI [3.1, 8.3], p < 0.001.  
This difference in percentage body fat did not persist at 3 months, (preterm infants 
23.7 ± 0.7%; term infants 24.6 ± 0.7%). This remained so after adjustment for gender 
and breast milk intake (β = -0.3, 95% CI [-2.8, 2.2], p = 0.82) (Figure 3.3). This was 
despite male gender appearing to lower percentage fat mass in this model. Table 3.3 
details the regression coefficients for the covariates. Although some previous studies 
in full term breast fed or formula fed infants have not shown a difference with gender 
(Roggero et al., 2010) (Eriksson et al., 2010) (Carberry et al., 2010), others have 
shown that although gender did not affect fat mass in preterm infants, but it did so in 
full term infants (Simon et al., 2013). In our study, adjustment for gender was 
undertaken in view of the large disparity between the two groups. Adjustment for 
mode of feeding was performed since body composition is associated with method of 
infant feeding (Gale et al., 2012). 
At 1 year, preterm infants had lower triceps skin fold thickness standard deviation 
score (1.4 ± 0.2) than term infants (2.1 ± 0.2). The mean difference, 0.8, 95%CI [0.3, 
1.3], was significant t = 3.3, p = 0.001. There were no differences in subscapular skin 
fold thickness. (Figure 3.4) 
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Figure 3.3 Percentage fat mass in term and preterm infants 
Box and whisker plot: 10th to the 90th percentile with the line at median (+ indicates 
the mean). Term infants: n = 32 at birth and 30 at 3 months. Preterm infants: n = 21 
at term corrected age and 32 at 3 months. **p < 0.001  
 
    β [95% CI] t p 
          
Model Prematurity -0.3 [-2.8, 2.2] -0.2 0.82 
  Male 2.1 [-4.2, -0.05] -2.1 0.045 
  Breast milk at 3 months -0.3 [-2.7, 2.0] -0.3 0.78 
          
R2 = 0.1 (p = 0.15) 
 
Table 3.3 Multiple regression model of predictors of percentage fat mass at 3 


















    94 
 
Figure 3.4 Skinfold thickness in term and preterm infants at 1 year 
Box and whisker plot: 10th to the 90th percentile with the line at median (+ indicates 
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3.4.3 Salivary cortisol 
Preterm infants demonstrated a blunted cortisol response to a stressor (0.23 ± 0.04 
µg/dl) compared to term infants (0.31 ± 0.04 µg/dl) at 3 months. The mean 
difference, 0.4, 95%CI [0.05, 0.7], was significant, t = 2.3, p = 0.02. 
 
Figure 3.5 Salivary cortisol in term and preterm infants at 3 months 
Scatter plot with mean ± SEM. n = 34 per group. *p < 0.05 
3.4.4 DNA Methylation at IGF2/H19 
3.4.4.1 IGF2 DMR2 
Percentage methylation in term infants at birth at DMR2 was 38.5 ± 0.8% and at 1 
year was 40.3 ± 1.3%. The mean difference, -1.9 95%CI [-5.2, 1.4], was not 
significant t = -1.3, p = 0.24 (14 paired values). 
Percentage methylation in preterm infants at birth was 28.3 ± 1.7%. This was 
markedly lower than in term infants at birth, mean difference = -10.2, 95% CI [-13.9, 
-6.5], p < 0.001. This remained significant in adjusted analysis, β = -11.5, 95%CI [-
15.3, -7.7], p < 0.001. Social deprivation was an independent contributor towards 
reducing 5mC, β = -1.7, 95%CI [-2.9, -0.5], p = 0.006. None of the other covariates 
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Percentage methylation in preterm infants at term corrected age was 36.6 ± 0.5%. 
This was significantly lower than in term infants at birth, mean difference = -2.2, 
95%CI [-4.2, -0.2], p = 0.03. This remained significant in adjusted analysis, β = -2.8, 
95%CI [-5.1, -0.6], p = 0.01. The significance was abolished when social deprivation 
was added into the model, β = -2.2, 95%CI [-4.3, 0.03], p = 0.053. Again, social 
deprivation appeared to be an independent contributor towards reducing methylation, 
β = -0.9, 95%CI [-1.6, -0.2], p = 0.02. None of the other covariates were significant 
contributors individually. The regression coefficients for all covariates are shown in 
Table 3.4.  
      Predictors β [95% CI] t p 
          
Model 1 Prematurity -2.2 [-4.2, -0.2] -2.2 0.03 
          
Model 2 Prematurity -2.8 [-5.1, -0.6] -2.6 0.01 
  Male 2.0 [-0.1, 4.1] 1.9 0.07 
  Maternal smoking 0.1 [-1.0, 1.2] 0.1 0.90 
  Labour 0.2 [-1.8, 2.2] 0.2 0.83 
          
Model 3 Prematurity -2.2 [-4.3, 0.03] -2.0 0.05 
  Male 1.8 [-0.2, 3.8] 1.8 0.08 
  Maternal smoking 0.02 [-1.0, 1.0] 0.03 0.97 
  Labour 0.4 [-1.5, 2.4] 0.4 0.66 
  Social deprivation -0.9 [-1.6, -0.2] -2.5 0.02 
 
        
R2 = 0.1 for model 2 (p = 0.33) and R2 = 0.2 for model 3 (p = 0.02) 
Table 3.4 Multiple regression models for predictors of percentage methylation 
at IGF2 DMR2 in preterm infants at term corrected age and term infants at 
birth 
The difference in methylation between preterm infants at birth and at term corrected 
age, -7.4, 95%CI [-12.5, -2.2], was significant t = -3.1, p = 0.01. However, the paired 
values available for analysis was small, n = 12.  
At 1 year, percentage methylation in the preterm infants was 38.4 ± 0.7% and this 
was not significantly different from term infants, mean difference = -0.3, 95%CI [-
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4.0, 3.3], p = 0.86. The effect of socioeconomic deprivation to reduce methylation 
approached significance, β = -0.9, 95%CI [-1.9, 0.1], p = 0.07. None of the other 
covariates were significant contributors individually. 
The difference in mean methylation between preterm at term age and preterm at 1 
year, -1.7, 95%CI [-3.8, 0.4], was not significant t = -1.7, p = 0.1 (21 paired values).  
 
Figure 3.6 Percentage methylation at IGF2 DMR2 in term and preterm infants 
Scatter plot with mean ± SEM. Term infants:  n = 25 at birth and 23 at 1 year. 
Preterm infants: n = 22 at birth, 32 at term corrected and 28 at 1 year. *p < 0.05 **p 
< 0.001 
 
In univariate analyses, there was no relationship between percentage methylation at 
IGF2 DMR2 and weight SD score at birth, R = 0.01, p = 0.98 or at 1 year, R = -0.08, 
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In the preterm infants, birth weight SD score correlated strongly with percentage 
methylation at IGF2 DMR2 at birth, R = 0.71, p = 0. There was no relationship 
between percentage methylation at this region and weight SD score at term corrected 
age, R = 0.01, p = 0.96, or at 1 year, R = -0.06, p = 0.75.  
 
There was no relationship between percentage body fat and percentage methylation 
in term infants at birth, R = 0.02, p = 0.94, or in preterm infants at term corrected 
age, R = -0.17, p = 0.51.  
 
The number of antenatal steroids in the preterm infants did not relate to percentage 
methylation at birth, Spearman’s rho = -0.35, p = 0.11. The number of days of 
parenteral nutrition did not relate to percentage methylation at term corrected age, R 
= -0.19, p =0.15. 
 
3.4.4.2 H19 ICR 
Percentage methylation at the H19 ICR in the term infants at birth was 49.2 ± 0.8% 
and was lower by 1 year, 45.4 ± 0.5%. The mean difference, 3.9%, 95%CI [1.4, 6.4] 
was significant, t = 3.3, p = 0.004 (22 paired values).  
Percentage methylation at the H19 ICR in the preterm infants at birth was 48.1 ± 
0.7%. The difference between term infants at birth, mean difference = -1.0, 95%CI [-
3.2, 1.2], was not significant, p = 0.35. This remained non-significant in adjusted 
analysis, β = -1.3, 95%CI [-3.9, 1.2], p = 0.3. None of the covariates were significant 
contributors individually.  
At term corrected age, percentage methylation in the preterm infants was 46.8 ± 
0.5% and the difference with term infants at birth was significant, mean difference = 
-2.4, 95%CI [-4.4, -0.4], p = 0.02. This remained significant in adjusted analysis, β = 
-2.3, 95%CI [-4.6, -0.02], p = 0.048. None of the covariates were significant 
contributors individually. The difference in methylation between preterm infants at 
birth and at term corrected age, 1.9, 95%CI [-0.2, 4.0], was not significant t = 2.0, p 
= 0.07. However, the paired values available for analysis was small, n = 13.  
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At 1 year, percentage methylation in the preterm infants was 46.0 ± 0.6%. There was 
no significant difference with term infants at 1 year, mean difference = 0.6, 95%CI [-
1.0, 2.3], p = 0.47. This remained non-significant in adjusted analysis, β = 0.8, 
95%CI [-1.5, 3.0], p = 0.50. None of the covariates were significant contributors 
individually.  
There was no significant reduction in percentage methylation observed in preterm 
infants at 1 year compared with at birth (mean difference = 2.6, 95%CI [-0.4, 5.7], t 
= 1.9, p = 0.09, (12 paired values)) or term corrected age (mean difference = 0.4, 
95%CI [-1.4, 2.3], t = 0.5, p = 0.65, (20 paired values)). 
 
Figure 3.7 Percentage methylation at H19 ICR in term and preterm infants 
Scatter plot with mean ± SEM. Term infants: at birth, n = 28 at birth, 31 at 1 year. 
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In univariate analyses, there was no relationship between percentage methylation at 
H19 ICR and weight SD score at birth, R = - 0.15, p = 0.44 or at 1 year, R = 0.2, p = 
0.28 in the term infants. 
 
In the preterm infants, there was no relationship between percentage methylation at 
this region and weight SD score at birth, R = 0.18, p = 0.41, term corrected age, R = 
0.18, p = 0.37, or at 1 year, R = 0.27, p = 0.14.  
 
There was no relationship between percentage body fat and percentage methylation 
in term infants at birth, R = -0.22, p = 0.29, or in preterm infants at term corrected 
age, R = -0.16, p = 0.62.  
 
The number of antenatal steroids in the preterm infants did not relate to percentage 
methylation at birth, Spearman’s rho = -0.23, p = 0.29. The number of days of 
parenteral nutrition did not relate to percentage methylation at term corrected age, R 
= -0.01, p =0.95. 
 
3.5 Discussion 
In this study I established a cohort of preterm and term infants, obtained longitudinal 
data on anthropometry, measured salivary cortisol and related this to DNA 
methylation at IGF2/H19. 
The preterm infants in this cohort were lighter at birth than the average preterm 
infant. This is over and above the fact that the reference SD scores are based on 
delivered preterm infants who are smaller than the healthy fetus at the same gestation 
(Bukowski et al., 2001) (Lackman et al., 2001). By term corrected age, preterm 
infants showed a downward deviation in weight SD score and were smaller than term 
infants. This pattern of growth during neonatal care is not dissimilar to that recently 
described for a population of infants born < 32 weeks gestation in the UK where 
following a drop in weight percentile, a steady state of growth is achieved, between 
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the 0.4th and 9th percentiles (Cole et al., 2014), albeit lower than in my cohort (mean 
weight percentile at term corrected age was 17.6  ± 3.3).  
Additionally, at term corrected age, the preterm infants showed asymmetry with 
relative sparing of head growth. Growth restriction during the third trimester occurs 
as a result of factors such as placental insufficiency or maternal illness and there is a 
relative sparing of head growth (Kramer et al., 1989). Data suggests that this pattern 
of growth tends to persist in the neonatal unit, with spared head growth (Cockerill et 
al., 2006) resulting in asymmetric growth restriction at term corrected age (Uthaya et 
al., 2005). The data suggest that the preterm infants did not follow the expected fetal 
growth pattern, however it is not known which growth pattern in the neonatal period 
is ideal in the long-term with respect to metabolic health and intact 
neurodevelopmental health.  
Following discharge from hospital and until 1 year, the preterm infants remained, on 
the whole, smaller than their full-term counterparts. However, the differences 
observed later in infancy were mainly as the term infants were larger than the 
reference mean. Although this gives the suggestion of catch-up growth, there was no 
statistically significant difference in rate of gain in body weight to support the 
contention that catch-up growth occurred in infancy. The infants may yet go on to do 
so in childhood and adolescence as described (Hack et al., 2003) which has been 
linked to later metabolic sequelae (Rotteveel et al., 2008) (Fewtrell et al., 2000). 
Nevertheless, the pattern of growth in infancy in this preterm cohort is typical of 
what has been published (Hack et al., 2003) (Roze et al., 2012). However, there are 
known to be sex differences in the pattern of growth in preterm infants: VLBW 
females show a greater increase in z-score (SD score) than males during infancy and 
also childhood (Hack et al., 2003). As the majority of my cohort was male, this may 
be another reason why I did not see increased growth velocity in my study. 
Preterm infants had increased percentage fat mass as measured by PEAPOD at term 
corrected age but there was no persisting difference at 3 months; this is in keeping 
with previous independent studies using the same device (Roggero et al., 2009) 
(Carberry et al., 2010) (Ramel et al., 2011) (Simon et al., 2013). The measured 
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percentage fat mass values for the preterm and term infants were within the range of 
those published in these studies. Only 21 out of 44 preterm infants had PEAPOD 
assessment due to early discharge or complications of prematurity. These issues may 
have been faced by the independent research groups as well and so the measured 
values may not be accurate of all preterm infants reaching term corrected age.  
Complications such as BPD and dependence on parenteral nutrition are the severest 
on the neonatal unit and inability to include them may underestimate percentage fat 
mass (Uthaya et al., 2005). 
The increased percentage fat mass (inferring a reduction in lean/fat-free mass as the 
preterm infants were smaller) at term corrected age probably reflects, at least in part, 
current nutritional practices during neonatal care. Due to difficulties in providing 
adequate intake to meet metabolic demands, preterm infants develop a cumulative 
protein and energy deficit that starts during the first weeks after birth (Embleton et 
al., 2001). Early growth and nutrition was shown to predict fat-free mass in preterm 
infants (Simon et al., 2014) particularly protein intake (Roggero et al., 2012) 
(Roggero et al., 2008). After term corrected age, the pattern suggests that preterm 
infants acquire relatively more fat-free mass and possibly indicates growth of various 
organs such as the brain. This increase in fat-free mass may be attributed to formula 
feeding that was predominant in the preterm cohort and this phenomenon has been 
described in a systematic review (Gale et al., 2012). Whether the use of air 
displacement plethysmography would detect changes in body composition beyond 6 
months is unknown as this is not practical using the PEAPOD device. This would be 
important to know as the highest change of fat mass in relation to body weight is in 
infancy and not limited to the first 6 months (Fomon et al., 1982). Nevertheless, air 
displacement plethysmography does not describe the distribution of body fat, for 
which MRI would be useful. Two different studies have shown that preterm infants 
at term corrected age and adults born preterm have more visceral fat and less 
subcutaneous fat compared with those born at term (Uthaya et al., 2005) (Thomas et 
al., 2011). The reduced triceps skin fold thickness at 1 year in my study could mirror 
this feature. However, we did not measure skin fold thickness earlier in life to 
corroborate this.  
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Preterm infants had lower salivary cortisol levels than term infants at 3 months. The 
measurements were all done in the afternoon at the end of the clinic visit during 
which the infants were undressed and had growth measurements performed including 
the body composition measurement using the PEAPOD. The blunted response in the 
preterm group to this activity may be attributed to suppression from antenatal 
steroids as proposed in the literature (Tegethoff et al., 2009) (Glover et al., 2005) as 
96% of preterm infants in this cohort were exposed to at least one dose of 
dexamethasone. Adding to this would be endogenous cortisol release whilst being 
exposed to stressful conditions during intensive care (Ng et al., 2011) (Glover et al., 
2005) and possibly during fetal life. The difference observed is despite that most of 
the term infants were born by elective Caesarean section which may associate with 
an altered HPA axis activity and a lower cortisol response to a stressor in early 
infancy (Taylor et al., 2000) (Miller et al., 2005). Following lower cortisol levels in 
early infancy, the trajectory is for higher levels in late infancy and toddlerhood 
(Grunau et al., 2007) and altered cortisol homeostasis may have collateral effects on 
developing organ systems that are long lasting. An altered HPA axis may persist into 
adulthood, which has been associated with a myriad of cardiovascular risk factors 
including central adiposity (Reynolds, 2013a). The low basal cortisol levels may 
have promoted the acquisition of lean mass by 3 months following reportedly high 
levels of cortisol during neonatal intensive care (Ng et al., 2011) (Glover et al., 2005) 
which is thought to promote the central adiposity at term corrected age (Uthaya et al., 
2005). It would be informative to evaluate this cohort later in childhood and 
adolescence to see whether the altered basal cortisol levels manifest into an altered 
HPA axis and whether this has bearing on body composition and precursors of 
cardiovascular or metabolic disease such as elevated BP or insulin resistance. 
Preterm infants had lower percentage DNA methylation at both H19 ICR and IGF2 
DMR2 than term infants early in life. The H19 ICR is methylated on the paternal 
allele, which prevents binding of CTCF and therefore allows the enhancers to 
promote IGF2 expression. Similarly, IGF2 DMR2 is methylated on the paternal 
allele and promotes expression of IGF2 (Figure 1.2) (Phillips & Corces, 2009) 
(Kurukuti et al., 2006). In theory, the reduced DNA methylation at H19 ICR and 
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IGF2 DMR2 in the preterm infants at term corrected age would be predicted to 
reduce IGF2 expression. This could be one explanation for the observed growth 
faltering at term corrected age and that there were no persistent differences in DNA 
methylation at 1 year when the growth parameters were not as discrepant. Should 
altered DNA methylation at IGF2 have a bearing on growth, it must be noted that the 
absolute differences in DNA methylation at term corrected age are small and may be 
overestimated as the term cohort had greater SD scores than the reference mean. On 
the other hand, there were no statistically significant relationships between weight 
SD score and DNA methylation at any time point other than with IGF2 DMR2 at 
birth in preterm infants.. This points towards IGF2 being the major prenatal growth 
factor and whilst recent research suggests that it has a role in postnatal growth 
(Begermann et al., 2015) it is not known what the relationship is between circulating 
IGF2 and DNA methylation at 1 year. The lack of difference at 1 year is similar to 
the findings of a genome wide study of methylation from blood in preterm and term 
subjects at birth and then at 18 years in which differences in DNA methylation seen 
at birth were not persistent at 18 years (Cruickshank et al., 2013). The reduction in 
methylation at the H19 ICR between birth and 1 year may be attributed to the gradual 
loss of methylation that has been described to occur with time (Fraga et al., 2005) 
(Heyn et al., 2012).  
The changes in DNA methylation at IGF2 DMR2 are particularly interesting. Results 
from a mouse study suggest that DNA methylation at this DMR is particularly 
susceptible to nutritional modification whilst methylation at the other DMRs 
regulating IGF2 allelic expression are more stable (Waterland, 2006). To support 
this, the results of a separate study of IGF2/H19 in human newborn tissues showed 
the greatest and least variation in methylation at sites corresponding to IGF2 DMR2 
and H19 ICR respectively (Ollikainen et al., 2010). Additionally, in contrast to the 
other DMRs, IGF2 DMR2 demonstrates developmental changes throughout the 
postnatal period and into adulthood with a gradual increase in DNA methylation over 
time (Waterland, 2006). We observed stark differences in DNA methylation at IGF2 
DMR2 between preterm infants at birth and term infants at birth and a lesser 
difference at term corrected age. We can postulate based on this, that methylation at 
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IGF2 DMR2 also undergoes developmental changes in humans, at least during late 
gestation. The persistent reduction in methylation at term corrected age may reflect 
the altered nutritional state of the infants born preterm, but may be overestimated due 
to the term infants being larger than expected. We did not see any relationship 
between indicators of altered nutrition such as length of dependence on parenteral 
nutrition or percentage body fat at term corrected age and DNA methylation at IGF2 
DMR2. But, simple univariate analyses may not capture any relationship, should it 
exist, between many determinants of nutritional state and DNA methylation.  
Social deprivation as quantified by DEPCAT score was an independent predictor of 
reduced methylation at IGF2 DMR2 in early life with a trend towards this at 1 year. 
Social deprivation appeared to have a greater effect than prematurity on reducing 
methylation at term corrected age than at birth. Inter-related factors such as smoking 
(Elliott et al., 2014) and malnutrition (Heijmans et al., 2008) that contribute to 
stressors associated with socio-economic deprivation can impact on DNA 
methylation. Indeed a recent study revealed a relationship between childhood 
socioeconomic status and adult DNA methylation (Borghol et al., 2012), which 
supports our findings.  
DNA methylation at IGF2 DMR2 appeared to be more susceptible to early life events 
(factors associated with social deprivation and preterm birth) than H19 ICR. The 
variation that we observed supports the notion that imprinting is established at 
primary regions (e.g. H19 ICR) during gametogenesis and these marks are generally 
maintained during development (Edwards & Ferguson-Smith, 2007). Imprinting is 
established at secondary regions (e.g. IGF2 DMR2) as a consequence of its 
establishment at primary regions following fertilisation (Edwards & Ferguson-Smith, 
2007). Hence, these secondary regions may be more vulnerable to environmental 
influences, such as stress during gestation and the postnatal period or preterm birth, 
than primary regions. This is nevertheless an observational study and causation 
cannot be assumed. Whilst groups were mixed to reduce batch effect, I was not 
blinded to study groups and bias may have been introduced.  
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We only examined DNA methylation at two DMRs (IGF2 DMR2 and H19 ICR) and 
only at a short sequence of CpG dinucleotides within these loci. Study of the 
remaining regions as well as the study of IGF2 DMR0 is desirable. This was a 
candidate gene approach and although genome wide analyses have been done in 
other studies, the sample sizes were smaller (Parets et al., 2013) (Cruickshank et al., 
2013). Further study with an unbiased method may reveal additional interesting 
findings in other loci, but this is very costly for cohort studies with average to large 
sample sizes. Twins were included in this study as they are over-represented in 
preterm populations. This poses questions as to how twins are treated in study 
designs and analyses as their measured values do not meet the assumption of 
independence due to shared genetic and environmental factors. Twins were only in 
the preterm group and we chose to analyse them individually because we were 
interested in comparing preterm infants as a group with term infants. Whilst there 
were 13 preterm infants borne out of twin pregnancy, there were only 5 complete 
twin pairs. So the impact may be small and methods to account for correlational 
nature of the measurements may fail with small samples and classical statistical 
techniques may be sufficient (Shaffer et al., 2009). However, it may be more 
important to take into account twin pairs in regression modelling involving only 
preterm infants. Measuring salivary cortisol at birth / term corrected age was not 
possible as babies at this age do not salivate enough to collect a sufficient volume 
using sorbettes (BD Visitec, Massachusetts, USA). Salimetrics latterly manufactured 
a variety of swabs for different age groups allowing larger volumes to be collected. 
However infants at 1 year are unwilling to comply (and more able to resist) in 
keeping the swab in the mouth for the required duration, particularly following 
collection of saliva using 5 sponges for DNA which was prioritised. Older children 
may comply more enabling longitudinal cortisol analysis. When gathering 
measurements and collecting samples, I was not blinded to the gestation of the infant, 
thus unconscious bias may have factored. 
Despite the limitations, this study has several strengths. This was a prospective study 
and there was far less than the 50% drop out anticipated. The measurements were 
taken by one observer the majority of the time. The PEAPOD is a validated tool for 
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estimating body composition and was calibrated prior to each use. Saliva for cortisol 
was collected at the end of the clinical examination and the follow up appointments 
at 3 months were consistently held in the afternoons for this purpose. In saliva, the 
majority of the cortisol remains unbound to protein whereas in the blood, only 1 to 
15% of cortisol is in the unbound form. It is the unbound fraction that is biologically 
active and as there is report of high correlation between serum and saliva cortisol 
levels (Vining et al., 1983), we are confident that salivary cortisol measurements 
reliably reflect HPA axis activity. 
In summary, in this cohort of preterm infants who did not achieve the reference for 
growth by the time they reached 1 year of age, with lower basal cortisol levels in 
infancy, there were evolving changes in DNA methylation. These were at key 
regions of IGF2/H19 from mid-gestation until 1 year and preterm birth associated 
with decreased DNA methylation in the early postnatal period with apparent 
normalising by 1 year. As such, DNA methylation marks at these regions are 
unlikely to afford stable biomarkers of risk. Further analysis of other key regions is 
important, as would be an unbiased analysis. Follow up of the cohort would be 
desirable, firstly, to determine whether suppression of cortisol remains; follow up at 
school age may be ideal as this may reveal subtle differences in behavior or school 
performance. Thereafter, follow up in adolescence may reveal changes to the 
epigenome that may accompany dramatic changes in growth brought on by puberty. 
In addition to comparing how DNA methylation in preterm infants may differ from 
term infants, we aimed to study DNA methylation in relation to brain development. 
This is important, given that preterm birth poses a large burden of 
neurodevelopmental adversity in terms of special educational needs (MacKay et al., 
2010) and later psychiatric illness (Nosarti et al., 2012). Achieving both maximal 
neurodevelopmental outcome and optimum metabolic status may be difficult. In the 
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Chapter 4: DNA methylation and preterm brain 
development 
IntroductionThe main neuropathology in the preterm infant comprises periventricular 
leucomalacia and neuronal/axonal disease. This accounts for the majority of the 
observed neurodevelopmental abnormalities and collectively, this is now known as 
“the encephalopathy of prematurity” (Volpe, 2009). The cognitive component is 
attributed mainly to neuronal/axonal disease (Volpe, 2009) and rather than being 
separate conditions, there is considerable clinical overlap between cognitive 
impairment and other developmental disorders such as autism (Johnson & Marlow, 
2011). Schizophrenia is at the extreme end of the spectrum of disorders characterised 
by disturbance of cognition, affect and behaviour, but is commonly studied in adults 
as a hard end point and is considered to be a disease largely of white matter (Davis et 
al., 2003).  
Conventional and advanced MRI tools have identified neonatal imaging phenotypes 
following preterm birth which include reduced cortical complexity (Woodward et al., 
2006) tissue volume reduction (Boardman et al., 2010). Additionally, microstructural 
integrity of white matter tracts can be measured using diffusion MRI (dMRI) and 
tractography (Basser et al., 2000). The resulting metric, tract based fractional 
anisotropy (FA), can also indicate the reduced connectivity of neural systems that 
occur in preterm infants (Pandit et al., 2014). In addition to changes associated with 
preterm birth, other adverse early life environmental exposures such as maternal 
exposure to famine around the time of conception have been associated with 
structural brain abnormalities (focal white matter hyper-intensity and decreased brain 
volume) and an increased risk of psychiatric disease in the offspring (Hulshoff Pol et 
al., 2000). 
Imprinted genes are recognised to play a key role in normal neurodevelopment and 
brain function (Wilkinson et al., 2007) and it has been proposed that disorders such 
as autism and schizophrenia may have their origin in alterations of the normal 
balance of imprinted gene expression (Badcock & Crespi, 2008). In particular, IGF2 
is expressed in the brain in a parent of origin specific manner, and has been shown to 
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have roles in brain function such as cognition and memory (Chen et al., 2011) and in 
synapse formation (Schmeisser et al., 2012). DNA methylation at the IGF2/H19 
locus in peripheral blood can be altered by early life stressors such as famine 
(Heijmans et al., 2008) and maternal malnutrition (Drake et al., 2012). It has been 
hypothesised that the association between DNA methylation at IGF2 and adult brain 
weight may explain the epidemiological link between psychiatric disease and brain 
abnormalities in individuals exposed to pre-natal famine (Pidsley et al., 2009). Given 
that preterm birth may be associated with altered DNA methylation at IGF2/H19, 
these alterations may be one mechanism underpinning abnormal brain development 
after preterm birth.  
4.1 Hypothesis 
DNA methylation at the IGF2/H19 locus relates to FA, a measure of microstructural 




Following ethical approval and written parental consent, preterm infants were 
recruited whilst on the neonatal unit. Demographic details and history were obtained 
from the infant and mother’s case notes and during the study visit. Characteristics are 
shown in Tables 4.1 and 4.2. 
The study sample consisted of 50 infants born at less than 1500g or less than 32 
weeks’ gestation. Exclusion criteria were: major congenital abnormality, post-
haemorrhagic ventricular dilatation or porencephalic cysts.  
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4.2.2 Laboratory methods 
Saliva for buccal DNA was collected at the time of MRI scan acquisition at term 
corrected age (mean PMA 39.8, range 37+6 to 42+4). Saliva was collected using 
Oragene DNA (OG-250) kits. DNA was extracted following the manufacturer’s 
guidance. Percentage methylation was analysed using Pyrosequencing after 
bisulphite conversion.  
4.2.3 MR Image acquisition and analysis 
A Siemens Magnetom Verio 3 T MRI clinical scanner (Siemens AG, Healthcare 
Sector, Erlangen, Germany) and 12-channel phased-array head coil were used. White 
matter tract integrity was measured by probabilistic neighbourhood tractography 
(Anblagan et al., 2015). dMRI images were pre-processed using FSL (FMRIB, 
Oxford, UK; http://www.fmrib.ox.ac.uk). FA for every infant was generated using 
“DTIFIT”. Tracts of interest (TOI) were: genu and splenium of corpus callosum, 
cingulate cingulum gyrus, corticospinal tract and inferior longitudinal fasciculus. 
Whole brain volume data were computed according to published methods (Serag et 
al., 2012).  
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Gestation at birth, weeks 29.2 (23+2 – 33+0) 
Birth weight, g 1165 (586 – 1635) 
Birth weight SDS -0.56 (-2.61-0.95) 
PMA at image acquisition, weeks 39.8 (37+6 -42+4) 
Weight SDS at image acquisition -1.35 (-3.34 – 0.36) 
OFC SDS at image acquisition 0.01 (-2.86 – 2.55) 
Male, n (%) 29 (58) 
Bronchopulmonary dysplasia, n (%) 15 (30) 
Laser for retinopathy of prematurity, n (%) 1 (2) 
Necrotising enterocolitis, n (%) 2 (4) 
Intraventricular haemorrhage, n (%) 2 (4) 
Periventricular leucomalacia, n (%) 2 (4) 
Late onset sepsis, n (%) 22 (44) 
    
Table 4.1 Characteristics of the study participants 
Values are means (range). N = 50 infants. Bronchopulmonary dysplasia is defined as 
need for respiratory support and/or supplemental oxygen at 36 weeks’ PMA to 
maintain oxygen saturations of 90% or more. Necrotising enterocolitis is defined as 
Bell stage 2 or greater. Intraventricular haemorrhage is defined as only grade III or 
IV events. The definition of late onset sepsis is taken from the Vermont Oxford 
Network Manual of Operations, release 16.3. Abbreviations: PMA – postmenstrual 
age, SDS – standard deviation score, OFC – occipito-frontal circumference 
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Age, years 30.4 (17 – 40) 
BMI, kg/m2 24.8 (18 – 36) 
DEPCAT score, mode 3 
Caucasian ethnicity, n (%) 41 (95.3) 
Smoking, n (%)   
Current 10 (23.3) 
Former 15 (34.9) 
Never 18 (41.9) 
Primiparity, n (%) 29 (67.4) 
Folic acid during first trimester, n (%) 41 (95.3) 
Assisted reproduction, n (%) 5 (11.6) 
Multiple pregnancy, n (%) 14 (32.6) 
Antenatal steroids, n (%)   
Any exposure 40 (93.0) 
Complete course 29 (67.4) 
Antenatal Magnesium sulphate, n (%) 20 (46.5) 
Caesarean section, n (%) 31 (72.1) 
    
Table 4.2 Maternal characteristics of the study participants 
Values are means (range). N = 43 mothers. A complete course of steroids was 
defined as the first dose of dexamethasone administered more than 24 hours before 
delivery. Abbreviation: DEPCAT – deprivation category. 
4.2.4 Statistics 
Since in general, neighbouring CpG sites tend to have similar levels of methylation 
(Nautiyal et al., 2010), percentage DNA methylation is expressed as the average 
across all CpG sites in the locus tested rather than at individual CpG sites and 
analysed as such.  
Pearson’s correlation coefficients were measured between percentage methylation (at 
H19 ICR and IGF2 DMR2), whole brain volume, FA at genu and splenium of corpus 
callosum, cingulate cingulum gyrus, corticospinal tract and inferior longitudinal 
fasciculus. 
In a linear regression model, whole brain volume and FA for each white matter tract 
were dependent (outcome) variables and age at image acquisition was added as an 
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independent variable. Age influences both whole brain volume and FA (Pandit et al., 
2014). The standardised regression (β) coefficients from these models indicate the 
number of standard deviations that whole brain volume / FA will change as a result 
of one standard deviation change in the other predictors. Data is expressed as mean ± 
SEM and standard deviation in brackets. Values were normally distributed. 
Statistical significance was set at 0.05 (2 tailed). Dr James Boardman performed the 
statistical analysis using SPSS v21 (SPSS Inc, Chicago, USA).  
 
4.3 Results 
Percentage methylation at the H19 ICR was 48.6 ± 0.5% (SD = 2.8) and at IGF2 
DMR2 was 38.0 ± 0.8 % (SD = 5.0). Whole brain volume was 450 ± 6.9 cc (SD = 
48.4). 
  Mean SEM SD 
    
 
  
Genu CC 0.22 0.006 0.04 
Splenium CC 0.28 0.007 0.05 
CST 0.29 0.005 0.04 
CCG 0.21 0.005 0.03 
ILF 0.22 0.005 0.03 
        
Table 4.3 FA values for the main white matter tracts 
Abbreviations: SEM – standard error of the mean, SD – standard deviation, CC – 
corpus callosum, CST – corticospinal tract, CCG – cingulum cingulate gyrus, ILF – 
inferior longitudinal fasciculi 
There was no significant correlation between percentage methylation at either site 
and whole brain volume. Nor were there any significant correlations between 
percentage at either site and FA at each of the major white matter tracts. 
For H19 ICR, age at image acquisition was a significant predictor in the model for 
FA in the genu of the corpus callosum (standardised β = 0.38, p = 0.04), 
corticospinal tract (standardised β = 0.74, p < 0.001) and the cingulum cingulate 
gyrus (standardised β = 0.54, p = 0.01). 
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For DMR2, age at image acquisition was a significant predictor in the model for 
whole brain volume (standardised β = 0.36, p = 0.046), genu of the corpus callosum 
(standardised β = 0.43, p = 0.02), corticospinal tract (standardised β = 0.72, p < 
0.001) and the cingulum cingulate gyrus (standardised β = 0.56, p = 0.003). 
Percentage methylation at either locus was not significant in any model where FA 
was the dependent variable. Nor was percentage methylation at either locus a 
significant predictor of brain volume (Table 4.4). 
 
 
  r p Standardised β p 
            
H19 ICR Whole brain volume -0.10 0.58 -0.02 0.92 
  Genu CC FA 0.04 0.83 0.14 0.43 
  Splenium CC FA  -0.03 0.90 -0.01 0.95 
  CST FA  0.01 0.95 0.21 0.12 
  CCG FA -0.01 0.96 0.10 0.58 
  ILF FA -0.12 0.50 -0.05 0.79 
            
DMR2 Whole brain volume -0.04 0.84 -0.14 0.94 
  Genu CC FA  -0.18 0.34 -0.12 0.48 
  Splenium CC FA  0.29 0.11 -0.08 0.68 
  CST FA -0.09 0.63 -0.04 0.75 
  CCG FA  -0.03 0.90 0.07 0.68 
  ILF FA  -0.07 0.72 -0.11 0.52 
            
Table 4.4 Relationships between DNA methylation and regions of the preterm 
brain 
Abbreviations: CC – corpus callosum, CST – corticospinal tract, CCG – cingulum 
cingulate gyrus, ILF – inferior longitudinal fasciculi 
4.4 Discussion 
The results of this study do not support a relationship between DNA methylation at 
the IGF2/H19 locus in peripheral cells and white matter microstructure or whole 
brain volume as measured by MR.  
White matter (preterm brain) abnormality results from a combination of destructive 
processes (free radicals, ischaemia, inflammation, excitotoxicity) and maturational 
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processes (Volpe, 2009) during the antenatal and neonatal period. We postulated that 
DNA methylation at IGF2 DMR2 and H19 ICR might mediate early life stressors on 
processes such as inflammation and maturation. Microstructural integrity of white 
matter at term equivalent age was measured by dMRI and the resulting metric used, 
FA, gives a measure of axonal size, pre and true myelination, fibre density and 
coherence. Therefore, whilst it is very sensitive, it is non-specific (Nossin-Manor et 
al., 2013). Additionally, the tract averaged FA values give an indication of the 
strength of connectivity in the tracts (Pandit et al., 2014). The results in this study 
suggest that DNA methylation at IGF2/H19 may not be associated with these 
processes.  
This is important given that a tract such as the splenium of the corpus callosum is 
involved in relevant neurodevelopmental outcomes. Volume loss in the splenium of 
corpus callosum has been described in ADHD (Valera et al., 2007) and a meta-
analysis concluded that there is reduced FA in patients with schizophrenia (Patel et 
al., 2011). As a whole, the corpus callosum is smaller in individuals with autism 
(Stanfield et al., 2008) and in children born preterm, the size (Nosarti et al., 2004) 
and FA (Counsell et al., 2008) of the corpus callosum relates to measures of 
cognition.  
Data on the relationship between DNA methylation at IGF2/H19 and brain size are 
limited to a few studies in adults. DNA methylation at IGF2 DMR2 in adult 
cerebellar tissue correlated in a positive manner with total brain weight, but only in 
males (Pidsley et al., 2009). In contrast, a negative correlation between DNA 
methylation at the CTCF binding sites (H19 ICR) in cerebellar tissue and cerebellar 
weight in humans (Pidsley et al., 2012a) and mice (Pidsley et al., 2012b) was 
observed. No relationship was observed with net brain mass in either of the latter two 
studies. However, DNA methylation at H19 ICR should, in theory, block the binding 
of the zinc-finger protein CCCTC-binding factor (CTCF) and the assembly of a 
chromatin insulator. This should then allow functional communication between the 
promoter of IGF2 and the enhancers and activate IGF2 expression (Phillips & 
Corces, 2009) (Kurukuti et al., 2006). Thus, we should expect a positive relationship 
between DNA methylation at the H19 ICR and cerebellar weight. DNA methylation 
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levels at IG2/H19, particularly H19 CTCF3, is reported to be similar between 4 
different brain areas, peripheral blood and buccal cells with mean methylation of 
40% (SD < 0.01) (Pidsley et al., 2012a). The differences between studies and the 
lack of a positive relationship may reflect the presence of 5-hydroxymethylcytosine 
in the brain (Kriaucionis & Heintz, 2009) that is not accounted for during bisulphite 
conversion and Pyrosequencing (Huang et al., 2010). 
Adolescents born preterm have been demonstrated to have smaller brain volumes 
(Nosarti et al., 2002) but, this was not found to be the case at term equivalent age in a 
select group of preterm infants without major parenchymal injury cared for in a 
modern neonatal unit (Boardman et al., 2007). Our cohort may have similar relative 
preservation of brain volume. Although not specifically measured, our sample of 
infants may not have had cerebellar volume loss either. This may be relevant as 
cerebellar growth appears to be conserved in preterm infants at term equivalent age 
in the absence of supra-tentorial lesions (Srinivasan et al., 2006) and infants with 
such lesions would have been excluded from imaging in our study.  
Nevertheless, initial normal cerebellar volumes may be followed by diminished later 
growth in association with cognitive deficits in individuals born preterm (Allin et al., 
2001). The cerebellum undergoes a lengthy period of development where it is last of 
the brain structures to reach maturity (Tiemeier et al., 2010) and it is a region 
important for cognition and behaviour (Schmahmann, 2004). This is borne out 
further in clinical studies: in autism, the cerebellar vermal lobules were found to be 
reduced in size with a different developmental trajectory (Stanfield et al., 2008) and 
in ADHD (Valera et al., 2007). The developmental trajectories of the cerebellum are 
sexually dimorphic and this may be the reason males are predisposed to these 
psychiatric disorders (Tiemeier et al., 2010). Thus, future studies could interrogate 
the relationship between DNA methylation at IGF2/H19 and cerebellar structure in 
children or adolescents born preterm. 
A further region of interest would be the hippocampus given the data suggesting that 
it is vulnerable to stress. Hippocampal volume measurements by MR were reduced in 
adult subjects experiencing major psychological stress such as combat related post-
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traumatic stress disorder (Bremner et al., 1995), child abuse (Teicher et al., 2012) 
and major depression (Sheline et al., 1996). This is substantiated by experimental 
data showing reduced hippocampal neuron numbers and smaller MR based 
hippocampal volumes in primate offspring exposed to antenatal dexamethasone (Uno 
et al., 1994). Altered DNA methylation at NR3C1 in the hippocampus has been 
shown in experimental models of early life stress (Weaver et al., 2004) and human 
studies (McGowan et al., 2009) and may mediate the abnormal stress reactivity seen 
in childhood. Volume decrease in the amygdala (where glucocorticoids have further 
action) has also been noted following early life stress and associated with 
behavioural difficulties in childhood (Hanson et al., 2015). MRI techniques to 
quantify hippocampal and amygdala volumes in early life would need to be 
optimised and these measures could be studied in relation to DNA methylation at 
NR3C1. 
Prior specification of the required sample size for this study was not possible as there 
is no established method for power calculation in this type of study. Using an online 
tool, www.danielsroper.com for a post hoc power calculation using observed R2 of 
0.001 for the model with whole brain volume as dependent variable and DNA 
methylation at DMR2 as an independent variable, the power was 0.89. So, as the 
study is powered to detect a relationship, we can be confident that there is not one. 
Nevertheless, we studied a sample of very preterm infants, and it is possible that a 
sample spanning from very preterm to full term may tease out a relationship between 
MR measurements and DNA methylation. As before, twins were included in the 
study as they form a large proportion of preterm infants. Whilst there were 21 
preterm infants borne out of twin pregnancy, there were only 7 complete twin pairs. 
However, due to the possibility that both FA and percentage methylation values may 
have a correlational nature (from shared genetic and environmental factors), it may 
have been important to take into account twin pairs in regression modelling (Carlin et 
al., 2005). Including twin pairs alone may be more informative in studying epigenetic 
variation and brain structure given the high heritability of IQ and brain structure 
(Kohannim et al., 2012). Any discordance in DNA methylation in twins could be 
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attributed mostly to environmental (including the non-shared intrauterine) and 
stochastic factors whereas genetic contributions will be less (Gordon et al., 2012). 
In this study, DNA methylation in buccal cells served as a proxy for gene function in 
the brain, but this is considered to be adequate as DNA methylation profiles of 
candidate genes and methylome wide in buccal cells are reportedly similar to those in 
the brain (Pidsley et al., 2012a) (Smith et al., 2014). Whilst the findings here showed 
no relationship, it cannot be excluded that there might be changes detectable in the 
brain matter. Post-mortem samples would then be necessary with DNA methylation 
finding compared with histo-pathological measures rather than MR imaging and 
extrapolation to childhood outcomes would not be valid. Further studies could 
address genetic variation and its relation to brain structure in prematurity. It would be 
important to do so given the high heritability of IQ and identification of common 
genetic variants that modify IQ (Caspi et al., 2007) but also relate to white matter 
integrity in adults (Kohannim et al., 2012) and preterm infants (Boardman et al., 
2014). Of particular interest is the gene FK506 binding protein 5 (FKBP5) and its 
single nucleotide polymorphism (SNP) rs1360780 that predisposes to affective 
disorders (Binder et al., 2008). FKBP5 modulates the sensitivity of the 
glucocorticoid receptor and early life stress exposure in the presence of rs1360780 
leads to epigenetic change in the glucocorticoid response elements of FKBP5 
resulting in imbalance of FKBP5 and NR3C1 activity and in the long term, 
increasing the risk of psychiatric disease (Klengel et al., 2012). Additionally, the 
presence of rs1360780 is associated with reduced FA in the posterior cingulum tract, 
a recognised imaging phenotype in depression and post-traumatic stress disorder 
(Fani et al., 2014). Similarly, the early life stress associated with preterm birth may 
interact with the presence of rs1360780 to predispose to white matter injury and 
neuro-psychiatric disease. This would be interesting to study further. 
In summary, our results do not suggest that DNA methylation at IGF2/H19 locus 
modulates brain development in preterm infants as measured by MR. Further studies 
could investigate whether specifically cerebellar development in later life relates to 
DNA methylation at this locus. Ultimately, inherited traits play a major role and the 
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Chapter 5: Telomere biology in programming 
5.1 Introduction 
We sought to utilise the cohort established and described in Chapter 3 to investigate 
an additional potential marker of early life stress – telomere attrition. This has 
received much research attention recently, yet very little is known about telomere 
biology in the perinatal period or in preterm infants. 
Telomeres are strings of repetitive, non-coding DNA sequences that cap the end of 
chromosomes and preserve genomic DNA integrity. During mitosis, due to a 
limitation of the function of DNA polymerase, a short part of the telomeric DNA is 
not fully replicated leading to telomere shortening with every replication. Eventually, 
cells with enough depleted telomeres undergo senescence (Blackburn, 1991) and 
consequently, telomeres offer a marker of cellular ageing.  
The association between short telomere length and mortality (Cawthon et al., 2003) 
and age-related illnesses such as cardiovascular disease (Samani et al., 2001) 
suggests that they can be markers of biological ageing and not just chronological 
ageing (Lindsey et al., 1991). The accumulating evidence that stress affects telomere 
integrity may be a mechanism linking stress and age-related illness. Psychological 
stress in pre-menopausal women has been shown to associate with shorter telomere 
length (Epel et al., 2004). In childhood, social deprivation associated with shorter 
telomeres (Mitchell et al., 2014) and exposure to violence associated with telomere 
attrition (Shalev et al., 2012). Intra-uterine stress was shown to associate with shorter 
telomere length in the offspring as adults (Entringer et al., 2011). This suggests that 
early life adversity may alter the trajectory of telomere attrition with measurable 
differences in telomere length in later life. 
Whilst some studies suggest that adults (Entringer et al., 2011) and children (Raqib et 
al., 2007) born small have shorter telomeres, no differences in telomere length was 
observed in a large cohort of adults with low birth weight or very preterm birth 
(Kajantie et al., 2012). Of note, this was a cohort where birth status predicted a 
 
 121 
number of adult diseases and their risk factors such as hypertension, type 2 diabetes 
or impaired glucose tolerance (Kajantie et al., 2012).   
There are, however, very few studies on telomere biology in early life or in preterm 
infants. Whilst data do not indicate that fetal growth restriction associates with 
shorter telomeres at birth (Akkad et al., 2006), it appears that telomere length is 
inversely proportional to gestational age – at least when measured at a single time 
point in a range of preterm infants at birth (Friedrich et al., 2001) (Menon et al., 
2012). Serial measurements during hospital stay indicated steady shortening of 
telomeres in preterm infants compared with unborn fetuses matched for gestational 
age (Holmes et al., 2009) and although this was a very small study (total n = 13), this 
suggests premature cellular ageing in the preterm group. Mechanisms proposed for 
this include oxidative stress (Kawanishi & Oikawa, 2004) (Zglinicki, 2002) or 
inflammation (Wong et al., 2014), both of which are known to cause telomere 
erosion and are implicated in morbidity in the neonatal period in preterm infants 
(Vento et al., 2012) (Dammann & Leviton, 2000). These previous studies were, 
however limited to the perinatal period, the preterm groups did not have telomere 
length measured at term corrected age and there was no longitudinal study in infancy 
or childhood. 
As opposed to the mean telomere restriction fragment method used in the study by 
Holmes et al (Holmes et al., 2009) and Friedrich et al (Friedrich et al., 2001), the 
qPCR method (Cawthon, 2002) used by Menon et al (Menon et al., 2012) allows for 
larger numbers of samples to be analysed. Comparing telomere length measurements 
of a larger sample of preterm infants with term infants from birth over an equivalent 
time period is required to determine whether preterm infants have faster telomere 
attrition and to explore the possibility of telomere length as a marker of early life 
stress response. 
5.2 Hypothesis 
I aimed to test the hypothesis that preterm birth is associated with faster telomere 





The study sample consisted of 86 infants as described in Chapter 3: 40 infants born at 
full term and 46 born at less than 32 weeks gestation. Saliva for buccal DNA was 
collected within the first week after birth and at 1 year corrected age. For the preterm 
infants, additional saliva was collected at term corrected age.  
5.3.2 Relative telomere length assay 
Telomere length (TL) values were measured from buccal DNA using a validated 
qPCR assay that determines the relative ratio of telomere repeat (T) copy number to 
single-copy gene (S) number (T/S ratio) in experimental samples as compared with a 
reference DNA sample (Cawthon, 2002).  
Telomere primers amplify the telomere sequences. The PCR signal is a measure of 
TL, because the number of telomere primers that can bind the telomeric DNA at the 
beginning of the PCR is directly proportional to the total summed length of all the 
telomeres in the cell. T/S = 1 when the unknown DNA is identical to the reference 
DNA in its ratio of telomere repeat copy number to single copy gene copy number. 
5.3.3 Statistics 
I tested the hypothesis that preterm birth would be associated with shorter TL using a 
multivariate linear regression analysis. The outcome variables were TL at birth, term 
age and 1 year. Variables that could confound the association or be in the causal 
pathway were added into the model in a hierarchical manner. These variables 
included characteristics that have been suggested to be associated with TL in 
previous studies: gender (Benetos et al., 2014) (Entringer et al., 2014), 
socioeconomic deprivation (Drury et al., 2011), smoking (Valdes et al., 2005) and 
paternal age (Broer et al., 2013) (Njajou et al., 2007). Also included were variables 
that were grossly unequal between the groups: breast milk at 3 months and mode of 
delivery. Male gender was over-represented in the preterm group and TL for this 
group may be shorter due to male gender being associated with shorter telomeres 
(Benetos et al., 2014). The unstandardised regression (β) coefficients from these 
models indicate the number of units that the T/S ratio will change as a result of one-
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unit change in the other predictors. Paired samples student’s t test was used to 
compare the mean TL between term and preterm infants where appropriate. Mean TL 
values were normally distributed. Data are expressed as mean ± SEM. Statistical 
significance was set at p < 0.05 (2 tailed). 
5.3.4 Covariates 
Socioeconomic deprivation was coded as DEPCAT (deprivation category) score. 
DEPCAT scores are based on the mother’s postcode at booking and obtained from 
“Carstairs scores for Scottish postcode sectors from the 2001 Census” (McLoone, 
2004). The scores are from 1 to 7 where 7 indicates the worst social deprivation. 
Maternal smoking was categorised as current smoker, never smoked, former 
(stopped pre-pregnancy) or former (stopped during pregnancy). Labour was whether 
the mother experienced labour prior to delivery or not.  Breast milk at 3 months was 
whether the infant was receiving any breast milk at 3 months corrected age or not. 





5.4.1 Relative telomere length at birth and term corrected age 
The mean TL at birth was 1.24 ± 0.1 for the term infants and 1.52 ± 0.1 for the 
preterm infants. The difference in mean TL between preterm infants and term infants 
at birth, 0.31 95% CI [0.1, 0.6], was significant, p = 0.02 (Figure 5.1).   
Figure 5.1 Relative telomere length in term and preterm infants over 1 year 
Box and whisker plot: 10th to the 90th percentile with the line at median (+ indicates 
the mean). Term infants at birth (n = 34), preterm infants at birth (n = 31), preterm 
infants at term age (n = 40), term infants at 1 year (n = 32) and preterm infants at 1 




















There was a slight increase in the coefficient for preterm birth with adjustment for 
gender, social deprivation score and paternal age, β = 0.3, 95% CI [0.03, 0.6], p = 
0.03. However, with the addition of maternal smoking and thereafter mode of 
delivery to the hierarchical model, the difference was no longer significant, β = 0.3, 
95% CI [-0.04, 0.5], p = 0.09. None of the covariates (gender, social deprivation, 
paternal age, maternal smoking or labour) were significant contributors individually. 
The regression coefficients for all covariates are in Table 5.1.  
    β [95% CI] t p 
          
Model 1 Prematurity 0.3 [0.01, 0.5] 2.1 0.04 
          
Model 2 Prematurity 0.3 [0.03, 0.6] 2.2 0.03 
  Male -0.02 [-0.3, 0.3] -0.2 0.88 
  Social deprivation -0.1 [-0.2, 0.03] -1.4 0.17 
  Paternal age -0.01 [-0.03, 0.02] -0.4 0.66 
          
Model 3 Prematurity 0.3 [-0.04, 0.5] 1.7 0.09 
  Male -0.04 [-0.3, 0.2] -0.3 0.77 
  Social deprivation -0.07 [-1.7, 0.03] -1.5 0.15 
  Paternal age -0.003 [-0.02, 0.02] -0.3 0.77 
  Maternal smoking 0.2 [-0.01, 0.3] 1.8 0.07 
  Labour -0.2 [-0.4, 0.1] -1.4 0.18 
          
R2 = 0.1 for model 2 (p = 0.7) and R2 = 0.2 for model 3 (p = 0.18) 
Table 5.1 Linear model of predictors of TL in preterm infants and term infants 




There was also a significant difference between mean TL of preterm infants at term 
age and term infants at birth, mean difference = 0.5, 95% CI [0.3, 0.7], p < 0.001. 
This remained significant with adjusted analysis, β = 0.6, 95% CI [0.4, 0.8], p < 
0.001. None of the covariates were significant contributors individually. The 
regression coefficients for all covariates are in Table 5.2. There was no difference in 
mean TL between preterm infants at birth and at term corrected age, 0.2, 95% CI [-
0.1, 0.5] t = 1.6, p = 0.12. 
 
    β [95% CI] t p 
          
Model 1 Prematurity 0.5 [0.3, 0.7] 5.2 < 0.001 
          
Model 2 Prematurity 0.6 [0.4, 0.8] 5.0 <0.001 
  Male -0.1 [-0.3, 0.1] -0.8 0.4 
  Social deprivation -0.02 [-0.1, 0.1] -0.5 0.61 
  Paternal age 0.01 [-0.01, 0.03] 0.9 0.36 
  Maternal smoking -0.02 [-0.1, 0.01] -0.4 0.7 
  Labour 0.1 [-0.1, 0.3] 0.9 0.37 
          
R2 = 0.33 for model 2 (p = 0.37) 
 
Table 5.2 Linear model of predictors of TL in preterm infants at term age and 
term infants at birth  
5.4.2 Relative telomere length at 1 year 
The mean TL at 1 year was 1.4 ± 0.1 for the term infants and 1.6 ± 0.1 for the 
preterm infants. This difference was not significant, mean difference = 0.2, 95% CI 
[0.1, 0.4], p = 0.16. In a hierarchical regression model, the difference was significant 
controlling for gender, maternal smoking and social deprivation score, β = 0.3, 95% 
CI [0.1, 0.6], p = 0.02. However, the significance was lost with the addition of breast 
milk exposure at 3 months, β = 0.3, 95% CI [-0.03, 0.6], p = 0.07. Although social 
deprivation score did not predict TL at birth, this was included in the model with the 
view that this may affect TL during infancy. Maternal smoking was included as there 
was a trend towards this being a significant predictor at birth. Paternal age and mode 
of delivery were not included at 1 year. Gender was a significant predictor at 1 year 
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of age with TL being shorter in males: β = -0.3 95% CI [-0.6, -0.02], p = 0.03. None 
of the other covariates (social deprivation, maternal smoking or breast milk at 3 
months) were significant contributors individually. The regression coefficients for all 
covariates are in Table 5.3.  
 
    β [95% CI] t p 
          
Model 1 Prematurity 0.2 [-0.1, 0.4] 1.4 0.16 
          
Model 2 Prematurity 0.3 [0.1, 0.6] 2.3 0.02 
  Male -0.3 [-0.6, -0.02] -2.2 0.03 
  Maternal smoking  -0.1 [-0.2, 0.1] -1.1 0.28 
  Social deprivation -0.03 [-0.1, 0.1] -0.7 0.52 
          
Model 3 Prematurity 0.3 [-0.03, 0.6] 1.8 0.07 
  Male -0.3 [-0.5, 0.01] -1.9 0.06 
  Maternal smoking  -0.1 [-0.2, 0.1] -1.1 0.26 
  Social deprivation -0.03 [-0.1, 0.1] -0.7 0.48 
  Breast milk at 3 months -0.1 [-0.4, 0.2] -0.5 0.61 
          
R2 = 0.1 for model 2 (p = 0.13) and R2 = 0.1 for model 3 (p = 0.61) 
 
Table 5.3 Linear model of predictors of TL in term infants and preterm infants 
at 1 year  
5.4.3 Change in relative telomere length over 1 year 
For the preterm infants, the change in mean TL from term age to 1 year was 0.1, 95% 
CI [-0.1, 0.4] and this was not statistically significant, t = 1.1, p = 0.29. Similarly, 
the change in mean TL from birth to 1 year was 0.2, 95% CI [-0.2, 0.6,] and this was 
not statistically significant, t = 1.0, p = 0.34. However, in the term infants, the mean 
TL was significantly longer at 1 year than at birth: mean difference = 0.3, 95% CI 





This study describes telomere dynamics in both preterm and term infants over the 
first year of age.  
As expected, preterm infants had longer TL at birth than term infants at birth. This is 
similar to the findings of Menon et al where TL was measured by qPCR in cord 
blood in a slightly larger group of full term and preterm infants at birth (n = 35 and 
69 respectively) but without preterm premature rupture of membranes (pPROM). 
Where there was pPROM, TL was equivalent to that of the term infants, and the 
authors speculate that this may be due to oxidative senescence from the pathological 
processes leading to rupture of membranes (Menon et al., 2012). The preterm infants 
in my study were born following a variety of obstetric circumstances and therefore 
included both intact membranes and pPROM. Despite this, TL was longer in the 
preterm group. In a much smaller study (total n = 26), Friedrich et al did not 
demonstrate that the average TL was longer in preterm infants compared to term 
infants, but showed an inverse relationship between TL and gestational age in the 
preterm infants only (Friedrich et al., 2001) as did Menon et al (Menon et al., 2012). 
Though extrapolated from single measurements from each preterm infant at birth, 
this suggests that there is a steady shortening of TL during fetal life. However, the 
findings of Holmes et al, again in a very small sample (total n = 13) showed steady 
shortening of TL in the preterm infants during hospital stay and not in the serial 
measurements from fetuses matched for gestational age (Holmes et al., 2009). Based 
on this, one might expect preterm infants to have shorter or equivalent TL to full 
term infants by their expected due date, however none of these previous studies 
measured TL at this time point.  
Here lies the main strength of this study - its longitudinal design. I did not observe 
shortening of TL in the preterm group postnatally i.e. by term corrected age, TL was 
equivalent to that of the term infants. It may be regarded that preterm infants mature 
rather than ‘age’ until term corrected age. TL in preterm infants did not shorten over 
the first year. Surprisingly, TL appeared to lengthen in term infants from birth to 1 
year, so by 1 year there was no significant difference in TL between the groups. 
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These results do not suggest accelerated cellular ageing as a result of preterm birth, at 
least up to one year of age. 
Other longitudinal studies have reported telomere lengthening in some individuals 
(Shalev et al., 2012) (Epel et al., 2009) and there are a number of potential 
explanations for this. Some have argued that TL can “oscillate” when measured over 
short periods of time (months) but that it can level out over longer periods (years) 
(Svenson et al., 2011). Telomere lengthening by telomere synthesis may also be due 
to up-regulation of telomerase activity, and lifestyle, nutrition and stress are factors 
that been shown to influence telomerase activity in adults (Ornish et al., 2008) which 
may have played a role in the relatively healthy term group. Thus, in the term infants 
in my study, the measured telomere lengthening may be a marker of resilience. As a 
biomarker of disease risk, a static measure of TL may not perform as well as a 
measure over time showing either attrition or lengthening of TL. 
There are limitations of this study of which tissue type is an important consideration. 
Many of the published studies involved quantifying TL in leucocytes, however 
obtaining blood for research in children poses an ethical problem. Buccal cells, on 
the other hand, are easily accessible. Although TL should be measured in single cell 
populations as much as possible, saliva samples may not yield purely buccal cells 
and may include dead or dying cells and leucocytes; both of which could lead to 
variation in TL measurement. Similarly, peripheral blood has varying proportions of 
leucocyte subsets, and again this may lead to variation in TL measurement. Two 
previous studies have reported opposite findings regarding the correlation of TL 
between buccal cells and leucocytes (Thomas et al., 2008) (Gadalla et al., 2010) in 
adults. In another study, although TL varied within individuals across different 
tissues, the rate of attrition was similar across tissues (Daniali et al., 2013). 
Nevertheless, there is good correlation of TL between skin cells and leucocytes in 
newborns (Okuda et al., 2002). In children, studies reported negative effects of early 
life stress on buccal cell TL (Shalev et al., 2012) (Drury et al., 2011) (Mitchell et al., 
2014) and showed that a more reactive temperament was associated with shorter TL 
(Kroenke et al., 2011). These studies re-inforce the potential utility of buccal cells for 
the study of telomere length.  
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Various methods for measuring TL, specifically in preterm infants, have been 
reviewed by Turner et al (Turner et al., 2014). The gold standard method of 
measuring TL is the Southern blot analysis of the terminal restriction fragments 
(TRF) (Kimura et al., 2010). We chose to quantify relative TL using the qPCR 
method and there is a strong correlation between this and the TRF method. 
(Cawthon, 2002) The primers are designed to only detect and amplify intact 
telomeric DNA sequences (TTAGGG sequences), whereas the TRF method 
overestimates TL due to human DNA containing a variable amount of TTAGGG-like 
repeat sequences (O’Callaghan & Fenech, 2011).  Measuring the telomeric repeat 
region by qPCR can be prone to the interference of primer-dimers and 
overestimation of TL. Great care and repeated optimisation was  undertaken in this 
study to avoid this. A modification of the qPCR method with the use of an oligomer 
standard has enabled absolute TL to be calculated as opposed to relative TL 
(O'Callaghan & Fenech, 2011). Cawthon, who developed the original qPCR method, 
referred to as a singleplex assay, also described a multiplex qPCR method which is 
reported to remove the variation in T/S introduced by varying amounts of DNA 
pipetted and to reduce cost and throughput by halving the number of reactions 
needed (Cawthon, 2009). It would be desirable to repeat the measurement of TL 
using these methods. 
In summary, preterm infants had longer telomeres at birth compared to term infants 
at birth, but did not show telomere attrition suggestive of accelerated senescence. In 
contrast, telomeres lengthened in the term born infants and this may be via a different 
mechanism. It would be invaluable to measure TL and additionally telomerase levels, 
at a later time point in this cohort. Telomere attrition is reported to be the fastest in 
the first 4 years of age (Frenck et al., 1998) (Zeichner et al., 1999), hence a time 
point thereafter may reveal larger discrepancies between the groups if preterm birth 
alters the trajectory of telomere attrition in the long term. 
The studies so far have focussed on changes in DNA in preterm infants after birth, 
yet the study of the placenta can yield clues exclusively about processes during intra-
uterine life. Interruption of placental support defines preterm birth and may be the 
outcome of pathological processes in the placenta. Altered DNA methylation may be 
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implicated with consequences for developmental programming. It also provides an 
opportunity to study 5-hydroxymethylcytosine in relation to fetal programming, 
which was recently re-discovered. In the next chapter, I present data on DNA 
methylation in the placenta and its relationship to size at birth.  
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Chapter 6: The placenta and developmental 
programming 
6.1 Introduction 
The DNA modification, 5-hydroxymethylcytosine (5hmC) has been the subject of 
much research in recent years. It is a stable modification in its own right and is 
thought to be an intermediate step in DNA de-methylation (He et al., 2011). 
However the positive relationship between 5hmC at gene bodies and transcription 
suggests that 5hmC may be a useful signature of transcriptional state (Mellén et al., 
2012). Unlike in blood or buccal DNA, 5hmC is present in the mature placenta 
(Nestor et al., 2012), however 5hmC in the placenta has not been studied in the 
context of fetal programming nor as a potential regulator of placental function. The 
placenta, being the key conduit of nutrients, hormones and oxygen to the fetus (Reik 
et al., 2003), is a valuable source of information about intra-uterine life. As it is a 
temporary organ, it is highly accessible to study in sufficient quantity and therefore 
this tissue has been used to examine the relationship between gene expression and/or 
5mC and birth weight (St-Pierre et al., 2012) (Banister et al., 2011) (Guo et al., 
2008). Studies using traditional bisulfite conversion methodology would have not 
been able to technically discriminate 5mC from 5hmC (Huang et al., 2010) and 
therefore the role of the latter and less well-studied modification may have been 
underestimated. Moreover, the true abundance of 5mC may not have been accurately 
captured.  
Being rich in imprinted genes, the placenta is the site that serves the parental 
‘conflict’ theory, which suggests that imprinting evolved as a result of competition 
between the maternal and paternal genomes over provision of maternal nutrients to 
the fetus (Moore & Haig, 1991). Imprinted genes are epigenetically regulated, in 
particular by DNA methylation and are therefore popular candidates for study in the 
context of early life programming.  
Most prior studies have compared IUGR/SGA vs. AGA pregnancies, however we 
know that morbidity and mortality is graded across the normal birth weight range 
with the lightest and heaviest babies being most affected (Basso et al., 2006). 
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Gestational age also affects gene expression and DNA methylation and may have 
confounded previous results (Novakovic et al., 2011) (Kumar et al., 2012). I 
therefore set out to study gene expression, 5mC and 5hmC in term placenta in 
relation to fetal growth across the normal range of birth weight. 
6.2 Hypothesis 
I aimed to test the hypothesis that expression in the placenta of candidate imprinted 
genes that mediate fetal growth associates with size at birth. In addition, since a 
number of non-imprinted genes that are expressed in the placenta have also been 
implicated in developmental programming, I also wished to study the expression of 
candidate non-imprinted genes that mediate fetal growth in the placenta in relation to 
size at birth. 
Thereafter, I aimed to study epigenetic control mechanisms that might affect gene 
dosage using new affinity based techniques that would distinguish between 5mC and 
5hmC allowing me to study their individual relationship with birth weight. 
6.3 Methods 
6.3.1 Subjects and tissue collection 
Placental samples from 72 women with a singleton pregnancy at full term (>37 
weeks) representing a wide variation in birth weight (range 2140 – 4750g) were 
obtained from the Edinburgh Reproductive Tissue Bio-bank (ERTBB). Women gave 
written informed consent and trained staff carried out sampling according to a 
standard operating procedure. The samples were collected straight after delivery 
from the centre of the placenta away from the cord and large blood vessels but from 
the fetal side. Samples were snap frozen or processed in RNAlater Stabilising 
Reagent (Qiagen, Crawley, UK), as appropriate at the point of collection. 
Pregnancies complicated by congenital abnormalities or diabetes (pre-pregnancy or 
gestational) were excluded as these might alter fetal growth. Deliveries by Caesarean 
section predominate samples collected for the ERTBB due to ease of obtaining 
informed consent.  
 
  134 
Samples were chosen by manually reviewing the demographic records held by the 
ERTBB. Samples were chosen with the aim to form equal groups comprising infants 
who were small for gestational age (SGA), appropriate for gestational age (AGA) 
and large for gestational age (LGA). SGA is defined as birth weight less than 10th 
percentile for gender and age. AGA is defined as birth weight greater than the 10th 
percentile but less than the 90th percentile and LGA is defined as greater than the 
90th percentile for gender and age. Baseline characteristics are listed in Table 6.1 and 
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6.3.2 Laboratory methods 
Total RNA was extracted using the Qiagen RNeasy Fibrous Tissue Minikit (Qiagen, 
Crawley, UK), following the manufacturer's instructions. High quality RNA as 
assessed by the 2100 Bioanalyser system (Agilent Technologies, Cheshire, UK) was 
available for 64 samples.  
The Lightcycler 480 system (Roche, Burgess Hill, UK) was used for qPCR. A 
combination of inventoried assays (Taqman Gene Expression Assays, Applied 
Biosystems (ABI), Life Technologies, Paisley, UK), and custom made assays 
Universal Probe Library assays (UPL) (Roche, Burgess Hill, UK) and Invitrogen 
(Life Technologies, Paisley, UK) with SYBR Green I technology were used. Details 
and accession numbers are in Table 2.8. 
Of the four candidate reference genes, YWHAZ, TBP, GAPDH and SDHA, YWHAZ 
was chosen as the most stable using Normfinder (Andersen et al., 2004) and 
geNormPLUS as part of the qbasePLUS software (Eclipse v 3.7, Biogazelle, Zwijnaarde, 
Belgium). Gene expression of the imprinted genes IGF2, H19, CDKN1C, GRB10, 
PHLDA2, DLK1, PEG10 and the non-imprinted genes, GR, HSD11β2, IGF2R and 
PPARγ was quantified using qPCR.  
High quality RNA-free DNA was obtained available for 72 samples. DNA was 
sonicated to the appropriately sized fragments. Enrichment of 5mC was achieved 
using the Active Motif MethylCollector Ultra kit. Enrichment of 5hmC was achieved 
using a hydroxymethyl DNA immunoprecipitation technique. Percentage enrichment 
at the DMRs controlling the expression of IGF2 and H19: IGF2 DMR0, IGF2 
DMR2, H19 ICR, H19 gene body, H19 promoter and the DMR controlling the 
expression of CDKN1C and PHLDA2: KvDMR was analysed using qPCR.  
6.3.3 Statistics 
Weight measurements were adjusted for gender by converting to standard deviation 
scores (z-scores) and centiles using LMSgrowth, a Microsoft Excel Add-in to access 
growth references that define the UK-WHO growth charts.  
 
   137 
Values for relative gene expression and percentage enrichment were log transformed 
using natural logs to achieve a normal distribution. 
Multivariate linear regression analysis was used to test the hypothesis that birth 
weight is associated with altered gene expression, 5mC and 5hmC. Covariates that 
could confound the association or be in the causal pathway were added into the 
model. The outcome variable was birth weight SD score. The standardised regression 
(β) coefficients from these models indicate the number of standard deviations in 
relative gene expression / percentage enrichment will change as a result of one 
standard deviation change in the other predictors. Statistical significance was set at p 
< 0.05 (2 sided). 
6.3.4 Covariates 
Birth weight is a complex outcome, which is influenced by many processes: 
gestational age, maternal weight, parity, illness, ethnicity and infant sex. Maternal 
smoking was whether the mother smoked during pregnancy. Maternal BMI was 
included as it has been shown in our department that it is associated with changes in 
gene expression. Other covariates included were pre-eclampsia and parity. Almost 
all the women were Caucasian. Ethnicity can influence fetal growth, but we chose 
not to include this as a covariate. The non-Caucasian women were a mix of Asian, 
Arabic and Chinese origin and adjustment for ethnicity would require assumptions as 
to the direction of fetal growth. Furthermore, ethnicity was self-reported, thus 
unreliable, and does not necessarily reflect the ethnicity of the fetus. Paternal 
ethnicity was not held on file by the Bio-bank. 
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6.4 Results 
6.4.1 Gene expression 
    r p Standardised β Adjusted p 
            
Paternally imprinted IGF2 0.3 0.02 0.2 0.10 
  DLK1 0.1 0.64 0.03 0.84 
  PEG10 -0.2 0.21 -0.1 0.35 
  ZIM2 0.2 0.23 0.1 0.33 
            
Maternally imprinted H19 0.2 0.08 0.2 0.14 
  CDKN1C -0.3 0.01 -0.3 0.04 
  PHLDA2 0.2 0.16 0.2 0.16 
  GRB10 0 0.97 0.1 0.39 
            
Non-imprinted HSD11β2 0.2 0.17 0.2 0.20 
  GR 0.1 0.36 0 0.98 
  IGF2R 0.04 0.78 0.03 0.80 
  PPARγ 0.2 0.15 0.2 0.21 
            
Table 6.2 Relationship between birth weight SD score and relative expression of 
imprinted and non-imprinted genes  
Pearson correlation coefficient, r, for unadjusted relationship and standardised β 
values adjusting for maternal BMI, parity, pre-eclampsia and maternal smoking.  
There was a positive correlation between birth weight SD score and relative 
expression of IGF2, r = 0.3, p = 0.02, which was significant when adjusted for 
maternal BMI, parity and pre-eclapmsia, standardised β = 0.3, p = 0.04, but not when 
smoking was added into the model, standardised β = 0.2, p = 0.1 (Tables 6.2 and 
6.3). Mean relative expression of IGF2 was 0.3 ± 0.1 compared with non-smokers, 
1.7 ± 0.4. The mean difference, 1.4, 95%CI [0.6, 2.2], was significant t = 3.6, p = 
0.001. However, the number of women who smoked was small (n = 4). 
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      Predictors β [95% CI] Standardised β Adjusted p 
          
Model 1 IGF2 mRNA 0.4 [0.1, 0.8] 0.3 0.02 
          
Model 2 IGF2 mRNA 0.4 [0.02, 0.7] 0.3 0.04 
  Maternal BMI 0.02 [-0.04, 0.1] 0.1 0.56 
  Parity 0.02 [-0.5, 0.5] 0.01 0.94 
  Pre-eclampsia -2.1 [-4.3, 0.2] -0.2 0.07 
          
Model 3 IGF2 mRNA 0.3 [-0.1, 0.6] 0.2 0.10 
  Maternal BMI 0.01 [-0.1, 0.1] 0.1 0.67 
  Parity 0.2 [-0.3, 0.7] 0.1 0.41 
  Pre-eclampsia -2.2 [-4.3, -0.1] -0.2 0.04 
  Maternal smoking -2.3 [-3.9, -0.7] -0.4 0.01 
          
R2 = 0.15 for model 2 (p = 0.266) and R2 = 0.26 for model 3 (p = 0.006) 
 
Table 6.3 Linear models of predictors of birth weight SD score  
There was a negative correlation between birth weight SD score and the relative 
expression of CDKN1C, r = -0.3, p = 0.01. The relationship remained significant 
after adjustment for maternal smoking, pre-eclampsia, BMI and parity, standardised 
β = -0.3, p = 0.04. None of the other genes tested varied significantly with birth 
weight SD score. Table 6.2  
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6.4.2 5-methylcytosine (5mC) 
Percentage enrichment of 5mC at IGF2 DMR0 was independently associated with 
birth weight SD score in adjusted analyses, standardised β = 0.3, p = 0.02. 5mC at 
the H19 promoter also showed a positive relationship with birth weight SD score, r = 
0.3, p = 0.048, however it was not significant after adjustment for confounders, 
standardised β = 0.2, p = 0.06. There was a strong relationship between birth weight 
and 5mC at the KvDMR, standardised β = 0.3, p = 0.02. Percentage enrichment of 
5mC at IGF2 DMR2 and 3 regions of H19 ICR studied (H19 DMR, CTCF3 and 
CTCF6) was not significantly related to size at birth. Table 6.4 
  r p Standardised β Adjusted p 
          
IGF2 DMR0 0.4 0.002 0.3 0.02 
IGF2 DMR2 0.1 0.39 0.1 0.62 
H19 DMR 0.1 0.39 0.1 0.46 
H19 CTCF3 -0.1 0.53 -0.1 0.49 
H19 CTCF6 0.2 0.20 0.1 0.50 
H19 Promoter 0.3 0.05 0.2 0.06 
KvDMR 0.3 0.02 0.3 0.02 
          
Table 6.4 Relationship between 5mC and birth weight SD score 
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I also analysed the correlations between DNA methylation and gene expression. 
There was a trend towards a positive correlation between 5mC at IGF2 DMR0 and 
relative expression of IGF2, r = 0.3, p = 0.06. There were no significant 
relationships between gene expressions and 5mC at the other regions studied. Table 
6.5.  
    r p 
        
IGF2 mRNA IGF2 DMR0 0.3 0.06 
  IGF2 DMR2 0.2 0.20 
  H19 DMR 0.2 0.14 
  H19 CTCF3 0.1 0.59 
  H19 CTCF6 0.1 0.67 
        
H19 mRNA H19 promoter -0.2 0.12 
        
CDKN1C mRNA KvDMR 0.04 0.79 
        
Table 6.5 Relationship between gene expression and 5mC 
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6.4.3 5-hydroxymethylcytosine (5hmC) 
Percentage enrichment of 5hmC within the H19 gene body correlated with birth 
weight SD score in adjusted analyses, standardised β = 0.2, p = 0.04. Table 6.6.  
  r p Standardised β Adjusted p 
          
H19 gene body  0.3 0.02 0.2  0.04 
IGF2 DMR0 0.2 0.17 0.2  0.12 
IGF2 DMR2 0.01 0.95 -0.1  0.58 
H19 CTCF6 0.1 0.48 0.03  0.81 
H19 promoter -0.1 0.59 -0.1  0.55 
KvDMR 0.03 0.80 0.01  0.94 
          
Table 6.6 Relationship between 5hmC and birth weight SD score 
Percentage enrichment of 5hmC at the H19 gene body was taken as the average of 3 
individual regions. 
  r p Standardised β Adjusted p 
          
H19 genic 1 0.3 0.004 0.3 0.002 
H19 genic 3 0.1 0.25 0.1 0.47 
H19 genic 4 0.2 0.05 0.2 0.20 
          
Table 6.7 Relationship between 5hmC at the individual H19 genic regions and 
birth weight SD score 
There was, however, no relationship between relative expression of H19 mRNA and 
percentage 5hmC enrichment at any of the H19 genic regions or the average of these 
or at the H19 promoter. Table 6.8 
  5hmC r p 
        
H19 mRNA H19 genic average -0.1 0.44 
  H19 genic 1 -0.03 0.83 
  H19 genic 3 -0.2 0.15 
  H19 genic 4 -0.1 0.64 
  H19 promoter -0.2 0.17 
        
Table 6.8 Relationship between relative expression of H19 and 5hmC at H19 
gene body and H19 promoter 
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Despite the lack of significant association between birth weight SD score and 5hmC 
at any other region studied, Table 6.6, it was notable that 5hmC was enriched at all of 
those regions, Figure 6.2, compared with enrichment of 5mC, Figure 6.1. 5hmC is 
relatively depleted at GAPDH and this was used as the negative control. 5mC is also 
depleted at GAPDH with no detectable amplification in the qPCR reaction.  
 
Figure 6.1 Percentage enrichment of 5mC at regions of interest 
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6.5 Discussion 
My study demonstrated relationships between the expression of two imprinted genes 
at the same cluster (one maternally and the other paternally imprinted) at 11p15.5 in 
the placenta and birth weight and thereafter variation in 5mC and 5hmC at known 
regulatory loci. Few prior studies have examined both gene expression and 5mC and 
none have studied 5hmC with respect to developmental programming.  
We observed variation in expression at imprinted genes as opposed to the non-
imprinted genes with birth weight. This is probably not unexpected. Genomic 
imprinting is fundamentally controlled by DNA methylation (Li et al., 1993) and 
thus is potentially vulnerable to environmental factors during development such as 
nutrition. On the other hand, as proposed by Moore and Haig, imprinting evolved to 
balance nutrient provision to the fetus, i.e. how much an offspring receives/extracts 
from its mother at the expense of its siblings (Moore & Haig, 1991). They predicted, 
correctly, that imprinted genes would affect placental growth and fetal growth, but 
also have further-reaching influences on neonatal behaviour, metabolism and 
postnatal growth (Fowden et al., 2011) (Tycko & Morison, 2002). Not only is the 
placenta abundant with imprinted genes, but genes have been identified that are 
solely imprinted in the placenta (Court et al., 2014) (Coan et al., 2005), one notable 
example was DNA methyltransferase 1 (DNMT1) (Das et al., 2013). Interestingly, 
patterns of imprinting in placental tissue adopts a different profile to somatic tissues 
(Court et al., 2014). So, imprinted genes in the placenta could be poised to adapt 
placental function to changing environmental conditions and can offer mechanisms 
of disease programming.  
The positive relationship between the relative expression of IGF2 and birth weight 
did not persist after adjusting for maternal smoking. Although the number of women 
who smoked was small, our data suggests that maternal smoking may explain part of 
the relationship. This is in line with recent data showing that maternal smoking 
associates with reduced DNA methylation and expression of IGF2 in human fetal 
liver, with altered availability of methyl donors as a probable cause (Drake et al., 
2015).  Data from mouse models in which the lack of placental IGF2 leads to fetal 
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growth restriction and smaller placentae confirm that placental IGF2 is a potent 
growth factor (DeChiara et al., 1991) (Constância et al., 2002). However, in humans, 
similar studies to ours have yielded conflicting results. Three studies comparing gene 
expression between SGA/IUGR vs. AGA babies showed higher IGF2 expression in 
the latter group (McMinn et al., 2006) (Guo et al., 2008) (Kappil et al., 2015) and 
similarly in a fourth, however in chorionic villus samples (Moore et al., 2015). Some 
studies showed no relationship (Apostolidou et al., 2007) (Lim et al., 2012) (Turan et 
al., 2010) whilst one demonstrated raised levels of mRNA in SGA/IUGR vs AGA 
(Börzsönyi et al., 2011). In contrast to similar studies (McMinn et al., 2006) (Lim et 
al., 2012) (Apostolidou et al., 2007) (Diplas et al., 2009), we found no association 
between relative expression of PHLDA2 and birth weight. The conflicting results 
may be due different methodology (AGA vs. SGA or IUGR rather than across the 
birth weight range, candidate gene vs. genome wide approach, varying sample sizes 
or variation in sampling from the placenta) and several studies did not control for 
gestation and gender. None of the studies reporting gene expression detailed any 
objective assessment of reference genes.  
The increased enrichment of 5mC at IGF2 DMR0 with increased birth weight may 
point towards a role of IGF2 in controlling fetal growth (Murrell et al., 2008). IGF2 
DMR0 is normally methylated on the paternal allele and is reported to show 
reciprocal patterns of methylation in some cases of Beckwith Wiedemann Syndrome 
(BWS) and Silver Russell Syndrome (SRS). In BWS, which is associated with 
increased fetal growth, IGF2 DMR0 is hypermethylated on the paternal allele in cis 
with hypermethylation at the H19 ICR. The opposite is the case in SRS (Murrell et 
al., 2008), which is associated with IUGR. Additionally, we saw a trend towards a 
correlation between 5mC at IGF2 DMR0 and relative expression of IGF2. It is 
important to note that IGF2 DMR0 is reported to house the promoter for the IGF2 P0 
transcript (Monk et al., 2006). Our qPCR assay for IGF2 would have measured all 
known transcripts, including the P0 transcript. In mice, the P0 transcript is expressed 
exclusively in the labyrinthine trophoblast layer (Constância et al., 2002) where it 
regulates the placenta’s capacity for diffusional exchange and P0-null mice have 
IUGR (Sibley et al., 2004). In humans, P0 is differentially expressed in term 
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placenta, but also in fetal skeletal muscle and widely in adult tissues (Monk et al., 
2006). Therefore, it is possible that 5mC at DMR0 may alter P0 transcription and 
potentially influence metabolism in the neonate and in later in life.  
There was a strong inverse relationship between the relative expression of CDKN1C 
and birth weight. This association has been observed in one prior study of the 
placenta comparing IUGR vs AGA (McMinn et al., 2006). CDKN1C, also known as 
p57KIP2, is maternally expressed (Matsuoka et al., 1996) and encodes a cyclin 
dependent kinase inhibitor which induces cell cycle arrest (Lee et al., 1995). In mice, 
cdkn1c knockout or loss of function mutations modelled BWS with enhanced cell 
differentiation and proliferation (Zhang et al., 1997) (Tunster et al., 2011), but also 
placental overgrowth (Takahashi et al., 2000). Indeed, cdkn1c is expressed in a tissue 
specific manner with high levels in the placenta (Lee et al., 1995). As placental 
weight is a key determinant of birth weight (Roland et al., 2012), it is likely that 
CDKN1C in humans also plays a role in regulating fetal growth via its effect on 
placental development. Whilst mutations at CDKN1C occur in a small proportion of 
BWS (Hatada et al., 1996), in the majority there is loss of methylation at KvDMR, an 
intron on KCNQ1, on the maternal allele (Lee et al., 1999) (Smilinich et al., 1999) 
with associated silencing of CDKN1C (Diaz-Meyer et al., 2003). A non-coding RNA 
(KCNQ1OT1), normally expressed only from the paternal allele of KCNQ1 (Lee et 
al., 1999) (Smilinich et al., 1999), is thought to cause the bi-allelic silencing of 
CDKN1C in cis (Mancini-DiNardo, 2003) (Figure 1.2) The converse findings have 
been reported in SRS (Schönherr et al., 2007).  
In this light, it is surprising to have seen a positive correlation between 5mC at 
KvDMR and birth weight, which is in the opposite direction to that which might be 
expected. There was also no relationship between the relative expression of 
CDKN1C and 5mC at KvDMR. This may indicate that the regulation of CDKN1C is 
more complex. Indeed, data indicates that KvDMR has methylation sensitive CTCF 
binding sites, independent of the KCNQ1OT1 promoter, with chromatin insulating 
properties, and that there may also be transcriptional enhancers just upstream of the 
promoter (Fitzpatrick et al., 2007). The relative expression of this anti-sense 
transcript has not been measured in this study but may yield useful data.  
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Where there was loss of methylation at KvDMR resulting in BWS, it was found to be 
independent of loss of methylation at IGF2 (Lee et al., 1999). However, CDKNIC 
and IGF2 peptides appear to antagonise actions on cell cycle progression (Caspary et 
al., 1999) and additionally, cdkn1c expression has been shown to be affected by 
increased IGF2 protein (Grandjean et al., 2000). So, as these two regions are not 
entirely independent, one may not expect perfectly congruent results in a group of 
normal but heterogeneous pregnancies, but may show elements of both. Where 5mC 
and gene expression were compared in the several studies of the human placenta, no 
relationship between the two was seen (Table 1.3) apart from Koukoura et al 
(Koukoura et al., 2011). A relationship was observed by Lim et al but this was not in 
placenta but in the umbilical cord which is of different embryonic origin (Lim et al., 
2012). This suggests that there are alternative mechanisms and/or additional layers of 
epigenetic modifications driving changes in gene expression. Histone modifications 
influence chromatin state and accessibility to transcription factors and other gene 
regulatory proteins. DNA methylation can, in turn, influence histone modifications 
closely associated with the locus, for example stimulation of histone deacetylation by 
methyl-CpG binding proteins. Thus transcriptional state depends on a certain balance 
between the interplay of factors that activate or silence transcription. Feedback loops 
also exist between several chromatin modifications that are either mutually re-
inforcing or mutually inhibitory and direct transcriptional state (Jaenisch & Bird, 
2003). Furthermore, histone modifying enzymes utilise co-factors or substrates 
belonging to pathways of intermediary metabolism and research suggests that histone 
modifications (and thereafter, gene expression) can alter dynamically in response to 
the metabolic status of the cell (Gut & Verdin, 2013). Another modification could be 
partially methylated domains, which have been recently identified in normal 
placental tissue and known to associate with gene repression and inactive chromatin 
marks (Schroeder et al., 2013).  
5hmC has been reported to be enriched in the bodies of highly expressed genes 
(Song et al., 2011).  I was, however, not able to demonstrate a relationship between 
5hmC at any of the chosen sites and relative expression of the corresponding mRNA. 
However, the positive relationship between increasing enrichment of 5hmC in the 
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H19 gene body and birth weight that I describe suggests more complex processes are 
implicated in modulating fetal growth. The function of 5hmC appears to be 
dependent on cell type: distinct roles for 5hmC in neurons and embryonic stem (ES) 
cells have been proposed (Mellén et al., 2012). It is possible the role of 5hmC in the 
placenta is very different from these described. As the enrichment of 5hmC in the 
placenta is several fold less than in the brain or ES cells (Nestor et al., 2012), it is 
also possible that in some genomic regions and some tissue types, 5hmC is indeed a 
passive intermediate in the demethylation pathway. That we could not demonstrate a 
significant relationship between 5hmC at any of the regions studied with gene 
expression may reflect this. Unlike 5mC, whether 5hmC is maintained during mitosis 
with high fidelity is unknown (Shen & Zhang, 2013) - it may be a short-lived entity. 
Thus the pattern of enrichment we describe may be of a snap shot in time (at full 
term when the placenta is nearing the end of its life) rather than a legacy of earlier 
intra-uterine events affecting fetal growth. 
In affinity based analyses of human and mouse ES cell and neuronal genomes, in 
addition to gene bodies of actively transcribed genes, 5hmC maps at or around 
promoters, transcription start sites, CpG islands as well as inter-genic regions (cis-
regulatory elements such as enhancers and insulator binding sites) (Shen & Zhang, 
2013). Of the regions we studied, the greatest enrichment was at IGF2 DMR2 (an 
intra-genic region), the second highest was at the H19 promoter and thirdly the H19 
gene body. In addition to the H19 gene body, the presence of 5hmC at the H19 
promoter, and sites corresponding to H19 ICR (insulator-binding site) and IGF2 
DMR2 have been demonstrated by others (Nestor et al., 2012). We have confirmed 
this and shown 5hmC enrichment at further sites: IGF2 DMR0 (housing the IGF2 
promoter) and KvDMR (an intra-genic site).  Enrichment at all of these sites prohibits 
us from using a more quantitative technique, such as pyrosequencing, for further 
study because it would not distinguish between 5mC and 5hmC (Huang et al., 2010). 
The results of DNA methylation studies, past and present, of these and other popular 
targets in placental tissue need to be interpreted with this in mind. The MBD protein 
affinity assay we used is specific for 5mC - it does not detect 5hmC (Jin et al., 2010). 
Although we can be confident about the interpretation of our data, further studies 
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could utilize newer techniques including oxidative bisulphite sequencing to study 
both 5mC and 5hmC at single nucleotide resolution (Booth et al., 2012). Utilising the 
same technique for both modifications may allow better determination of the relative 
amount of 5mC to 5hmC to each other at each region. 
The immunoprecipitation technique to capture 5hmC has a higher noise to signal 
ratio than the newer chemical capture technique and thus is less specific for 5hmC 
(Thomson et al., 2013). Exemplified here is the minimal apparent detection of 5hmC, 
but not 5mC, at GAPDH where the former is far less abundant. It also required DNA 
fragments that were relatively large (approximately 1 kilobase) and thus it is not 
possible to determine the modification status of individual CpGs (Thomson et al., 
2013). Techniques such as oxidative bisulphite sequencing or TET assisted bisulphite 
sequencing (Yu et al., 2012) offer single nucleotide resolution. Both do not require 
an enrichment step before sequencing, so the final result reflects the absolute 5hmC 
at each site (Shen & Zhang, 2013). They may, in the fullness of time, become cost-
effective and further work could take advantage of this. Nevertheless, the 
immunoprecipitation technique is an acceptable method and has been shown to 
display highly reproducible patterns of 5hmC enrichment between individuals 
(Thomson et al., 2013). 
Other limitations in this study need to be considered. The placental samples from the 
SGA babies comprise those that are constitutionally small or growth restricted due to 
a variety of pathologies such as smoking or pre-eclampsia. We aimed to correct for 
this in the regression model. Limiting the study to full term pregnancies meant that 
many cases of growth restriction were excluded as these are often delivered before 
37 completed weeks. Some cases of fetal growth restriction do not result in SGA and 
may be classified as AGA. Choosing to analyse variation in 5mC, 5hmC and gene 
expression across the birth weight range as opposed to SGA vs AGA circumvents 
this problem, but does not specifically identify patterns associated with fetal growth 
restriction. Samples were not randomly chosen and I was not blinded to the size 
category of each sample when performing laboratory assays or analysing data, but 
groups were mixed to avoid batch effect.  
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Analysis of placental tissue may be confounded by contamination with maternal 
tissue and heterogenous cell lines. Placental sampling was en block and tissue was 
not washed prior to freezing, thus may have been contaminated with maternal blood. 
For the Bio-bank, sampling of chorionic villi is from the fetal surface to avoid 
contamination with maternal decidua, as recommended by Hogg et al (Hogg et al., 
2014). A preferable option would be to select chorionic villous trophoblast cells by 
immunoselection as these cells form the feto-maternal barrier, as opposed to the 
extra-villous component of which includes interstitial and endovascular trophoblast. 
DNA methylation levels are known to vary between the cellular components and 
correcting for multiple cell types is not currently feasible (Hogg et al., 2014). 
Structural abnormalities occur in placentas with fetal growth restriction as underlying 
pathological processes such as pre-eclampsia are fundamentally abnormalities of 
trophoblast invasion. Abnormalities include villus regression, volume decrease in the 
fetal and maternal blood spaces and reduction in the surface area of fetal capillaries 
(Burton, 2011). This can alter the cellular composition of samples collected and 
hence also the methylation and gene expression profiles. The shortcomings 
associated with examining placental samples as a whole would have been 
encountered in almost all prior studies to date detailed in Tables 1.1 to 1.4. DNA 
methylation and gene expression were assayed in this study in 2 different tissue 
samples and may contribute to the discrepancy we observed. Integrity of tissue 
placental tissue is also a key determinant. It has been recognised that the placenta 
degrades quickly and can interfere with RNA quality and ultimately the results of 
gene expression (Lanoix et al., 2012). Almost all the tissues collected were from 
Caesarean section deliveries since this is mostly what is available in the Bio Bank 
but this also means the samples were collected soon after delivery for snap freezing. I 
also only used RNA that was of high quality for the assays. Further, following the 
MIQE guidelines (Bustin et al., 2009), I analysed reference genes objectively. This is 
crucial for gene expression studies involving human tissue. There may be concerns 
regarding intra-placental variation in gene expression. However, a study suggests 
that there is more variation between individuals than within an individual (Turan et 
al., 2010). Nevertheless, placental sampling location was consistent to minimise 
variation, again as per Hogg et al (Hogg et al., 2014). We have observed many of the 
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recommendations for reporting DNA methylation data of the human placenta – 
gestational age and fetal sex were adjusted for using standard deviation scores, 
maternal characteristics detailed (bar alcohol consumption and medication use), β 
and percentage enrichment values were reported as well as negative findings (Hogg 
et al., 2014). 
Obtaining samples from a Bio-bank meant being restricted to information already 
gathered. By the nature of information collected at the time of delivery, it is limited 
to the details about pregnancy and the newborn at birth. There may be newborns with 
as yet undiagnosed congenital anomalies that would ordinarily not be included in this 
study. The effect of social deprivation on gene expression, 5mC and 5hmC could not 
be measured or adjusted for this as the information needed to assess this is not held 
by the ERTBB and it is not within the remit of the current ethics approval to obtain 
this information. There is a high heritability of birth weight i.e. mother’s birth weight 
is a good predictor of offspring birth weight. This information is not available to us, 
however, we did control for maternal BMI. We did not look at SNPs that may 
influence the expression of genes at these domains.  
In summary, we present further evidence that altered gene expression and DNA 
methylation (5mC) at imprinted loci could provide a link between the supply of 
nutrients, fetal growth and ultimately, programming of later disease. We further 
suggest that 5hmC may also play a role in modulating this process. Whilst there was 
no relationship with gene expression it must be noted that we are comparing single 
time point measurements of gene expression at term vs. epigenetic changes that may 
have occurred much earlier in development. Equally, as 5mC and 5hmC are 
considered to be dynamically related to each other, the enrichment patterns we 
describe could also be snap-shots within these processes. Clearly, mechanisms 
mediating gene expression other than methylation must be considered but imprinted 
genes remain popular targets for studying molecular mechanisms of programming. 
Moreover, as DMRs are established during gametogenesis and post-fertilisation, they 
point towards a non-genetic heritability of birth weight and thereby disease risk. 
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Chapter 7: Conclusion 
Following preterm birth, the neurological sequelae of sensor-motor and cognitive 
deficits in childhood are well documented (Marlow et al., 2005) (MacKay et al., 
2010) and the increased prevalence of psychiatric disorders in later life is becoming 
more apparent (Nosarti et al., 2012). Also emerging are risk factors for cardio-
metabolic disease in young adults following very preterm birth (Parkinson et al., 
2013) (Tinnion et al., 2014). The advancements in neonatal intensive care resulting 
in increased survival following very preterm birth, coupled with the increasing 
incidence of preterm birth worldwide (Blencowe et al., 2013) means we have yet to 
encounter the true extent and impact of the associated morbidity in later adulthood. 
The spectrum of morbidity and risk factors is similar to that described by Barker and 
colleagues for full term babies who were low birth weight or growth restricted in 
utero and where the phenomenon is known as ‘early life programming’ (Barker, 
1998) (Gillman, 2005). The two principal theories are fetal undernutrition (Hales & 
Barker, 2001) and overexposure to glucocorticoids (Edwards et al., 1993), which are 
not mutually exclusive. Both of them are relevant in the context of preterm birth; 
manifesting as failure to achieve the expected in utero growth trajectory after preterm 
delivery, followed up by catch-up growth, altered adiposity and altered HPA axis 
activity (Cole et al., 2014) (Hack et al., 2003) (Thomas et al., 2011) (Tegethoff et al., 
2009). Evidence is building that these features may operate in the pathogenesis of 
disease risk in preterm infants as in growth restricted term infants (Dalziel et al., 
2005b) (Rotteveel et al., 2008).  
In this thesis, by establishing a cohort of very preterm and full term infants and 
describing those phenotypic characteristics implicated in early life programming, I 
have explored specific molecular mechanisms (DNA methylation and telomere 
attrition) that may mediate these processes. I have also examined the role of DNA 
methylation in the placenta in developmental programming. 
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7.1 Growth 
The growth pattern displayed by the preterm group was similar to that described in 
the literature: downward deviation in weight standard deviation score from birth to 
term corrected age (Cole et al., 2014), with relative head sparing (Uthaya et al., 
2005) (Cockerill et al., 2006) reminiscent of fetal growth restriction (Kramer et al., 
1989). Preterm infants remained, on the whole, smaller than their full term 
counterparts over the first year (Roze et al., 2012). Whilst they did not demonstrate 
catch-up growth, as evidenced by greater velocity of weight gain than the term 
group, length was equivalent in both groups by 1 year. Moreover, catch-up growth 
has been shown to continue during childhood and adolescence (Hack et al., 2003).  
Preterm infants had greater percentage body fat at term equivalent age as measured 
by air displacement plethysmography (densitometry), which normalised (by 
acquisition of relatively more lean mass) by 3 months corrected and this pattern has 
been widely reported using this device (Roggero et al., 2009) (Carberry et al., 2010) 
(Ramel et al., 2011) (Simon et al., 2013). This probably reflects, at least in part, 
current nutritional practices during neonatal care and post-discharge (Simon et al., 
2014) (Gale et al., 2012). Whether changes in body composition beyond 6 months 
can be detected by densitometry is unknown as this is not practical using the 
PEAPOD body composition system, but the Pediatric Option accessory to the adult 
system (BODPOD) can assess children as small as 12kg, which is typically 2 years 
of age, and up to 6 years of age (http://www.cosmed.it/en/products/related-
products/options/bod-pod-pediatric-option, accessed 1 July 2015). It is likely that 
data on body composition will appear for ex-preterm children using this device.  
Aberrant adiposity at term corrected age has been attributed, at least in part, to raised 
cortisol levels (Uthaya et al., 2005). Likewise, it would be interesting to observe the 
trajectory of cortisol dynamics in childhood and later years following the low 
salivary cortisol levels measured at 3 months (possible suppression from antenatal 
glucocorticoids or from raised endogenous cortisol due to the stressors associated 
with neonatal intensive care). If an alteration in the ‘set point’ of the HPA axis is 
demonstrated, this could predispose to cardio-metabolic risk factors such as central 
adiposity (Reynolds, 2013b), but also cognitive impairment (Reynolds et al., 2010).  
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7.2 DNA methylation 
It is speculated that epigenetic processes, such as DNA methylation (5-
methylcytosine or 5mC), can transfer early environmental signals into changes in 
metabolic, endocrine, and neural regulatory pathways. These changes, in turn, may 
be responsible for distinct profiles of growth, metabolism, development and behavior 
(Jirtle & Skinner, 2007). I chose imprinted genes as candidates as they are known to 
be involved in these processes and 5mC is fundamental in the control of their 
expression (Li et al., 1993). Specifically, 5mC at DMRs controlling the expression of 
IGF2/H19 are normally distributed traits with heterogeneity following early life 
stress in humans (Heijmans et al., 2007) (Heijmans et al., 2008) (Drake et al., 2012). 
By term equivalent age, preterm infants had decreased 5mC at both IGF2 DMR2 and 
the H19 ICR  compared with term infants at birth. The changes are in the direction 
that would predict a reduction in expression of IGF2 and this could be one 
explanation for the observed growth faltering. There were no persistent differences in 
5mC at 1 year when the growth parameters were not as discrepant. Given the 
analyses were in buccal cells, reduced IGF2 expression cannot be proven and we can 
merely view this as a surrogate for what might be occuring in other organ systems. It 
is also not possible to imply causation of the failure to achieve growth potential by 
reduced 5mC in observational studies such as mine. IGF2 is regarded a key fetal 
growth factor and its functional relevance in infancy is not well known however, 
recent data suggests there is indeed a role for circulating IGF2 levels (probably from 
both hepatic and non-hepatic sources) in postnatal growth (Begermann et al., 2015).  
Certain genomic regions that acquire methylation marks during development are 
probably more susceptible to early life events than others. Exemplified here was the 
marked reduction in 5mC at IGF2 DMR2 following preterm birth. It is a secondary 
imprinted region established post-fertilisatiion whereas imprinting marks at primary 
regions (such as H19 ICR) established during gametogenesis are generally 
maintained (Edwards & Ferguson-Smith, 2007). This study also added to evidence 
that stressors associated with lower socio-economic status can impact DNA 
methylation in early life (Borghol et al., 2012), here at IGF2 DMR2. This region was 
shown to be susceptible to nutritional modifications in a mouse study (Waterland, 
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2006) and overall it points towards the neonatal period being a ‘programming 
window’.  
The optimal growth pattern for preterm infants which would be associated with a 
favourable metabolic profile along with intact neurodevelopment is not known. A 
trial of a concentrated parenteral nutrition regimen with more glucose, protein and 
lipid (Standardised, Concentrated with Added Macronutrients Parenteral nutrition 
(SCAMP trial ISRCTN76597892)) promoted head growth in the neonatal period as 
the primary outcome in very preterm infants. And measures of 2 year 
neurodevelopmental outcomes in this study is awaited (Morgan et al., 2014). But 
paradoxically, preterm infants who were breastfed without supplementation in-
hospital and post-discharge, had better head growth and neurodevelopmental 
outcome despite an initial drop in weight standard deviation score (Roze et al., 
2012). The mechanism for these processes needs to be resolved for what might be 
seen as competing outcomes. In recognition of this, we explored but did not find a 
relation between 5mC at IGF2/H19 and MR derived measures of white matter 
integrity or whole brain volume. The basis was that genomic imprinting has been 
implicated in neuropsychiatric disorders (Badcock & Crespi, 2008) which are 
regarded largely as diseases of white matter (Davis et al., 2003). Nevertheless, the 
pathway that was established for obtaining advanced magnetic resonance images of 
the preterm brain is now suitable for other mechanistic as well as therapeutic studies.  
7.3 Telomeres 
We investigated whether telomere attrition is an alternative mechanism for how early 
life stress ‘gets under the skin’ (Epel et al., 2004) and becomes a marker of increased 
disease risk. The were no differences in relative telomere length between the two 
groups by 1 year, and this was not suggestive of accelerated cellular ageing as a 
result of preterm birth, at least up until this time point. The full term infants 
demonstrated telomere lengthening over the first year, a phenomenon observed in 
other longitudinal studies (Shalev et al., 2012) (Epel et al., 2009), and this may be 
due to favourable lifestyle factors that up-regulate telomerase (Ornish et al., 2008). 
This is key considering the outpouring of work on telomeres in childhood and 
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adulthood (particularly with strong links to cardiovascular risk (Haycock et al., 
2014)) and the paucity of data regarding early life. Telomere attrition is reported to 
be the fastest in the first 4 years of age (Frenck et al., 1998) (Zeichner et al., 1999), 
hence a time point thereafter may reveal larger discrepancies between the groups if 
preterm birth alters the trajectory of telomere attrition in the long term. Choice of 
assay and tissue for measuring telomere length in this context has been reviewed 
(Turner et al., 2014) and according to this, our choice of buccal epithelial cells and 
the qPCR method are acceptable. Modifications to this method have been developed 
to enhance accuracy, reduce throughput and to quantify absolute telomere length 
enabling comparison between laboratories (Cawthon, 2009) (O'Callaghan & Fenech, 
2011) and should be considered in future. 
7.4 DNA methylation and the placenta 
Normal placentation is disrupted with preterm birth and this may be a reason for 
programmed effects – for example the lack of the placental barrier to glucocorticoids 
and the carefully controlled delivery of nutrients and growth factors. There has been 
a wealth of research studying the relationship between 5mC in the placenta and size 
at birth, but few studies have included birth weights across the full range. Several 
have included the measurement of both DNA methylation and gene expression, but 
none have investigated 5-hydroxymethylcytosine (5hmC) which has received much 
recent attention. The role of 5hmC in neurons and embryonic stem cells has been 
well studied (Mellén et al., 2012), however its role in the placenta is not known. As 
gestational age influences the methylome and gene expression (Novakovic et al., 
2011) (Kumar et al., 2012), it was necessary to restrict to full term placental samples. 
Opposite patterns of gene expression in relation to birth weight were demonstrated 
for IGF2 and CDKN1C, two oppositely imprinted genes in keeping with the ‘parental 
conflict’ hypothesis (Moore & Haig, 1991). Analysis of 5mC and 5hmC at the 
relevant regulatory regions showed associations with birth weight. Furthermore, the 
presence of 5hmC at loci commonly studied in the context of developmental 
programming in the placenta was confirmed. This was aided by the use of new 
techniques, chemical capture and immunoprecipitation, to estimate 5mC and 5hmC 
respectively and they discriminate between modifications that previous research 
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employing methods such as bisulphite conversion would not have been able to do 
(Huang et al., 2010).  
7.5 Biomarkers of risk 
Obtaining a biomarker of disease risk prior to the development of the phenotype 
would help the development and targeting of appropriate therapies. As 5mC at 
IGF2/H19 in buccal epithelia does not appear to be stable, it may not serve as a 
biomarker, however other genomic regions may have more utility, as might a 
methylome wide ‘signature’ or a composite measure of phenotype and epigenotype. 
Similarly, a static measure of telomere length may not perform as well as a measure 
over time showing either attrition or lengthening. The placenta or umbilical cord 
blood, of course, can only serve as static measures. They would be more suited to 
full term neonates, as aspects of the neonatal course (e.g. late onset infection) have a 
bearing on outcomes for preterm infants, so samples at term corrected age or later are 
more useful. It may be necessary for diagnostic purposes to identify tissue specific 
profiles for diseases in general, but in infancy and childhood, buccal epithelial cells 
seem to be the most appropriate. 
Very preterm infants are at the highest risk of long term morbidity. However late 
preterm infants are still at risk and although affected individuals are rare, late preterm 
infants are greater in number. These infants are not routinely followed up in medical 
clinics and along with very preterm infants, would greatly benefit from “precision 
medicine” by identifying biomarkers of risk early in life. This is more likely to be in 
the form of “precision prevention” with institution of educational support but also 
social support given the lower quality of life that these individuals endure into 
adulthood following on from social difficulties earlier in life (Baumann et al., 2016). 
Continued efforts should also focus on modifying behaviour such as encouraging 
physical activity and improving diet as individuals born preterm exercise less than 
their term born counterparts (Kajantie et al., 2010) despite ability to achieve normal 
exercise capacity in response to training (Clemm et al., 2012). 
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7.6 Intergenerational effects 
The transmission of an environmentally acquired phenotype to subsequent 
generations has been well described in animal studies and one mechanism may be 
heritable epigenetic changes (Radford et al., 2014). Suggestions of intergenerational 
effects have also been reported in humans following prenatal exposure to the Dutch 
famine (Painter et al., 2008). Data is emerging showing that the full term children of 
adults born preterm, like their parents, have increased central adiposity (after 
adjusting for parental BMI) (Mathai et al., 2013), abnormal ambulatory BP (Mathai 
et al., 2015) but not insulin resistance (Mathai et al., 2012). The association would be 
further compounded should the offspring be born preterm, for which there is a 
recognised family risk (Bhattacharya et al., 2010) despite reduced reproductive 
capacity (Swamy et al., 2008). This is mostly via the maternal line, but the paternal 
line contributes as well (Wilcox et al., 2008). It is likely to be a genetic trait, but 
epigenetic modification may play a role. Future studies should consider obtaining 
paternal, in addition to maternal, biological samples to investigate intergenerational 
effects of preterm birth.  
7.7 Future research 
The current cohort of preterm and term infants and the biological samples gathered 
can be utilised to address the issues raised.  
Whole blood samples (rather than serum) from this cohort at various time points in 
infancy (both cord and peripheral blood ) kept in long-term storage could be utilised 
to determine whether altered DNA methylation at IGF2 has a functional relevance by 
measuring circulating IGF2. 
Additionally, genome wide analyses would yield other loci that are altered by 
preterm birth and information about whether any changes persist during infancy and 
beyond. Of interest would be pathways pertaining to inflammation given that this is 
common to both cardiovascular disease (Libby, 2006) and preterm brain injury 
(Volpe, 2009), and that very preterm birth has inflammatory antecedents 
(Goldenberg et al., 2000). Loci that retain altered DNA methylation in buccal cells 
should be studied in other tissues already collected - cord blood, peripheral blood and 
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placenta - to understand the tissue-specific nature of DNA methylation. Comparison 
with maternal blood collected can also be informative. Given the altered HPA axis 
activity in infancy, studying 5mC at regulatory regions of NR3C1, HSD11β2 and 
CRH should be considered. 
It would be important to conduct further follow up, ideally be at school age both 
before and after puberty. Cortisol secretion can be related to subtle differences in 
behavior and school performance that may be evident in the primary years. 
Thereafter it would be interesting to observe the trajectory of cortisol secretion in 
adolescence. Body composition should be assessed at both time points as children 
born preterm have been shown to demonstrate a greater increase in BMI than term 
born children during these years (Hack et al., 2011). In this regard, exercise and 
dietary intake should be measured. Follow up will allow the opportunity to study 
telomere length in relation to those in infancy; newer techniques can be trialed and 
telomerase activity should be measured. The extent to which the epigenome is fluid 
can be gleaned by studying DNA methylation over the life course including any 
changes that accompany the dramatic changes in development during puberty. It 
would then remain to be seen whether any changes in the epigenome associate with 
emerging risk factors for cardio-metabolic disease such as insulin resistance, 
hypertension and dyslipidaemia. Study over the life-course is required to establish 
whether there is an enduring legacy of preterm birth reflected in the epigenome.  
Observational studies cannot establish causation but randomised controlled trials can 
asssist, particularly trials of nutritional interventions for this area of research. It may 
be informative to measure DNA methylation in participants in trials such as the 
SCAMP trial to investigate whether nutrition alters the methylome as it does for head 
growth. This may be an opportunity to identify genes or pathways that are implicated 
in both cardio-metabolic and neurological sequelae and point towards a common 
mechanism.  
Developing and optimising MR techniques to quantify volume of brain regions such 
as the hippocampus and amygdala in early life and relating these measures to DNA 
methylation at NR3C1 can be considered. Common genetic variants have been 
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identified that modify cognition, neuropsychiatric risk and white matter integrity 
(Caspi et al., 2007) (Kohannim et al., 2012) (Boardman et al., 2014). As genotype 
influences variation in DNA methylation (The et al., 2014), the study of gene-
environment interactions may yield further clues about individual risk or resilience to 
disease.  
With respect to the placenta, genome wide study to could identify other loci where 
hydroxymethylation may modulate fetal growth, but using newer techniques such as 
oxidative or TET assisted bisulphite sequencing that can offer single nucleotide 
resolution of hydroxymethylcytosine (Yu et al., 2012). Additionally, study of histone 
modifications or partially methylated domains have been under-explored. The study 
could be extended to compare the findings at full term with placentas from preterm 
deliveries that were collected at various gestational ages to better understand the role 
of DNA modifications during stages of human development.  
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